{
  "graph": {
    "directed": false,
    "type": "BEL-V1.0",
    "label": "Clock-2.0-Hs",
    "metadata": {
      "description": "The Clock network depicts the causal mechanisms that regulate circadian clock signaling leading to cell proliferation. The network focuses on downstream targets of the CLOCK:ARNTL transcriptional complex such as NR1D1, CRY1, PERs, and BHLHs.",
      "species_common_name": "Human",
      "version": "2.0",
      "boundary_conditions": "The human model sets represent early COPD (GOLD stage I and II) processes. If supporting literature from early COPD studies were not available, stage-independent COPD studies were used. If COPD studies were not found, we expanded our inclusion criteria to studies from healthy context and incorporated mechanisms active in processes implicated in COPD into the disease models. Literature describing processes active in acute exacerbation in COPD patients was excluded from supporting edges of the network models. We prioritized data collected from studies of lung and COPD-relevant cell types, but excluded literature related to asthma or bronchitis. Human-specific connections were preferred, but rat and mouse were also included where human data was not available."
    },
    "nodes": [
      {
        "id": "tscript(p(HGNC:MYC))",
        "label": "tscript(p(HGNC:MYC))",
        "metadata": {
          "coordinate": [
            0.5424771734815403,
            0.7348611321900137
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051421"
        }
      },
      {
        "id": "kin(p(HGNC:ATM))",
        "label": "kin(p(HGNC:ATM))",
        "metadata": {
          "coordinate": [
            0.23441842000793967,
            0.34178175747457884
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051422"
        }
      },
      {
        "id": "kin(p(HGNC:CHEK2))",
        "label": "kin(p(HGNC:CHEK2))",
        "metadata": {
          "coordinate": [
            0.08793171893608574,
            0.35202610411291546
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051423"
        }
      },
      {
        "id": "tscript(p(HGNC:E2F1))",
        "label": "tscript(p(HGNC:E2F1))",
        "metadata": {
          "coordinate": [
            0.7127828503374355,
            0.8483077857034452
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051424"
        }
      },
      {
        "id": "tscript(p(HGNC:BHLHE40))",
        "label": "tscript(p(HGNC:BHLHE40))",
        "metadata": {
          "coordinate": [
            0.9108773322747122,
            0.44422522385794505
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051425"
        }
      },
      {
        "id": "deg(p(HGNC:PER1))",
        "label": "deg(p(HGNC:PER1))",
        "metadata": {
          "coordinate": [
            0.45355299722111947,
            0.23174988617392622
          ],
          "bel_function_type": "degradation",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051426"
        }
      },
      {
        "id": "p(HGNC:PER3)",
        "label": "p(HGNC:PER3)",
        "metadata": {
          "coordinate": [
            0.7092100039698293,
            0.5121414478676583
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051427"
        }
      },
      {
        "id": "p(HGNC:CCNB1)",
        "label": "p(HGNC:CCNB1)",
        "metadata": {
          "coordinate": [
            0.16891623660182611,
            0.5132797086052512
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051428"
        }
      },
      {
        "id": "kin(p(HGNC:CHEK1))",
        "label": "kin(p(HGNC:CHEK1))",
        "metadata": {
          "coordinate": [
            0.44124652639936485,
            0.8938382152071636
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051429"
        }
      },
      {
        "id": "p(HGNC:PER2,pmod(P))",
        "label": "p(HGNC:PER2,pmod(P))",
        "metadata": {
          "coordinate": [
            0.4281460897181421,
            0.5485657914706329
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405142a"
        }
      },
      {
        "id": "tscript(p(HGNC:ARNTL))",
        "label": "tscript(p(HGNC:ARNTL))",
        "metadata": {
          "coordinate": [
            0.47102024612941645,
            0.301563211412961
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405142b"
        }
      },
      {
        "id": "kin(p(HGNC:CSNK1D))",
        "label": "kin(p(HGNC:CSNK1D))",
        "metadata": {
          "coordinate": [
            0.3622469233822946,
            0.4582637729549249
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405142c"
        }
      },
      {
        "id": "p(HGNC:CRY2,pmod(P))",
        "label": "p(HGNC:CRY2,pmod(P))",
        "metadata": {
          "coordinate": [
            0.4908693926161175,
            0.4741994232812263
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405142d"
        }
      },
      {
        "id": "kin(p(HGNC:CSNK1E))",
        "label": "kin(p(HGNC:CSNK1E))",
        "metadata": {
          "coordinate": [
            0.38209606986899564,
            0.5072089846714221
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405142e"
        }
      },
      {
        "id": "p(HGNC:ARNTL)",
        "label": "p(HGNC:ARNTL)",
        "metadata": {
          "coordinate": [
            0.6103612544660579,
            0.2514797389588708
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405142f"
        }
      },
      {
        "id": "kin(p(HGNC:WEE1))",
        "label": "kin(p(HGNC:WEE1))",
        "metadata": {
          "coordinate": [
            0.32096069868995636,
            0.35202610411291546
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051430"
        }
      },
      {
        "id": "p(EGID:5424,pmod(P,Y,15))",
        "label": "p(EGID:5424,pmod(P,Y,15))",
        "metadata": {
          "coordinate": [
            0.2888050813815006,
            0.22112611928972528
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051431"
        }
      },
      {
        "id": "p(HGNC:PER1,pmod(P,S))",
        "label": "p(HGNC:PER1,pmod(P,S))",
        "metadata": {
          "coordinate": [
            0.46268360460500196,
            0.36947943542267414
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051432"
        }
      },
      {
        "id": "p(HGNC:NR1D1)",
        "label": "p(HGNC:NR1D1)",
        "metadata": {
          "coordinate": [
            0.8104406510520048,
            0.2973895887084535
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051433"
        }
      },
      {
        "id": "p(HGNC:PER3,pmod(P))",
        "label": "p(HGNC:PER3,pmod(P))",
        "metadata": {
          "coordinate": [
            0.4904724096863835,
            0.5322507208984671
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051434"
        }
      },
      {
        "id": "p(HGNC:CSNK1D)",
        "label": "p(HGNC:CSNK1D)",
        "metadata": {
          "coordinate": [
            0.2721317983326717,
            0.4787524662315981
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051435"
        }
      },
      {
        "id": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "label": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "coordinate": [
            0.5932909884874951,
            0.045454545454545456
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051436"
        }
      },
      {
        "id": "complex(p(HGNC:CRY2),p(HGNC:PER3))",
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER3))",
        "metadata": {
          "coordinate": [
            0.8136165144898769,
            0.5072089846714221
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051437"
        }
      },
      {
        "id": "p(HGNC:CHEK2)",
        "label": "p(HGNC:CHEK2)",
        "metadata": {
          "coordinate": [
            0.045454545454545456,
            0.43473971771133707
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051438"
        }
      },
      {
        "id": "complex(p(HGNC:CDK1),p(HGNC:CCNB1))",
        "label": "complex(p(HGNC:CDK1),p(HGNC:CCNB1))",
        "metadata": {
          "coordinate": [
            0.17328304882890036,
            0.426392472302322
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051439"
        }
      },
      {
        "id": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "metadata": {
          "coordinate": [
            0.6750694720127035,
            0.4104568219760206
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405143a"
        }
      },
      {
        "id": "p(HGNC:PER2)",
        "label": "p(HGNC:PER2)",
        "metadata": {
          "coordinate": [
            0.6123461691147281,
            0.5227652147518591
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405143b"
        }
      },
      {
        "id": "kin(p(HGNC:ATR))",
        "label": "kin(p(HGNC:ATR))",
        "metadata": {
          "coordinate": [
            0.6897578404128623,
            0.9545454545454547
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405143c"
        }
      },
      {
        "id": "tscript(p(HGNC:RB1))",
        "label": "tscript(p(HGNC:RB1))",
        "metadata": {
          "coordinate": [
            0.8747518856689163,
            0.7959477917741692
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405143d"
        }
      },
      {
        "id": "complex(p(HGNC:CRY1),p(HGNC:PER3))",
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER3))",
        "metadata": {
          "coordinate": [
            0.7897975387058357,
            0.3801032023068751
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405143e"
        }
      },
      {
        "id": "p(HGNC:ATM)",
        "label": "p(HGNC:ATM)",
        "metadata": {
          "coordinate": [
            0.15780071456927353,
            0.264759447564122
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405143f"
        }
      },
      {
        "id": "complex(p(HGNC:CRY1),p(HGNC:PER2))",
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER2))",
        "metadata": {
          "coordinate": [
            0.6321953156014292,
            0.3527849446046441
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051440"
        }
      },
      {
        "id": "p(HGNC:CCNB1,pmod(P))",
        "label": "p(HGNC:CCNB1,pmod(P))",
        "metadata": {
          "coordinate": [
            0.240770146883684,
            0.5595689786006981
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051441"
        }
      },
      {
        "id": "deg(p(HGNC:PER2))",
        "label": "deg(p(HGNC:PER2))",
        "metadata": {
          "coordinate": [
            0.5031758634378721,
            0.6673243284261648
          ],
          "bel_function_type": "degradation",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051442"
        }
      },
      {
        "id": "p(HGNC:CDKN1A)",
        "label": "p(HGNC:CDKN1A)",
        "metadata": {
          "coordinate": [
            0.6619690353314808,
            0.0970556988920929
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051443"
        }
      },
      {
        "id": "tscript(p(HGNC:BHLHE41))",
        "label": "tscript(p(HGNC:BHLHE41))",
        "metadata": {
          "coordinate": [
            0.9235807860262009,
            0.26779480953103657
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051444"
        }
      },
      {
        "id": "p(HGNC:TIMELESS)",
        "label": "p(HGNC:TIMELESS)",
        "metadata": {
          "coordinate": [
            0.7465263993648273,
            0.7409318561238428
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051445"
        }
      },
      {
        "id": "complex(p(HGNC:CRY2),p(HGNC:PER2))",
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER2))",
        "metadata": {
          "coordinate": [
            0.7127828503374355,
            0.309910456821976
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051446"
        }
      },
      {
        "id": "p(HGNC:WEE1)",
        "label": "p(HGNC:WEE1)",
        "metadata": {
          "coordinate": [
            0.5996427153632394,
            0.454848990742146
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051447"
        }
      },
      {
        "id": "tscript(p(HGNC:RORA))",
        "label": "tscript(p(HGNC:RORA))",
        "metadata": {
          "coordinate": [
            0.5627233028979753,
            0.12399453634845957
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051448"
        }
      },
      {
        "id": "bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
        "label": "bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
        "metadata": {
          "coordinate": [
            0.14350932909884875,
            0.5918196994991652
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051449"
        }
      },
      {
        "id": "p(HGNC:PER1,pmod(P))",
        "label": "p(HGNC:PER1,pmod(P))",
        "metadata": {
          "coordinate": [
            0.44124652639936485,
            0.44536348459553804
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405144a"
        }
      },
      {
        "id": "p(HGNC:ATR)",
        "label": "p(HGNC:ATR)",
        "metadata": {
          "coordinate": [
            0.7810639142516872,
            0.925330095613902
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405144b"
        }
      },
      {
        "id": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS))",
        "label": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS))",
        "metadata": {
          "coordinate": [
            0.6425168717745137,
            0.6574594020336926
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405144c"
        }
      },
      {
        "id": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS))",
        "label": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS))",
        "metadata": {
          "coordinate": [
            0.8747518856689163,
            0.6100318713006526
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405144d"
        }
      },
      {
        "id": "bp(GOBP:\"cell cycle\")",
        "label": "bp(GOBP:\"cell cycle\")",
        "metadata": {
          "coordinate": [
            0.4245732433505359,
            0.6885718621945667
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405144e"
        }
      },
      {
        "id": "complex(p(HGNC:PER2),p(HGNC:TIMELESS))",
        "label": "complex(p(HGNC:PER2),p(HGNC:TIMELESS))",
        "metadata": {
          "coordinate": [
            0.6552203255260024,
            0.7454848990742146
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405144f"
        }
      },
      {
        "id": "p(HGNC:PER2,pmod(P,S))",
        "label": "p(HGNC:PER2,pmod(P,S))",
        "metadata": {
          "coordinate": [
            0.4551409289400556,
            0.6039611473668235
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051450"
        }
      },
      {
        "id": "p(HGNC:NPAS2)",
        "label": "p(HGNC:NPAS2)",
        "metadata": {
          "coordinate": [
            0.775903136165145,
            0.23250872666565486
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051451"
        }
      },
      {
        "id": "p(HGNC:CLOCK)",
        "label": "p(HGNC:CLOCK)",
        "metadata": {
          "coordinate": [
            0.5615323541087733,
            0.5087266656548793
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051452"
        }
      },
      {
        "id": "p(HGNC:CCND1)",
        "label": "p(HGNC:CCND1)",
        "metadata": {
          "coordinate": [
            0.5480349344978166,
            0.22378206101077552
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051453"
        }
      },
      {
        "id": "p(HGNC:CCNA2,pmod(P))",
        "label": "p(HGNC:CCNA2,pmod(P))",
        "metadata": {
          "coordinate": [
            0.24672489082969432,
            0.6415237517073911
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051454"
        }
      },
      {
        "id": "p(HGNC:CRY1)",
        "label": "p(HGNC:CRY1)",
        "metadata": {
          "coordinate": [
            0.5623263199682413,
            0.41918348763089996
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051455"
        }
      },
      {
        "id": "p(HGNC:E2F1)",
        "label": "p(HGNC:E2F1)",
        "metadata": {
          "coordinate": [
            0.6246526399364827,
            0.9112915465169222
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051456"
        }
      },
      {
        "id": "complex(p(HGNC:CRY1),p(HGNC:PER1))",
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER1))",
        "metadata": {
          "coordinate": [
            0.5797935688765383,
            0.30839277583851876
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051457"
        }
      },
      {
        "id": "tscript(p(HGNC:CLOCK))",
        "label": "tscript(p(HGNC:CLOCK))",
        "metadata": {
          "coordinate": [
            0.5956728860658992,
            0.5815753528608286
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051458"
        }
      },
      {
        "id": "p(EGID:5424)",
        "label": "p(EGID:5424)",
        "metadata": {
          "coordinate": [
            0.24473997618102422,
            0.27462437395659434
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051459"
        }
      },
      {
        "id": "complex(p(HGNC:PER3),p(HGNC:TIMELESS))",
        "label": "complex(p(HGNC:PER3),p(HGNC:TIMELESS))",
        "metadata": {
          "coordinate": [
            0.8290988487495038,
            0.690089543178024
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405145a"
        }
      },
      {
        "id": "complex(p(HGNC:CRY2),p(HGNC:PER1))",
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER1))",
        "metadata": {
          "coordinate": [
            0.758832870186582,
            0.45219304902109575
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405145b"
        }
      },
      {
        "id": "p(HGNC:CSNK1E)",
        "label": "p(HGNC:CSNK1E)",
        "metadata": {
          "coordinate": [
            0.33048828900357285,
            0.6157231749886174
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405145c"
        }
      },
      {
        "id": "complex(p(HGNC:PER1),p(HGNC:TIMELESS))",
        "label": "complex(p(HGNC:PER1),p(HGNC:TIMELESS))",
        "metadata": {
          "coordinate": [
            0.7334259626836046,
            0.6312794050690544
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405145d"
        }
      },
      {
        "id": "p(HGNC:MYC)",
        "label": "p(HGNC:MYC)",
        "metadata": {
          "coordinate": [
            0.7127828503374355,
            0.5622249203217484
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405145e"
        }
      },
      {
        "id": "p(HGNC:CRY2)",
        "label": "p(HGNC:CRY2)",
        "metadata": {
          "coordinate": [
            0.6913457721317984,
            0.47040522082258307
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405145f"
        }
      },
      {
        "id": "p(HGNC:CTNNB1)",
        "label": "p(HGNC:CTNNB1)",
        "metadata": {
          "coordinate": [
            0.5389043271139341,
            0.6157231749886174
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051460"
        }
      },
      {
        "id": "p(HGNC:PER1)",
        "label": "p(HGNC:PER1)",
        "metadata": {
          "coordinate": [
            0.5484319174275506,
            0.37744726058582484
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051461"
        }
      },
      {
        "id": "p(HGNC:CRY1,pmod(P))",
        "label": "p(HGNC:CRY1,pmod(P))",
        "metadata": {
          "coordinate": [
            0.3983723699880905,
            0.4115950827136136
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051462"
        }
      },
      {
        "id": "p(HGNC:RB1)",
        "label": "p(HGNC:RB1)",
        "metadata": {
          "coordinate": [
            0.9545454545454546,
            0.744726058582486
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051463"
        }
      },
      {
        "id": "kin(p(HGNC:POLD1))",
        "label": "kin(p(HGNC:POLD1))",
        "metadata": {
          "coordinate": [
            0.3610559745930925,
            0.24996205797541357
          ],
          "bel_function_type": "kinaseActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051464"
        }
      },
      {
        "id": "p(HGNC:CCNA2)",
        "label": "p(HGNC:CCNA2)",
        "metadata": {
          "coordinate": [
            0.23799126637554585,
            0.7344817119441494
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051465"
        }
      },
      {
        "id": "p(HGNC:CHEK1)",
        "label": "p(HGNC:CHEK1)",
        "metadata": {
          "coordinate": [
            0.5107185391028186,
            0.8794202458643194
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051466"
        }
      },
      {
        "id": "p(HGNC:BHLHE40)",
        "label": "p(HGNC:BHLHE40)",
        "metadata": {
          "coordinate": [
            0.8473600635172688,
            0.4199423281226286
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051467"
        }
      },
      {
        "id": "p(HGNC:ARNTL,pmod(P))",
        "label": "p(HGNC:ARNTL,pmod(P))",
        "metadata": {
          "coordinate": [
            0.407502977371973,
            0.3501290028835939
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051468"
        }
      },
      {
        "id": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "metadata": {
          "coordinate": [
            0.7179436284239777,
            0.3820003035361967
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c34051469"
        }
      },
      {
        "id": "tscript(p(HGNC:NR1D1))",
        "label": "tscript(p(HGNC:NR1D1))",
        "metadata": {
          "coordinate": [
            0.7306470821754665,
            0.1619365609348915
          ],
          "bel_function_type": "transcriptionalActivity",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405146a"
        }
      },
      {
        "id": "p(HGNC:BHLHE41)",
        "label": "p(HGNC:BHLHE41)",
        "metadata": {
          "coordinate": [
            0.8612544660579595,
            0.3303991500986493
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405146b"
        }
      },
      {
        "id": "p(HGNC:CHEK1,pmod(P,S,345))",
        "label": "p(HGNC:CHEK1,pmod(P,S,345))",
        "metadata": {
          "coordinate": [
            0.5897181421198888,
            0.8532402488996814
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405146c"
        }
      },
      {
        "id": "p(HGNC:RORA)",
        "label": "p(HGNC:RORA)",
        "metadata": {
          "coordinate": [
            0.46784438269154427,
            0.07998178782819852
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "selventa",
          "nodeId": "524b3517d3fbfd4c3405146d"
        }
      },
      {
        "id": "complex(p(HGNC:SIRT1),p(HGNC:CLOCK))",
        "label": "complex(p(HGNC:SIRT1),p(HGNC:CLOCK))",
        "metadata": {
          "coordinate": [
            0.214860629390395,
            0.175514067604912
          ],
          "bel_function_type": "complexAbundance",
          "createdBy": "edwardsanders",
          "nodeId": "52cd29b5bf21ca064415252c"
        }
      },
      {
        "id": "p(HGNC:SIRT1)",
        "label": "p(HGNC:SIRT1)",
        "metadata": {
          "coordinate": [
            0.675326702499449,
            0.37869708024836
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "edwardsanders",
          "nodeId": "52cd29b5bf21ca064415252e"
        }
      },
      {
        "id": "bp(GOBP:\"circadian behavior\")",
        "label": "bp(GOBP:\"circadian behavior\")",
        "metadata": {
          "coordinate": [
            0.39748061559977,
            0.498899119207123
          ],
          "bel_function_type": "biologicalProcess",
          "createdBy": "susana.martinez.arbas",
          "nodeId": "552d779f89e36208d4d873ab"
        }
      },
      {
        "id": "a(SCHEM:\"Smoke, cigarette\")",
        "label": "a(SCHEM:\"Smoke, cigarette\")",
        "metadata": {
          "coordinate": [
            0.350651867385326,
            0.379725557463116
          ],
          "bel_function_type": "abundance",
          "createdBy": "susana.martinez.arbas",
          "nodeId": "552d796389e36208d4d8841f"
        }
      },
      {
        "id": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "metadata": {
          "coordinate": [
            0.180506034838271,
            0.468555097686385
          ],
          "bel_function_type": "pathology",
          "createdBy": "susana.martinez.arbas",
          "nodeId": "552d7d4589e36208d4d90e0d"
        }
      },
      {
        "id": "p(HGNC:DEC1)",
        "label": "p(HGNC:DEC1)",
        "metadata": {
          "coordinate": [
            0.857172711220185,
            0.296195842929276
          ],
          "bel_function_type": "proteinAbundance",
          "createdBy": "susana.martinez.arbas",
          "nodeId": "553eb7b689e3620a80208398"
        }
      }
    ],
    "edges": [
      {
        "source": "p(HGNC:CHEK1)",
        "relation": " hasModification",
        "target": "p(HGNC:CHEK1,pmod(P,S,345))",
        "directed": false,
        "label": "p(HGNC:CHEK1)  hasModification p(HGNC:CHEK1,pmod(P,S,345))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d8",
          "evidences": [

          ]
        }
      },
      {
        "source": "tscript(p(HGNC:BHLHE40))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:MYC)",
        "directed": false,
        "label": "tscript(p(HGNC:BHLHE40)) directlyDecreases p(HGNC:MYC)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513bc",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:BHLHE40)) directlyDecreases p(HGNC:MYC)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e663"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:RORA))",
        "relation": "increases",
        "target": "p(HGNC:CDKN1A)",
        "directed": false,
        "label": "tscript(p(HGNC:RORA)) increases p(HGNC:CDKN1A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405138f",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:RORA)) increases p(HGNC:CDKN1A)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e666"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:RORA))",
        "relation": "increases",
        "target": "p(HGNC:ARNTL)",
        "directed": false,
        "label": "tscript(p(HGNC:RORA)) increases p(HGNC:ARNTL)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051390",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:RORA)) increases p(HGNC:ARNTL)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e671"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CRY2)",
        "relation": "decreases",
        "target": "p(HGNC:WEE1)",
        "directed": false,
        "label": "p(HGNC:CRY2) decreases p(HGNC:WEE1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f4",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CRY2) decreases p(HGNC:WEE1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e677"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:E2F1))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:TIMELESS)",
        "directed": false,
        "label": "tscript(p(HGNC:E2F1)) directlyIncreases p(HGNC:TIMELESS)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ae",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:E2F1)) directlyIncreases p(HGNC:TIMELESS)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e67d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER2)",
        "relation": "decreases",
        "target": "p(HGNC:MYC)",
        "directed": false,
        "label": "p(HGNC:PER2) decreases p(HGNC:MYC)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405141f",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PER2) decreases p(HGNC:MYC)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e69b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:CRY2,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:CRY2,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c8",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:CRY2,pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e69d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER2))",
        "relation": "decreases",
        "target": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER2)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d6",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:BHLHE41)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:BHLHE41)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051403",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:BHLHE41)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:PER1)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:PER1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405140e",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:PER1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CRY1)",
        "relation": "increases",
        "target": "bp(GOBP:\"cell cycle\")",
        "directed": false,
        "label": "p(HGNC:CRY1) increases bp(GOBP:\"cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051419",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CRY1) increases bp(GOBP:\"cell cycle\")",
              "summary_text": "from full text - Furthermore, Cdc2 kinase activity was reduced (Figs. 2B and 1C). Therefore, the cell cycle progression from S to M phase was impaired during liver regeneration in Cry-deficient mice",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Oct 10 302(5643) 255-9",
                "id": "12934012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCNB1)",
        "relation": " hasModification",
        "target": "p(HGNC:CCNB1,pmod(P))",
        "directed": false,
        "label": "p(HGNC:CCNB1)  hasModification p(HGNC:CCNB1,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ea",
          "evidences": [

          ]
        }
      },
      {
        "source": "tscript(p(HGNC:BHLHE40))",
        "relation": "decreases",
        "target": "p(HGNC:NR1D1)",
        "directed": false,
        "label": "tscript(p(HGNC:BHLHE40)) decreases p(HGNC:NR1D1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ba",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:BHLHE40)) decreases p(HGNC:NR1D1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:BHLHE40)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:BHLHE40)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051405",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:BHLHE40)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:PER2,pmod(P,S))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:PER2,pmod(P,S))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c7",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:PER2,pmod(P,S))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER1)",
        "relation": " hasModification",
        "target": "p(HGNC:PER1,pmod(P,S))",
        "directed": false,
        "label": "p(HGNC:PER1)  hasModification p(HGNC:PER1,pmod(P,S))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513bf",
          "evidences": [

          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:PER2)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:PER2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051404",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:PER2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e707"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER1))",
        "relation": "decreases",
        "target": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER1)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b7",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e71a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:CRY1)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:CRY1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051407",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:CRY1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e71e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:PER2,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:PER2,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c9",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:PER2,pmod(P))",
              "summary_text": "both hCKIdelta and hCKIepsilon phosphorylated and caused protein instability of human period 2 protein (hPER2)",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 159-65",
                "id": "11165242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e72b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1D))",
        "relation": "increases",
        "target": "p(HGNC:CRY2,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1D)) increases p(HGNC:CRY2,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051397",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1D)) increases p(HGNC:CRY2,pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e732"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER3))",
        "relation": "decreases",
        "target": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER3)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a4",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER3)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e735"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:ARNTL,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:ARNTL,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ca",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:ARNTL,pmod(P))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e756"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER3))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER3)",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER3)) hasComponent p(HGNC:PER3)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f7",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER3)) hasComponent p(HGNC:PER3)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e757"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CDK1),p(HGNC:CCNB1))",
        "relation": "increases",
        "target": "bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
        "directed": false,
        "label": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) increases bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405139b",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) increases bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e761"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:WEE1)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:WEE1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051415",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:WEE1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e762"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CTNNB1)",
        "relation": "decreases",
        "target": "p(HGNC:PER2)",
        "directed": false,
        "label": "p(HGNC:CTNNB1) decreases p(HGNC:PER2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d1",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CTNNB1) decreases p(HGNC:PER2)",
              "summary_text": "In colon cancer cells, HCT116 and SW480, endogenous b-catenin protein is elevated due to a mutation of b-catenin (HCT116) or APC (SW480) genes. In both cell lines, when b-catenin is down regulated by siRNA, PER2 protein levels are increased (Fig. 1). Knocking down b-catenin in these cells also decreases c-Myc protein (Fig. 1). This is consistent with the finding that c-Myc expression is activated by the b-catenin/TCF4 transcriptional factor (32).",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem 2009 Mar 145(3) 289-97",
                "id": "19106159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e777"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CTNNB1) decreases p(HGNC:PER2)",
              "summary_text": "Here we report that increased beta-catenin destabilizes PER2 clock protein",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem 2009 Mar 145(3) 289-97",
                "id": "19106159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e768"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:WEE1)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:WEE1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051408",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:WEE1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e783"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER3))",
        "relation": "decreases",
        "target": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER3)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f5",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER3)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e799"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CTNNB1)",
        "relation": "increases",
        "target": "deg(p(HGNC:PER2))",
        "directed": false,
        "label": "p(HGNC:CTNNB1) increases deg(p(HGNC:PER2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CTNNB1) increases deg(p(HGNC:PER2))",
              "summary_text": "On the other hand, co-expression of wildtype b-catenin or b-catenin S37A mutant markedly shortens PER2 protein half-life in 293T cells (Fig. 2C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem 2009 Mar 145(3) 289-97",
                "id": "19106159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e79f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:RB1))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:TIMELESS)",
        "directed": false,
        "label": "tscript(p(HGNC:RB1)) directlyDecreases p(HGNC:TIMELESS)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513aa",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:RB1)) directlyDecreases p(HGNC:TIMELESS)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:PER3),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER3)",
        "directed": false,
        "label": "complex(p(HGNC:PER3),p(HGNC:TIMELESS)) hasComponent p(HGNC:PER3)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f2",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:PER3),p(HGNC:TIMELESS)) hasComponent p(HGNC:PER3)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER1,pmod(P,S))",
        "relation": "directlyIncreases",
        "target": "deg(p(HGNC:PER1))",
        "directed": false,
        "label": "p(HGNC:PER1,pmod(P,S)) directlyIncreases deg(p(HGNC:PER1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c0",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PER1,pmod(P,S)) directlyIncreases deg(p(HGNC:PER1))",
              "summary_text": "The inhibition of hPER1 phosphorylation by CKI-7 [ N -(2-aminoethyl)-5-chloro-isoquinoline-8-sulphonamide], a CKI inhibitor, disturbed hPER1 degradation, delayed the nuclear entry of hPER1 and allowed it to persist for longer in the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 May 15 380(Pt 1) 95-103",
                "id": "14750904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CDK1),p(HGNC:CCNB1))",
        "relation": "hasComponent",
        "target": "p(EGID:5424)",
        "directed": false,
        "label": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(EGID:5424)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405139c",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(EGID:5424)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:TIMELESS)",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK1,pmod(P,S,345))",
        "directed": false,
        "label": "p(HGNC:TIMELESS) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f0",
          "evidences": [
            {
              "bel_statement": "p(HGNC:TIMELESS) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER1)",
        "relation": " hasModification",
        "target": "p(HGNC:PER1,pmod(P))",
        "directed": false,
        "label": "p(HGNC:PER1)  hasModification p(HGNC:PER1,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513cd",
          "evidences": [

          ]
        }
      },
      {
        "source": "complex(p(HGNC:PER2),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:TIMELESS)",
        "directed": false,
        "label": "complex(p(HGNC:PER2),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a8",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:PER2),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 1998 Nov 21(5) 1101-13",
                "id": "9856465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:PER2),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e78e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:CRY1,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:CRY1,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c6",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:CRY1,pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:WEE1))",
        "relation": "increases",
        "target": "p(EGID:5424,pmod(P,Y,15))",
        "directed": false,
        "label": "kin(p(HGNC:WEE1)) increases p(EGID:5424,pmod(P,Y,15))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a2",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:WEE1)) increases p(EGID:5424,pmod(P,Y,15))",
              "summary_text": "In higher eukaryotes, Cdc2 activity is in part regulated by inhibitory phosphorylation of Thr14 and Tyr15, catalyzed by Wee1 and Myt1, which prevents catastrophic premature entry into mitosis.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 1999 Oct 112 ( Pt 19) 3361-71",
                "id": "10504341"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER1))",
        "relation": "decreases",
        "target": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER1)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405141b",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e80d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER3))",
        "relation": "hasComponent",
        "target": "p(HGNC:CRY2)",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER3)) hasComponent p(HGNC:CRY2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f8",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER3)) hasComponent p(HGNC:CRY2)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e81c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:WEE1))",
        "relation": "decreases",
        "target": "complex(p(HGNC:CDK1),p(HGNC:CCNB1))",
        "directed": false,
        "label": "kin(p(HGNC:WEE1)) decreases complex(p(HGNC:CDK1),p(HGNC:CCNB1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a1",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:WEE1)) decreases complex(p(HGNC:CDK1),p(HGNC:CCNB1))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e81f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CRY1)",
        "relation": " hasModification",
        "target": "p(HGNC:CRY1,pmod(P))",
        "directed": false,
        "label": "p(HGNC:CRY1)  hasModification p(HGNC:CRY1,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ce",
          "evidences": [

          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:CRY1)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:CRY1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405140d",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:CRY1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e831"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:CRY2)",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS)) hasComponent p(HGNC:CRY2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405139f",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS)) hasComponent p(HGNC:CRY2)",
              "summary_text": "Affinity Capture-Western",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Apr 25(8) 3109-16",
                "id": "15798197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e846"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS)) hasComponent p(HGNC:CRY2)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e83a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER2)",
        "relation": " hasModification",
        "target": "p(HGNC:PER2,pmod(P,S))",
        "directed": false,
        "label": "p(HGNC:PER2)  hasModification p(HGNC:PER2,pmod(P,S))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d9",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:PER1)",
        "relation": "decreases",
        "target": "p(HGNC:CCND1)",
        "directed": false,
        "label": "p(HGNC:PER1) decreases p(HGNC:CCND1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513fd",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PER1) decreases p(HGNC:CCND1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e87e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CRY1)",
        "relation": "increases",
        "target": "p(HGNC:CCND1)",
        "directed": false,
        "label": "p(HGNC:CRY1) increases p(HGNC:CCND1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051418",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CRY1) increases p(HGNC:CCND1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e88b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1D))",
        "relation": "increases",
        "target": "p(HGNC:PER3,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1D)) increases p(HGNC:PER3,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051394",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1D)) increases p(HGNC:PER3,pmod(P))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e895"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "tscript(p(HGNC:ARNTL))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases tscript(p(HGNC:ARNTL))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c3",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases tscript(p(HGNC:ARNTL))",
              "summary_text": "overexpression of dominant-negative CKI-epsilon leads to decreased BMAL1-driven transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e89c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NR1D1))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:ARNTL)",
        "directed": false,
        "label": "tscript(p(HGNC:NR1D1)) directlyDecreases p(HGNC:ARNTL)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513de",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NR1D1)) directlyDecreases p(HGNC:ARNTL)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:CCNB1,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:CCNB1,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513cc",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:CCNB1,pmod(P))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CRY1)",
        "relation": "decreases",
        "target": "p(HGNC:WEE1)",
        "directed": false,
        "label": "p(HGNC:CRY1) decreases p(HGNC:WEE1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051417",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CRY1) decreases p(HGNC:WEE1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER3))",
        "relation": "hasComponent",
        "target": "p(HGNC:CRY1)",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER3)) hasComponent p(HGNC:CRY1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a3",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER3)) hasComponent p(HGNC:CRY1)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER3)) hasComponent p(HGNC:CRY1)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jul 23 98(2) 193-205",
                "id": "10428031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCNB1,pmod(P))",
        "relation": "increases",
        "target": "bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
        "directed": false,
        "label": "p(HGNC:CCNB1,pmod(P)) increases bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e9",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCNB1,pmod(P)) increases bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER1)",
        "relation": "increases",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "p(HGNC:PER1) increases kin(p(HGNC:ATM))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513fc",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PER1) increases kin(p(HGNC:ATM))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ARNTL)",
        "relation": " hasModification",
        "target": "p(HGNC:ARNTL,pmod(P))",
        "directed": false,
        "label": "p(HGNC:ARNTL)  hasModification p(HGNC:ARNTL,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ef",
          "evidences": [

          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER3))",
        "relation": "decreases",
        "target": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER3)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f6",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER3)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:NR1D1)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:NR1D1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405140b",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:NR1D1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "deg(p(HGNC:PER1))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:PER1)",
        "directed": false,
        "label": "deg(p(HGNC:PER1)) directlyDecreases p(HGNC:PER1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ac",
          "evidences": [
            {
              "bel_statement": "deg(p(HGNC:PER1)) directlyDecreases p(HGNC:PER1)",
              "summary_text": "Thus the SCF system provides a primary route for phosphorylation-dependent degradation of proteins.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 26863-72",
                "id": "15917222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:PER1)) directlyDecreases p(HGNC:PER1)",
              "summary_text": "The inhibition of hPER1 phosphorylation by CKI-7 [ N -(2-aminoethyl)-5-chloro-isoquinoline-8-sulphonamide], a CKI inhibitor, disturbed hPER1 degradation, delayed the nuclear entry of hPER1 and allowed it to persist for longer in the nucleus.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 May 15 380(Pt 1) 95-103",
                "id": "14750904"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e887"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:PER1)) directlyDecreases p(HGNC:PER1)",
              "summary_text": "human casein kinase Idelta (hCKIdelta), the closest homologue to hCKIepsilon, associates with and phosphorylates hPER1 and causes protein instability",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 159-65",
                "id": "11165242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e722"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:CRY2)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:CRY2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051413",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:CRY2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER1))",
        "relation": "hasComponent",
        "target": "p(HGNC:CRY1)",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:CRY1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405141d",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:CRY1)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:CRY1)",
              "summary_text": "mCRY is phosphorylated by CKIepsilon only when both proteins are bound to mammalian PERIOD proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e877"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:CRY1)",
              "summary_text": "once synthesized, Per1 and Per2 are phosphorylated by CKIepsilon and interacts with corresponding crytochromes CRY1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(4) 408-16",
                "id": "14754509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e825"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:CRY1)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:CRY1)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Oct 22 286(5440) 768-71",
                "id": "10531061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e77f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:PER1)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:PER1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051406",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:PER1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e904"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "hasComponent",
        "target": "p(HGNC:ARNTL)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051410",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "5-flanking region of the 1.3 kbp mouse PER1 (period homolog 1) gene consists of three E-boxes and a DBP-binding responsive site. 7.7-fold increase in DBP transcriptional activity was observed on cotransfection of HepG2 cells with CLOCK and BMAL1 heterodimers and only a negligible increase was detected when either CLOCK or BMAL1 was examined alone. Mutation of the upstream E-boxes abolished the transcriptional activation by 1.5-fold, while mutation of the downstream E-box resulted in 4.6-fold reduction, suggesting that CLOCK-BMAL1 act through the E-box elements. The data thus indicate that CLOCK-BMAL1 has the ability to regulate DBP transcription through E-boxes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jul 20(13) 4773-81",
                "id": "10848603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e907"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "CRY1 or CRY2 (or both) showed light-independent interactions with CLOCK and BMAL1, as well as with PER1, PER2, and TIM.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Oct 22 286(5440) 768-71",
                "id": "10531061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jan 8 96(1) 57-68",
                "id": "9989497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e784"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "the promoter regions of per and cry genes are activated by heterodimers of Clock and Bmal1 proteins",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(4) 408-16",
                "id": "14754509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e769"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "forced expression of Clock/Bmal1 and Clock/Bmal2 markedly increased Dec2 mRNA levels, and up-regulated the transcription of the Dec2 gene through the CACGTG E-boxes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Aug 15 382(Pt 1) 43-50",
                "id": "15147242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e727"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "coexpression of both CLOCK and BMAL1 strongly increased the luciferase signal from both human ER beta and mouse ER beta  promoters 11- or 5-fold, respectively suggesting that the CLOCK-BMAL1 heterodimer is involved in the regulation of ERbeta expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Jan 28(2) 784-93",
                "id": "18039858"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e667"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "decreases",
        "target": "p(HGNC:MYC)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) decreases p(HGNC:MYC)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405140a",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) decreases p(HGNC:MYC)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e909"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER3)",
        "relation": "decreases",
        "target": "p(HGNC:WEE1)",
        "directed": false,
        "label": "p(HGNC:PER3) decreases p(HGNC:WEE1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f3",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PER3) decreases p(HGNC:WEE1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e920"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER2))",
        "relation": "decreases",
        "target": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER2)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e4",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e927"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:TIMELESS)",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a0",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "Affinity Capture-Western",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Apr 25(8) 3109-16",
                "id": "15798197"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e92d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e740"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER3))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER3)",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER3)) hasComponent p(HGNC:PER3)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a6",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER3)) hasComponent p(HGNC:PER3)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e933"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER3)) hasComponent p(HGNC:PER3)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jul 23 98(2) 193-205",
                "id": "10428031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e83d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1D))",
        "relation": "increases",
        "target": "p(HGNC:ARNTL,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1D)) increases p(HGNC:ARNTL,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051396",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1D)) increases p(HGNC:ARNTL,pmod(P))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e93d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:PER3,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:PER3,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c2",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:PER3,pmod(P))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e947"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CRY1)",
        "relation": "increases",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(HGNC:CRY1) increases kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051416",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CRY1) increases kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e95a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCNA2,pmod(P))",
        "relation": "increases",
        "target": "bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
        "directed": false,
        "label": "p(HGNC:CCNA2,pmod(P)) increases bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ec",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCNA2,pmod(P)) increases bp(GOBP:\"G2/M transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e961"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:NR1D1)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:NR1D1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051409",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:NR1D1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e96a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER3))",
        "relation": "decreases",
        "target": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER3)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a5",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER3)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e971"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BHLHE41)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:BHLHE41))",
        "directed": false,
        "label": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e8",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "Constitutive expression of Sharp-1 in C2C12 myoblasts promotes cell cycle exit causing a decrease in cyclin D1 expression but blocks terminal differentiation. Although MyoD expression is not inhibited, the induction of differentiation-specific genes such as myogenin, MEF2C, and myosin heavy chain is impaired by Sharp-1 overexpression. We demonstrate that the interaction of Sharp-1 with MyoD and E-proteins results in reduced DNA binding and transactivation from MyoD-dependent E-box sites.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 10 279(50) 52643-52",
                "id": "15448136"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e974"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "The proteins Clock and Bmal1 form a heterodimer which activates the transcription of the Per gene from the E-box elements in its promoter region. Protein products of Per act together with Cry proteins to inhibit Per transcription, thus closing the autoregulatory feedback loop. We found that Dec1 and Dec2, basic helix-loop-helix transcription factors, repressed Clock/Bmal1-induced transactivation of the mouse Per1 promoter through direct protein-protein interactions with Bmal1 and/or competition for E-box elements.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Oct 24 419(6909) 841-4",
                "id": "12397359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e962"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "he inhibitory activity of mSharp-1 occurs through several mechanisms including occupancy of E box sites by mSharp-1 homodimers and by direct physical interaction with MyoD and E proteins. Furthermore, by using gel mobility shift assays and chromatin immunoprecipitation experiments, we have identified Stra13 as a target for mSharp-1-mediated repression. We demonstrate that transcriptional repression of Stra13 depends, in part, on binding of mSharp-1 to three conserved E box motifs in the Stra13 proximal promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 30 278(22) 20098-109",
                "id": "12657651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e749"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "In this study, we focused on the downregulation of a key MMR gene, MLH1, and demonstrated that hypoxia-inducible transcription repressors, differentiated embryo chondrocytes (DEC1 and 2), participated in its transcriptional regulation via their bindings to E-box-like motif(s) in MLH1 promoter region. Co-transfection reporter assay revealed that DEC1 and, to greater extent, DEC2 as well as hypoxia-repressed MLH1 promoter activity. We further found that the action was remarkably inhibited by trichostatin A, and identified a possible DEC-response element in the MLH1 promoter. In vitro electrophoretic gel mobility shift and chromatin immunoprecipitation assays demonstrated that DEC1 or 2 directly bounds to the suggested element, and transient transfection assay revealed that overexpression of DEC2 repressed endogenous MLH1 expression in the cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Jul 10 27(30) 4200-9",
                "id": "18345027"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e67f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "From full text of Table 1 and following up on references in table 1: A list of potential BHLHB2- and BHLHB3-target genes",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2005 10 3151-71",
                "id": "15970569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e928"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "expression of Dec2 was negatively regulated by binding of Dec2 or Dec1 to two CACGTG E-boxes in the Dec2 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Aug 15 382(Pt 1) 43-50",
                "id": "15147242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e89e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "Consistently, cotransfection assays demonstrate that STRA13 and DEC2 both antagonize CLOCK:BMAL1 dependent transactivation of the Rev-erbalpha {NR1D1} and Dbp promoters. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2008 May 16 369(4) 1184-9",
                "id": "18342625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e88e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e75b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "Although expression of the early marker CCAAT/enhancer binding protein beta (C/EBPbeta) is not altered, its crucial downstream targets C/EBPalpha and peroxisome proliferator-activated receptor gamma (PPARgamma) are downregulated by SHARP1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2009 Jan 10(1) 79-86",
                "id": "19029947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e74b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE41) actsIn tscript(p(HGNC:BHLHE41))",
              "summary_text": "Transfection assays showed that DEC2, but not DEC1, suppressed the transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A), overwhelming the potent enhancement by D-site binding protein (DBP). Electrophoretic mobility shift assays indicated that DEC2 binds to the E-box (CACATG) at the -219/-214 region of CYP7A. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2004 Apr 9(4) 317-29",
                "id": "15066123"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e736"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CDKN1A)",
        "relation": "decreases",
        "target": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "directed": false,
        "label": "p(HGNC:CDKN1A) decreases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513dd",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CDKN1A) decreases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e97a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER1))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER1)",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b5",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "in vitro; in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jun 1 17(11) 1366-79",
                "id": "12782655"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e985"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "mCRY is phosphorylated by CKIepsilon only when both proteins are bound to mammalian PERIOD proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "CRY1 or CRY2 (or both) showed light-independent interactions with CLOCK and BMAL1, as well as with PER1, PER2, and TIM.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Oct 22 286(5440) 768-71",
                "id": "10531061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e720"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:PER2),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER2)",
        "directed": false,
        "label": "complex(p(HGNC:PER2),p(HGNC:TIMELESS)) hasComponent p(HGNC:PER2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a7",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:PER2),p(HGNC:TIMELESS)) hasComponent p(HGNC:PER2)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e99e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:PER2),p(HGNC:TIMELESS)) hasComponent p(HGNC:PER2)",
              "summary_text": "in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 1998 Nov 21(5) 1101-13",
                "id": "9856465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e78c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:BHLHE41))",
        "relation": "decreases",
        "target": "p(HGNC:NR1D1)",
        "directed": false,
        "label": "tscript(p(HGNC:BHLHE41)) decreases p(HGNC:NR1D1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e7",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:BHLHE41)) decreases p(HGNC:NR1D1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:PER2)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:PER2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051411",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:PER2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:CCNA2,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:CCNA2,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c4",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:CCNA2,pmod(P))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:TIMELESS)",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b4",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jul 23 98(2) 193-205",
                "id": "10428031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e92b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCNA2)",
        "relation": " hasModification",
        "target": "p(HGNC:CCNA2,pmod(P))",
        "directed": false,
        "label": "p(HGNC:CCNA2)  hasModification p(HGNC:CCNA2,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513eb",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(EGID:5424,pmod(P,Y,15))",
        "relation": "decreases",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(EGID:5424,pmod(P,Y,15)) decreases kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405139d",
          "evidences": [
            {
              "bel_statement": "p(EGID:5424,pmod(P,Y,15)) decreases kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:PER3)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:PER3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051402",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:PER3)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:NR1D1))",
        "relation": "decreases",
        "target": "p(HGNC:CDKN1A)",
        "directed": false,
        "label": "tscript(p(HGNC:NR1D1)) decreases p(HGNC:CDKN1A)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513df",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:NR1D1)) decreases p(HGNC:CDKN1A)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CSNK1D)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:CSNK1D))",
        "directed": false,
        "label": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051391",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 44962-8",
                "id": "12270943"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9eb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
              "summary_text": "human casein kinase Idelta (hCKIdelta), the closest homologue to hCKIepsilon, associates with and phosphorylates hPER1 and causes protein instability",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 159-65",
                "id": "11165242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
              "summary_text": "Using in vitro gain-of-function and loss-of-function approaches, we reveal that casein kinase 1 (CK1) delta and CK1epsilon are crucial for Dvl phosphorylation by non-canonical Wnts. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Feb 15 120(Pt 4) 586-95",
                "id": "17244647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
              "summary_text": "9990034;9558331",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
              "summary_text": "Recombinant, purified glutathione S-transferase (GST)-CK1delta and GST-CK1epsilon fusion proteins each phosphorylate p53 in vitro at serines 4, 6 and 9, the sites recognised by p53NK. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Oct 2 15(14) 1727-36",
                "id": "9349507"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
              "summary_text": "<p3> CSNK1D phosphorylates p53 at Thr18, but requires Ser15 to be already phosphorylated",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e728"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1D) actsIn kin(p(HGNC:CSNK1D))",
              "summary_text": "In this paper, we identify threonine 18 of p53, a key site in regulating the interaction between p53 and its regulatory partner MDM2, as a novel site phosphorylated in vitro by purified recombinant casein kinase 1 (CK1) delta. Strikingly, phosphorylation of threonine 18 is dependent upon prior phosphorylation of serine 15",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 1999 Dec 17 463(3) 312-6",
                "id": "10606744"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e717"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:MYC))",
        "relation": "increases",
        "target": "bp(GOBP:\"cell cycle\")",
        "directed": false,
        "label": "tscript(p(HGNC:MYC)) increases bp(GOBP:\"cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513db",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:MYC)) increases bp(GOBP:\"cell cycle\")",
              "summary_text": "The c-Myc oncoprotein is strongly induced during the G0 to S-phase transition and is an important regulator of cell cycle entry.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 May 9 169(3) 405-13",
                "id": "15866886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9fc"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:MYC)) increases bp(GOBP:\"cell cycle\")",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e837"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "increases",
        "target": "p(HGNC:PER1,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) increases p(HGNC:PER1,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513cb",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) increases p(HGNC:PER1,pmod(P))",
              "summary_text": "Casein kinase Iepsilon (CKIepsilon), a central component of the circadian clock, interacts with and phosphorylates human period protein 1 (hPER1)",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 159-65",
                "id": "11165242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER1))",
        "relation": "hasComponent",
        "target": "p(HGNC:CRY2)",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:CRY2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b6",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:CRY2)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:CRY2)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:CRY2)",
              "summary_text": "in vitro; in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jun 1 17(11) 1366-79",
                "id": "12782655"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e90d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:CRY2)",
              "summary_text": "CRY1 or CRY2 (or both) showed light-independent interactions with CLOCK and BMAL1, as well as with PER1, PER2, and TIM.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Oct 22 286(5440) 768-71",
                "id": "10531061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) hasComponent p(HGNC:CRY2)",
              "summary_text": "mCRY is phosphorylated by CKIepsilon only when both proteins are bound to mammalian PERIOD proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e679"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:NR1D1)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:NR1D1))",
        "directed": false,
        "label": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e5",
          "evidences": [
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "To identify potential downstream targets of NR1D1 and PBP that are related to fat metabolism and pertinent to breast cancer cell survival, we looked at mRNA levels of the three major enzymes of de novo fatty acid synthesis: ATP citrate lyase (ACLY), acetyl-CoA carboxylase ? (ACACA), and FASN. The transcript level of each enzyme is significantly reduced after transfection with NR1D1 and PBP shRNAs (Fig. 5A) or PPAR? antagonist treatment (Supplementary Fig. S7A). Transcript levels of FADS2, a fat metabolism-related gene that was identified in the screen (Table 1), are also downregulated under the same conditions (Fig. 5A; Supplementary Fig. S7A).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2010 Mar 1 70(5) 1783-92",
                "id": "20160030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea11"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "To investigate the role of Rev-erb{alpha} in metabolic gene regulation, we first depleted Rev-erb{alpha} from HepG2 human hepatoma cells with small interfering RNA molecules (siRNAs). Expression of genes encoding gluconenogenic enzymes G6Pase and PEPCK was significantly increased when Rev-erb{alpha} amounts were reduced (Fig. 1A). By contrast, loss of Rev-erb{alpha} did not affect the expression of acetyl–coenzyme A (CoA) carboxylase or fatty acid synthase, which are involved fatty acid metabolism (fig. S1). Overexpression of full-length Rev-erb{alpha} in HepG2 cells decreased expression of G6Pase, PEPCK, and the known Rev-erb{alpha} target Bmal1 (Fig. 1B). Further, Rev-erb{alpha} repressed expression of a luciferase reporter driven by the human G6Pase promoter (Fig. 1C). With chromatin immunoprecipitation (ChIP), we observed Rev-erb{alpha}, along with NCoR, in the vicinity of potential Rev-erb{alpha} binding sites (ROREs) (Fig. 1D). Deletion of the distal RORE from human G6Pase promoter abrogated Rev-erb{alpha}–dependent repression activity on this promoter (fig. S2). Taken together, these results suggest that Rev-erb{alpha} recruits the NCoR-HDAC3 corepressor complex to actively repress the expression of gluconeogenic genes and in turn may have a role in circadian oscillation of gluconeogenesis.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2007 Dec 14 318(5857) 1786-9",
                "id": "18006707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "REV-ERB and ROR Nuclear Receptors Regulate p21 Expression—A close analysis of the phase relationship between the profiles of p21  and other known clock components suggested the orphan nuclear receptors Rev-erb? and Rev-erb? (NR1D2) as two putative direct negative regulators because they are Bmal1 targets, and both peak when p21 is low. Consistently, Rev-erb? is a known target of the CLOCK:BMAL1 heterodimer (5, 37). These two repressors bind to the same DNA response elements as ROR orphan nuclear receptors (termed RORE; consensus sequence: WAWNTRGGTCA), which in contrast, activates transcription. Although Rev-erb? and Reverb? are ubiquitously expressed, ROR receptors display more complex expression patterns, with ROR?4 and ROR? (NR1F3) being the only isotypes detected in liver. Interestingly, two evolutionary conserved RORE are present in the promoter and first intron regions of the p21 gene (Fig. 3A). This suggested that p21 oscillation could directly result from an alternative activation and repression mediated by ROR and REV-ERB proteins, respectively. However, because we could not exclude a direct negative regulation of the p21 gene by the CLOCK:BMAL1 heterodimer as shown previously for c-myc (19), we tested the response of a 2240-bp 5? fragment of the p21 promoter fused to a luciferase reporter gene (p21Prom::Luc construct) in a cotransfection assay. No significant increase over basal activity could be observed in contrast to the reporter gene driven by Per1 consensus E-box elements (Fig. 3B). In contrast, ROR? transactivated the same p21Prom::Luc reporter construct, which contained the proRORE, by ?2.5-fold, whereas ROR?4 did not (Fig. 3C). A deletion mutant lacking the proRORE site (p21Prom?1663::Luc construct) abolished the ROR?-dependent activation (Fig. 3C). Both REV-ERB? and REV-ERB? could antagonize the ROR?-dependent transactivation of the p21 promoter (Fig. 3C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Feb 22 283(8) 4535-42",
                "id": "18086663"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e79e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "In the present study, transient cotransfection experiments in rat hepatocytes in primary culture and rabbit kidney RK13 cells demonstrated that overexpression of Rev-erbalpha specifically decreases basal and HNF-4 stimulated human apoC-III promoter activity. A Rev-erbalpha response element was mapped by promoter deletion, mutation analysis, and gel-shift experiments to a AGGTCA half-site located at position -23/-18 (downstream of the TATA box) in the apoC-III promoter. Finally, Rev-erbalpha-deficient mice displayed elevated serum and liver mRNA levels of apoC-III together with increased serum VLDL triglycerides.",
              "citation": {
                "type": "PubMed",
                "name": "J Lipid Res 2002 Dec 43(12) 2172-9",
                "id": "12454280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e77e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "Rev-erb{alpha} represses PPAR{gamma}2 gene expression. Because Rev-erb{alpha} is a potent transcriptional repressor, we hypothesized that it might directly repress PPAR{gamma} expression. Indeed, overexpression of WT Rev-erb{alpha} repressed the luciferase activity of a murine PPAR{gamma}2 reporter in 3T3-L1 cells (Fig. 6A). Expression of SD Rev-erb{alpha} led to even greater repression of the mPPAR{gamma}2 promoter, indicating that the SD Rev-erb{alpha} mutant was not functionally defective and was, in fact, a more potent repressor, likely due to its expression at higher levels. Conversely, knockdown of endogenous Rev-erb{alpha} led to increased mPPAR{gamma}2 promoter activity, indicating that, at its endogenous level, Rev-erb{alpha} suppresses PPAR{gamma}2 gene expression (Fig. 6A). Ectopic expression of SD Rev-erb{alpha} by removal of doxycycline significantly repressed endogenous PPAR{gamma}2 and Bmal1 expression in mature adipocytes (Fig. 6B). Consistent with this, Rev-erb{alpha} knockdown increased native PPAR{gamma}2 mRNA, as well as the expression of Bmal1, a known Rev-erb{alpha} target gene (Fig. 6C). A similar result was obtained with a second, nonoverlapping shRNA targeting Rev-erb{alpha} (",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Apr 28(7) 2213-20",
                "id": "18227153"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e748"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "However, Rev-erbalpha overexpression represses the induction of toll-like receptor (TLR)-4 by LXR agonists, whereas Rev-erbalpha silencing by short interfering RNA results in enhanced TLR-4 expression upon LXR activation. Electrophoretic mobility shift, chromatin immunoprecipitation, and transient transfection experiments demonstrate that Rev-erbalpha represses human TLR-4 promoter activity by binding as a monomer to a RevRE site overlapping with the LXR response element site in the TLR-4 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2008 Aug 22(8) 1797-811",
                "id": "18511497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e706"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "Hepatic expression of E4BP4 and the orphan nuclear receptor small heterodimer partner (SHP), both negative regulators of CYP7A1 expression, is increased in Rev-erbalpha-deficient mice. Promoter analysis and chromatin immunoprecipitation experiments demonstrated that SHP and E4BP4 are direct Rev-erbalpha target genes.",
              "citation": {
                "type": "PubMed",
                "name": "Gastroenterology 2008 Aug 135(2) 689-98",
                "id": "18565334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea13"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "Fibrates also induce the expression of Rev-erbalpha, which binds to a RebRE site in the rat aposA-1 promoteor and then represses the expression of apoA-I",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 3 278(40) 38188-93",
                "id": "12882972"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "Transient transfection experiments performed with human HepG2 hepatoma cells showed that overproduction of ROR alpha 4 stimulated the activity of the AFP enhancer in a dose-dependent manner, while that of Rev-erb alpha and Rev-erb beta had the opposite effect",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2000 Oct 19(10) 589-99",
                "id": "11058961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e97d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "coactivators, such as ncoa1 and creb are required for efficient steroid receptor transactivation",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1997 Jul 22 94(15) 7879-84",
                "id": "9223281"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e958"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "In apoCIII expressing human hepatic HepG2 cells, transfection of Rev-erbalpha specifically repressed apoCIII gene promoter activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Jul 26 277(30) 27120-9",
                "id": "12021280"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "hepatocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "clock and bmal1 also activate transcription of rev-erb-alpha, which in turn represses the transcription of bmal1",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Oct 10 302(5643) 234-5",
                "id": "14551421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e848"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "However, the mechanisms that determine PAI-1 circadian rhythmicity remain poorly understood. We discovered that the orphan nuclear receptor Rev-erb alpha, a core component of the circadian loop, represses human PAI-1 gene expression through two Rev-erb alpha binding sites in the PAI-1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 10 281(45) 33842-8",
                "id": "16968709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e80e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "SUNCoR - Represses TR and RevErb.",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e770"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:NR1D1) actsIn tscript(p(HGNC:NR1D1))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e741"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1D))",
        "relation": "increases",
        "target": "p(HGNC:CRY1,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1D)) increases p(HGNC:CRY1,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051393",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1D)) increases p(HGNC:CRY1,pmod(P))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea17"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER2))",
        "relation": "hasComponent",
        "target": "p(HGNC:CRY1)",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:CRY1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d3",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:CRY1)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea19"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:CRY1)",
              "summary_text": "The complex between PER2 and CRY1 or CRY2 enhances Bmal1 expression in an indirect manner ( 5 ) by binding to CLOCKBMAL1, and thereby reducing the transcription of the Rev-Erb alpha gene ( 13 ).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jun 10 100(12) 7051-6",
                "id": "12775757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:CRY1)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e804"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:CRY1)",
              "summary_text": "in vitro; in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jul 23 98(2) 193-205",
                "id": "10428031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:CRY1)",
              "summary_text": "mCRY is phosphorylated by CKIepsilon only when both proteins are bound to mammalian PERIOD proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e75c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:BHLHE41))",
        "relation": "decreases",
        "target": "p(HGNC:BHLHE41)",
        "directed": false,
        "label": "tscript(p(HGNC:BHLHE41)) decreases p(HGNC:BHLHE41)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e6",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:BHLHE41)) decreases p(HGNC:BHLHE41)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea25"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "hasComponent",
        "target": "p(HGNC:NPAS2)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:NPAS2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051400",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:NPAS2)",
              "summary_text": "from full text - NPAS2/BMAL1 circadian transcription complex repressed c-Myc promoter expression",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Causes Control 2006 May 17(4) 525-30",
                "id": "16596306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea29"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:NPAS2)",
              "summary_text": "in vitro; in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 May 12 95(10) 5474-9",
                "id": "9576906"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e926"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:NPAS2)",
              "summary_text": "Here we report that the transcription factor NPAS2 (MOP4) is able to functionally substitute for CLOCK in the master brain clock in mice to regulate circadian rhythmicity.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:NPAS2)",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER2))",
        "relation": "decreases",
        "target": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER2)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d5",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea2e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CSNK1E)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:CSNK1E))",
        "directed": false,
        "label": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513be",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "We find that CKIepsilon binds to LRP5 and LRP6 in vitro and in vivo and identify three CKIepsilon-specific phosphorylation sites in LRP6. Two of the identified phosphorylation sites, Ser1420 and Ser1430, influence Wnt signaling in vivo, since LRP6 with mutation of these sites is a more potent activator of both beta-catenin accumulation and Lef-1 reporter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 5 281(18) 12233-41",
                "id": "16513652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "DHPG activates CK1(epsilon) via Ca(2+)-dependent stimulation of calcineurin and subsequent dephosphorylation of inhibitory C-terminal autophosphorylation sites.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 22 277(47) 45393-9",
                "id": "12223474"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea2f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "overexpression of dominant-negative CKI-epsilon leads to decreased BMAL1-driven transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Nov 5 274(45) 32063-70",
                "id": "10542239"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "human casein kinase Idelta (hCKIdelta), the closest homologue to hCKIepsilon, associates with and phosphorylates hPER1 and causes protein instability",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 159-65",
                "id": "11165242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e975"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "CKIepsilon inhibition also slows the degradation of PER2 in cells. CKIepsilon-mediated phosphorylation of PER2 recruits the ubiquitin ligase adapter protein beta-TrCP to a specific site, and dominant negative beta-TrCP blocks phosphorylation-dependent degradation of mPER2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Apr 25(7) 2795-807",
                "id": "15767683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e96c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Oct 19 276(42) 39037-45",
                "id": "11487578"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e929"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e91c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "depletion of CKI epsilon reduced the Wnt-3a-induced accumulation of beta-catenin",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 18 278(16) 14066-73",
                "id": "12556519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "11232563;11475410",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "The recruitment of Axin to the plasma membrane- associated LRP5/6 co-receptor of Fz1 has been shown to be mediated by a rapid phosphorylation of LRP5/6 by CK1y as well as by GSK3b  ",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Signal 2007 2 11",
                "id": "17961224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e84a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "We show that in response to Wnt-5a, CK1epsilon binds Dvl and is subsequently phosphorylated.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 2007 Feb 15 120(Pt 4) 586-95",
                "id": "17244647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e816"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "CKI phosphorylation of mDvl-1 at two highly conserved residues, serines 139 and 142, was observed by MS and confirmed by phosphopeptide mapping of in vivo phosphorylated protein. Phosphorylation of these sites is dependent on casein kinase I epsilon activity in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2006 Oct 273(20) 4594-602",
                "id": "16965538"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "CK1epsilon and CK1gamma2 were found to bind to Per1 and to promote its degradation in an in vivo degradation assay.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jul 22 280(29) 26863-72",
                "id": "15917222"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "casein kinase I epsilon (CKI epsilon) has been shown to be a positive regulator of the Wnt pathway Ser-45 is phosphorylated not by GSK3 but by CKI epsilon. Axin, a scaffold protein that binds CKI epsilon and beta-catenin, enhances this CKI epsilon-mediated phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem (Tokyo) 2002 Nov 132(5) 697-703",
                "id": "12417018"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "once synthesized, Per1 and Per2 are phosphorylated by CKIepsilon and interacts with corresponding crytochromes CRY1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(4) 408-16",
                "id": "14754509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "CKIepsilon inhibition also slows the degradation of PER2 in cells. CKIepsilon-mediated phosphorylation of PER2 recruits the ubiquitin ligase adapter protein beta-TrCP to a specific site, and dominant negative beta-TrCP blocks phosphorylation-dependent degradation of mPER2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Apr 25(7) 2795-807",
                "id": "15767683"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e73f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "We find that CKIepsilon binds to LRP5 and LRP6 in vitro and in vivo and identify three CKIepsilon-specific phosphorylation sites in LRP6. Two of the identified phosphorylation sites, Ser1420 and Ser1430, influence Wnt signaling in vivo, since LRP6 with mutation of these sites is a more potent activator of both beta-catenin accumulation and Lef-1 reporter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 5 281(18) 12233-41",
                "id": "16513652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e730"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CSNK1E) actsIn kin(p(HGNC:CSNK1E))",
              "summary_text": "Recombinant, purified glutathione S-transferase (GST)-CK1delta and GST-CK1epsilon fusion proteins each phosphorylate p53 in vitro at serines 4, 6 and 9, the sites recognised by p53NK. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Oct 2 15(14) 1727-36",
                "id": "9349507"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e661"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:PER3)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:PER3)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405140f",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:PER3)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea32"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER1))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER1)",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405141a",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e87b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "mCRY is phosphorylated by CKIepsilon only when both proteins are bound to mammalian PERIOD proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea43"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "hprd",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Oct 22 286(5440) 768-71",
                "id": "10531061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "once synthesized, Per1 and Per2 are phosphorylated by CKIepsilon and interacts with corresponding crytochromes CRY1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(4) 408-16",
                "id": "14754509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) hasComponent p(HGNC:PER1)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER2)",
        "relation": " hasModification",
        "target": "p(HGNC:PER2,pmod(P))",
        "directed": false,
        "label": "p(HGNC:PER2)  hasModification p(HGNC:PER2,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c1",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(EGID:5424)",
        "relation": " hasModification",
        "target": "p(EGID:5424,pmod(P,Y,15))",
        "directed": false,
        "label": "p(EGID:5424)  hasModification p(EGID:5424,pmod(P,Y,15))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405139e",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(EGID:5424)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:POLD1))",
        "directed": false,
        "label": "p(EGID:5424) actsIn kin(p(HGNC:POLD1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b0",
          "evidences": [
            {
              "bel_statement": "p(EGID:5424) actsIn kin(p(HGNC:POLD1))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea50"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:CRY1)",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS)) hasComponent p(HGNC:CRY1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b3",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS)) hasComponent p(HGNC:CRY1)",
              "summary_text": "in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jul 23 98(2) 193-205",
                "id": "10428031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea55"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:TIMELESS)) hasComponent p(HGNC:CRY1)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e856"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER1)",
        "relation": "decreases",
        "target": "p(HGNC:WEE1)",
        "directed": false,
        "label": "p(HGNC:PER1) decreases p(HGNC:WEE1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513fe",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PER1) decreases p(HGNC:WEE1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea5c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER2))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER2)",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e1",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea64"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "The complex between PER2 and CRY1 or CRY2 enhances Bmal1 expression in an indirect manner ( 5 ) by binding to CLOCKBMAL1, and thereby reducing the transcription of the Rev-Erb alpha gene ( 13 ).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jun 10 100(12) 7051-6",
                "id": "12775757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea41"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "CRY1 or CRY2 (or both) showed light-independent interactions with CLOCK and BMAL1, as well as with PER1, PER2, and TIM.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Oct 22 286(5440) 768-71",
                "id": "10531061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e867"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "once synthesized, Per1 and Per2 are phosphorylated by CKIepsilon and interacts with corresponding crytochromes CRY1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(4) 408-16",
                "id": "14754509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jul 23 98(2) 193-205",
                "id": "10428031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e70f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "mCRY is phosphorylated by CKIepsilon only when both proteins are bound to mammalian PERIOD proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER2))",
        "relation": "hasComponent",
        "target": "p(HGNC:CRY2)",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:CRY2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e2",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:CRY2)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:CRY2)",
              "summary_text": "CRY1 or CRY2 (or both) showed light-independent interactions with CLOCK and BMAL1, as well as with PER1, PER2, and TIM.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Oct 22 286(5440) 768-71",
                "id": "10531061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea6d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:CRY2)",
              "summary_text": "in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jul 23 98(2) 193-205",
                "id": "10428031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea65"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:CRY2)",
              "summary_text": "once synthesized, Per1 and Per2 are phosphorylated by CKIepsilon and interacts with corresponding crytochromes CRY1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(4) 408-16",
                "id": "14754509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:CRY2)",
              "summary_text": "The complex between PER2 and CRY1 or CRY2 enhances Bmal1 expression in an indirect manner ( 5 ) by binding to CLOCKBMAL1, and thereby reducing the transcription of the Rev-Erb alpha gene ( 13 ).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jun 10 100(12) 7051-6",
                "id": "12775757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e792"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:CRY2)",
              "summary_text": "mCRY is phosphorylated by CKIepsilon only when both proteins are bound to mammalian PERIOD proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e775"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) hasComponent p(HGNC:CRY2)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e737"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER2))",
        "relation": "decreases",
        "target": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER2)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e3",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER2)) decreases complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea76"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BHLHE40)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:BHLHE40))",
        "directed": false,
        "label": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b9",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "The proteins Clock and Bmal1 form a heterodimer which activates the transcription of the Per gene from the E-box elements in its promoter region. Protein products of Per act together with Cry proteins to inhibit Per transcription, thus closing the autoregulatory feedback loop. We found that Dec1 and Dec2, basic helix-loop-helix transcription factors, repressed Clock/Bmal1-induced transactivation of the mouse Per1 promoter through direct protein-protein interactions with Bmal1 and/or competition for E-box elements.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2002 Oct 24 419(6909) 841-4",
                "id": "12397359"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e872"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "Interestingly, expression of a constitutively active form of Akt causes spontaneous differentiation of 3T3-L1 cells.37 The experimental manipulation of cAMP, various G proteins, and protein kinase C isoforms have also been shown to affect adipogenesis in vitro.38 A more thorough knowledge of the critical extracellular signals involved in fat cell development would better enable us to place these findings in their appropriate context.  Another environmental condition that affects adipogenesis is hypoxia, which inhibits the process. This effect seems to be mediated through hypoxia-inducible factor 1{alpha} (HIF-1 {alpha}), which represses transcriptional induction of PPAR{gamma} via an intermediate factor, called DEC1/Stra13.39",
              "citation": {
                "type": "PubMed",
                "name": "Ann N Y Acad Sci 2002 Dec 979 143-58; discussion 188-96",
                "id": "12543724"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e865"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "In this study, we focused on the downregulation of a key MMR gene, MLH1, and demonstrated that hypoxia-inducible transcription repressors, differentiated embryo chondrocytes (DEC1 and 2), participated in its transcriptional regulation via their bindings to E-box-like motif(s) in MLH1 promoter region. Co-transfection reporter assay revealed that DEC1 and, to greater extent, DEC2 as well as hypoxia-repressed MLH1 promoter activity. We further found that the action was remarkably inhibited by trichostatin A, and identified a possible DEC-response element in the MLH1 promoter. In vitro electrophoretic gel mobility shift and chromatin immunoprecipitation assays demonstrated that DEC1 or 2 directly bounds to the suggested element, and transient transfection assay revealed that overexpression of DEC2 repressed endogenous MLH1 expression in the cells.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Jul 10 27(30) 4200-9",
                "id": "18345027"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e755"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea7c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "We discovered a sequence within Bdnf promoter 4 that binds the basic helix-loop-helix protein BHLHB2 and is a target for BHLHB2-mediated transcriptional repression. ",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2008 Jan 30 28(5) 1118-30",
                "id": "18234890"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea1b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "From full text of Table 1 and following up on references in table 1: A list of potential BHLHB2- and BHLHB3-target genes",
              "citation": {
                "type": "PubMed",
                "name": "Front Biosci 2005 10 3151-71",
                "id": "15970569"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "Forced expression of Clock/Bmal increased endogenous Dec1 mRNA level, and overexpression of Dec1 resulted in suppression of Dec2, Per2, and Dbp expression",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 2 313(1) 117-24",
                "id": "14672706"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9be"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "DEC1 is abundantly expressed in tumors and protects against apoptosis induced by serum starvation. In this study, we report that DEC1 antiapoptosis is achieved by inducing survivin, an antiapoptotic protein. In paired tumor-normal tissues, survivin and DEC1 exhibited a paralleled expression pattern. Tetracycline-induced expression of DEC1 in stable lines proportionally increased the expression of survivin.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jun 1 25(23) 3296-306",
                "id": "16462771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e956"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "Stra13 strongly represses the expression of the cell proliferation-associated gene c-Myc through an HDAC1-independent pathway that involves its interaction with the basal transcription factor TFIIB",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Apr 11 97(8) 4058-63",
                "id": "10737769"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "The HIF-1-regulated gene DEC1/Stra13, a member of the Drosophila hairy/Enhancer of split transcription repressor family, represses PPAR gamma 2 promoter activation",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2002 Mar 2(3) 331-41",
                "id": "11879638"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "In reporter assays, DEC1 transactivated the survivin promoter but repressed the DEC2 promoter. In contrast to the repression, the activation was delayed and varied depending on serum concentrations and cycle blockers. Studies with reporter mutants located, in the survivin promoter, two Sp1 sites that supported DEC1 transactivation",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Jun 1 25(23) 3296-306",
                "id": "16462771"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e86f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "the STAT3-regulated promoter of the pro-apoptotic Fas gene was activated upon STRA13 over-expression and that co-expression of STRA13 with STAT3 beta or STAT3 alpha modulated the transcriptional outcome",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2004 Jul 16 340(4) 641-53",
                "id": "15223310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e82f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "we performed microarray analyses of differential gene expression in the liver between wild type and Stra13-/- mice and identified 42 target genes including a subset of 20 previously known as clock-controlled genes metabolism genes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 9 279(2) 1141-50",
                "id": "14581485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e72a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 2 313(1) 117-24",
                "id": "14672706"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "These findings provide direct  evidence that DEC1 negatively regulates the expression of DEC2, which is  largely achieved through direct DNA binding to the E-box in the proximal  promoter of DEC2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16899-907",
                "id": "12624110"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "Consistently, cotransfection assays demonstrate that STRA13 and DEC2 both antagonize CLOCK:BMAL1 dependent transactivation of the Rev-erbalpha {NR1D1} and Dbp promoters. ",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2008 May 16 369(4) 1184-9",
                "id": "18342625"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:BHLHE40) actsIn tscript(p(HGNC:BHLHE40))",
              "summary_text": "when a SHARP-2 expression plasmid was transiently transfected with various reporter plasmids into MH1C1 cells, the promoter activity of a PEPCK reporter plasmid was specifically decreased",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2005 Feb 28 579(6) 1509-14",
                "id": "15733865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e674"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1E))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:PER1,pmod(P,S))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1E)) directlyIncreases p(HGNC:PER1,pmod(P,S))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513c5",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1E)) directlyIncreases p(HGNC:PER1,pmod(P,S))",
              "summary_text": "once synthesized, Per1 and Per2 are phosphorylated by CKIepsilon and interacts with corresponding crytochromes CRY1/2",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(4) 408-16",
                "id": "14754509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea7e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:CLOCK))",
        "relation": "increases",
        "target": "p(HGNC:WEE1)",
        "directed": false,
        "label": "tscript(p(HGNC:CLOCK)) increases p(HGNC:WEE1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513cf",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:CLOCK)) increases p(HGNC:WEE1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea81"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CRY2)",
        "relation": " hasModification",
        "target": "p(HGNC:CRY2,pmod(P))",
        "directed": false,
        "label": "p(HGNC:CRY2)  hasModification p(HGNC:CRY2,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ed",
          "evidences": [

          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1D))",
        "relation": "increases",
        "target": "p(HGNC:PER1,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1D)) increases p(HGNC:PER1,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051392",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1D)) increases p(HGNC:PER1,pmod(P))",
              "summary_text": "human casein kinase Idelta (hCKIdelta), the closest homologue to hCKIepsilon, associates with and phosphorylates hPER1 and causes protein instability",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 159-65",
                "id": "11165242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea95"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER2))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER2)",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d4",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e93c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "in vitro; in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jul 23 98(2) 193-205",
                "id": "10428031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea9d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "mCRY is phosphorylated by CKIepsilon only when both proteins are bound to mammalian PERIOD proteins. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e76a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER2)) hasComponent p(HGNC:PER2)",
              "summary_text": "The complex between PER2 and CRY1 or CRY2 enhances Bmal1 expression in an indirect manner ( 5 ) by binding to CLOCKBMAL1, and thereby reducing the transcription of the Rev-Erb alpha gene ( 13 ).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2003 Jun 10 100(12) 7051-6",
                "id": "12775757"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e698"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:PER1),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:PER1)",
        "directed": false,
        "label": "complex(p(HGNC:PER1),p(HGNC:TIMELESS)) hasComponent p(HGNC:PER1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051398",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:PER1),p(HGNC:TIMELESS)) hasComponent p(HGNC:PER1)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:PER1),p(HGNC:TIMELESS)) hasComponent p(HGNC:PER1)",
              "summary_text": "in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 1998 Nov 21(5) 1101-13",
                "id": "9856465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e782"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATR))",
        "relation": "directlyIncreases",
        "target": "p(HGNC:CHEK1,pmod(P,S,345))",
        "directed": false,
        "label": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b2",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Sep 2 19(5) 607-18",
                "id": "16137618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e810"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "11390642;10859164;15533933;15674326",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea94"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "We show that Rad9's role in Chk1 activation is to bind TopBP1, which stimulates ATR-mediated Chk1 phosphorylation via TopBP1's activation domain (AD), a domain that binds and activates ATR. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Jun 15 21(12) 1472-7",
                "id": "17575048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea8c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "ATM and Rad3-related (ATR) is a regulatory kinase that, when activated by hydroxyurea, UV, or human immunodeficiency virus-1 Vpr, causes cell cycle arrest through Chk1-Ser(345) phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Mar 9 282(10) 7287-98",
                "id": "17210576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e939"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "ATR phosphorylates Chk1 at Ser317 and Ser345 in vitro, and phosphorylation of these sites in human cells in response to UV and hydroxyurea is ATR-dependent [16–19].",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Jun 1 388(Pt 2) 705-12",
                "id": "15707391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e84d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "kin(p(HGNC:ATR)) directlyIncreases p(HGNC:CHEK1,pmod(P,S,345))",
              "summary_text": "Consistently, the RNAi-mediated ablation of Claspin selectively abrogated ATR's ability to phosphorylate Chk1 but not other ATR targets.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e67b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "increases",
        "target": "p(HGNC:CRY2)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:CRY2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ff",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) increases p(HGNC:CRY2)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK2)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:CHEK2))",
        "directed": false,
        "label": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ad",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway — for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-D–Cdk4 from phosphorylating Rb — unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 4–6,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea36"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "from full text - To study the effects of SOCS1 in normal cells, we infected the human diploid fibroblast strain IMR90 with a retroviral vector encoding SOCS1 or a control vector. Expression of SOCS1 inhibited cell growth (Figure 3A) and induced senescence, characterized by senescence-associated ?-galactosidase staining (Figure S3A) and the accumulation of PML bodies (Figure S3B). In addition, SOCS1 induced high levels of p53 and its target, p21; a reduction in Rb phosphorylation; and the inhibition of E2F target genes such as Mcm6 (Figure 3B). Intriguingly, during SOCS1-induced senescence, the increase in p53 levels was accompanied with serine 15 phosphorylation of p53 (Figure 3B) and activation of the DNA damage-regulated kinases ATM and Chk2 (Figure 3C). Staining of SOCS1-expressing cells with an antibody against ?H2AX revealed numerous DNA damage foci (Figure S3C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2009 Dec 11 36(5) 754-67",
                "id": "20005840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e969"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The main downstream targets (of BRCA1) identified so far are p53-responsive genes, including p21 and BcIX13. BRCA1 binds to BRCA2, p53, RAD51 and many other proteins involved in cell cycling and DNA-damage response14,15 (Fig. 2a). The involvement of BRCA1 in response to DNA damage is supported by extensive data, including evidence that BRCA1 is phosphorylated by the ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) proteins in response to DNA damage16,17, that cells without functional BRCA1 do not arrest in G2 after DNA damage and are deficient in transcription-coupled repair18,19, and that BRCA1 is part of the RAD50-MRE11-p95 complex, an essential component of recombination- mediated repair of DNA double-stranded breaks20.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2001 May 7(5) 552-6",
                "id": "11329055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "First, BRCA1 is a target for phosphorylation by several of the protein serine/threonine kinases (for example, ATM, ATR and CHK2) that signal the presence of DNA breakage46, and its modification by these enzymes seems essential for further participation in mechanisms that enforce cell-cycle checkpoints that are triggered by DNA damage in the S and G2 phases of the cell cycle47-49.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e786"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNA–PK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e89b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "In response to ionizing radiation, Cdc25A is phosphorylated by both Chk1 and Chk2 on Ser-123. This in turn leads to ubiquitylation and rapid degradation of Cdc25A by the proteasome resulting in cell cycle arrest",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29824-9",
                "id": "12759351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "In the p53-dependent pathway, p53 accumulates following E2F1 expression [29] through activation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) transcript p14ARF, which in turn interacts with mouse double minutes (MDM2), thereby preventing MDM2 from targeting p53 for ubiquitination and subsequent degradation",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Furthermore, FoxM1 protein is phosphorylated by checkpoint kinase 2 (Chk2) in response to DNA damage. This phosphorylation of FoxM1 on serine residue 361 caused increased stability of the FoxM1 protein with corresponding increased transcription of XRCC1 and BRCA2 genes",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Feb 27(3) 1007-16",
                "id": "17101782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea85"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Both Chk1 and Chk2/Cds1 have been shown to localize to the nucleus and to phosphorylate serine 216 of Cdc25C in vitro (13, 15) (18–21).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea5a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Chk2-mediated phosphorylation of MDMX on S367 is important for stimulating 14-3-3 binding, MDMX nuclear import by a cryptic nuclear import signal, and degradation by MDM2. Mutation of MDMX S367 inhibits ubiquitination and degradation",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Mar 22 25(6) 1196-206",
                "id": "16511560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea3b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "When ATM and ATR are recruited to sites of damage, they target many substrates, including checkpoint kinase-2 (CHK2) and CHK1, respectively (FIG. 2; BOX 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea34"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 278-88",
                "id": "10673500"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea20"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Two peptides derived from the DNA-binding domain of p53 bind to CHK2 and stimulate phosphorylation of full-length p53 at Thr 18 and Ser 20, thus identifying CHK2-docking sites. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2003 Aug 4(8) 787-92",
                "id": "12897801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e98a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Phosphorylation by Chk1 and Cds1/Chk2 down-regulates Cdc25A levels in response to genotoxic stresses",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31838-42",
                "id": "12801928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e925"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "activation of ATM and ATR in turn activates CHK2 and CHK1, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e91b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "However, no such activation was found in A-T cells indicating that caffeine inhibited the ATM-dependent Chk2/Cds1 activation (Fig. 3A, lanes 6 and 8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e913"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Evasion from apoptosis is a hallmark of cancer, and recent success using targeted therapeutics underscores the importance of identifying anti-apoptotic survival pathways. Here we utilize RNA interference (RNAi) to systematically screen the kinase and phosphatase component of the human genome.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Jun 7(6) 591-600",
                "id": "15864305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e90f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Whereas one mutation within the Chk2 forkhead homology-associated (FHA) domain, R145W, retains some basal kinase activity, this mutant cannot be phosphorylated at an ATM-dependent phosphorylation site (Thr-68) and cannot be activated following gamma radiation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Jan 26 276(4) 2971-4",
                "id": "11053450"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "from full text - Consistent with a role of ATM in the phosphorylation of Chk2, Thr68 phosphorylation and Chk2 activation were not detected in ATM-deficient FT169A cells after IR, while Chk2 was phosphorylated and activated in the isogenic, wild-type ATM-reconstituted YZ5 cells ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 47755-8",
                "id": "11668173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "oxidative stress has been shown to activate CHK2 (cell cycle checkpoint kinase), which in turn phosphorylated HuR (RNA binding protein) and triggered the dissociation of the HuR-SIRT1 protein-mRNA complex. Association of HuR with SIRT1 increases the stability and longevity of SIRT1 mRNA [61].",
              "citation": {
                "type": "PubMed",
                "name": "Exp Lung Res 2009 Aug 35(6) 439-85",
                "id": "19842832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "ATM is one of the major kinases that phosphorylate p53 at Ser15 after IR and that ATM also phosphorylates and activates Chk2 after IR, which then phosphorylates p53 at Ser20",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Jan 28(1) 448-56",
                "id": "17967874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e880"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "12399544;12676583;12759351;11298456",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e840"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The CHK2 phosphorylates p53 at S20 and in turn activates it.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 289-300",
                "id": "10673501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e830"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "We also show that senescent cells contain activated forms of the DNA damage checkpoint kinases CHK1 and CHK2",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Nov 13 426(6963) 194-8",
                "id": "14608368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e826"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "from full text - Accordingly, activation of the checkpoint kinase CHK2 (encoded by CHEK2) by DNA damage stimulates a rapid discharge of the mitochondrial pool of survivin in the cytosol (40)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Jan 8(1) 61-70",
                "id": "18075512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e820"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 30537-41",
                "id": "11390408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e809"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "activated CHK2 can phosphorylate and therefore inactivate the phosphatases CDC25A, which controls S phase entry (Melo et al., 2001), and CDC25C, which is required for activation of the mitotic promoting force (MPF) complex of CDK2/ cyclin B to enter mitosis (Figure 1) (Takai et al., 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7fc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Mutation of MDMX on S342, S367, and S403 each confers partial resistance to MDM2-mediated ubiquitination and degradation.  Phosphorylation of S342 and S367 in vivo require the Chk2 kinase. Chk2 also stimulates MDMX ubiquitination and degradation by MDM2",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Oct 5 24(19) 3411-22",
                "id": "16163388"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Phosphorylation of Chk2 in vivo by ataxia telangiectasia-mutated (ATM) on threonine 68 (T68) initiates a phosphorylation cascade that promotes the full activity of Chk2.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Nov 26(21) 7832-45",
                "id": "16940182"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Science 2000 Mar 10 287(5459) 1824-7",
                "id": "10710310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e79c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2003 Jun 1(8) 598-609",
                "id": "12805407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e780"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "The respective kinetics of p53-Ser15 phosphorylation versus ATM and Chk2 activation suggest that in response to DNA damage by TPT or MXT, Chk2 rather than ATM mediates p53 phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2008 Oct 7(19) 3048-55",
                "id": "18802408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e771"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "As shown in Figure 1A, in response to IR, ATM (pS1981) was efficiently activated regardless of cell cycle phase. We observed both rapid phosphorylation of Chk2 on Thr-68, a known ATM phosphorylation site, and enhanced Chk2 kinase activity (Figure 1B,C), after irradiation of interphase cells.",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Biol 2010 8(1) e1000287",
                "id": "20126263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 May 5(5) 401-9",
                "id": "12717439"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "Using chemical inhibitors and small interfering RNA of the signaling kinases, we show that a MMR-mediated 6-TG-induced G2 arrest is ATR/CHK1 dependent but ATM/CHK2 independent and that ATR/CHK1 signaling is responsible for both initiation and maintenance of the G2 arrest. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Sep 3(9) 1147-57",
                "id": "15367709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "As shown in Fig. 6A, Thr383 and Thr387 were not phosphorylated in kinase-dead hCds1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 30537-41",
                "id": "11390408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK2) actsIn kin(p(HGNC:CHEK2))",
              "summary_text": "However, activation of HA3-Cds1(T68A) was greatly compromised after irradiation.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Oct 2(10) 762-5",
                "id": "11025670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e696"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER2,pmod(P,S))",
        "relation": "directlyIncreases",
        "target": "deg(p(HGNC:PER2))",
        "directed": false,
        "label": "p(HGNC:PER2,pmod(P,S)) directlyIncreases deg(p(HGNC:PER2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513da",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PER2,pmod(P,S)) directlyIncreases deg(p(HGNC:PER2))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CCND1)",
        "relation": "increases",
        "target": "bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "directed": false,
        "label": "p(HGNC:CCND1) increases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513fb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CCND1) increases bp(GOBP:\"G1/S transition of mitotic cell cycle\")",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eabc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CHEK1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:CHEK1))",
        "directed": false,
        "label": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513e0",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea8d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Fhit overexpression leads to apoptosis in many cancer cell lines. We report in this study that Fhit-/- cells derived from gene knockout mice show much stronger S and G2 checkpoint responses than their wild type counterparts. The strong checkpoint responses are regulated by the ATR/CHK1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Feb 202(2) 518-23",
                "id": "15389587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea03"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We have shown recently that DNA damage effector kinase Chk1 is phosphorylated in vitro by protein kinase B/Akt (PKB/Akt) on serine 280. Activation of Chk1 by DNA damage in vivo is suppressed in presence of activated PKB. In this study we show that Chk1 is phosphorylated by PKB in vivo, and that increased phosphorylation by PKB on serine 280 correlates with impairment of Chk1 activation by DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e99c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The lithium-induced phosphorylation of cdc2 and G2/M arrest was abrogated largely by SB218078, a potent Chk1 inhibitor, as well as by Chk1 siRNA or the over-expression of kinase dead Chk1.  Furthermore, lithium-induced cdc25C phosphorylation in 7721 cells and in vitro kinase assay showed that the activity of Chk1 was enhanced after lithium treatment. ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 2008 Feb 4",
                "id": "18247328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e98e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "inhibition of ERK1/2 signaling resulted in marked attenuation in IR-induced ATR activity with little, if any, effect on IR-induced ATM activation. Furthermore, inhibition of ERK1/2 signaling resulted in >/=85% attenuation in IR-induced G2/M arrest and concomitant diminution of IR-induced activation of ataxia telangiectasia mutated- and rad3-related (ATR), Chk1 and Wee1 kinases as well as phosphorylation of Cdc25A-Thr506, Cdc25C-Ser216 and Cdc2-Tyr15.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4689-98",
                "id": "17297454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e898"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Phosphorylation of Chk1 controls Cdc25A stability through phosphorylation, leading to interaction of Cdc25A with SCF?-TrCP  ubiquitin ligase and acceleration of Cdc25A turnover ( 30). The resulting reduction of Cdc25A levels is instrumental in slowing progression through S phase, allowing time for DNA repair; if cell elimination is required, apoptosis can be induced through checkpoint termination ( 30).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Dec 1 66(23) 11287-92",
                "id": "17145874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNA–PK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e687"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "<C38> Chk1 binds and phosphorylates Cdc25A-C in vitro (Sanchez et al., 1997). Cdc25C becomes phosphorylated at Ser216.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eabe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Moreover, we showed that Chk1 is a negative regulator of polo-like kinase 1 (Plk1), in either the absence or presence of DNA damage. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Aug 8 103(32) 11964-9",
                "id": "16873548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Apr 1 22(7) 1676-87",
                "id": "12660173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea91"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "When ATM and ATR are recruited to sites of damage, they target many substrates, including checkpoint kinase-2 (CHK2) and CHK1, respectively (FIG. 2; BOX 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea75"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea40"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Feb 1 14(3) 289-300",
                "id": "10673501"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea04"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "12399544;12676583;12759351;11298456",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Furthermore, we show that CHK2 is hyperphosphorylated at later times following 6-TG treatment and the phosphorylation of CHK2 seems to be ATM independent but up-regulated when ATR or CHK1 is reduced.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Sep 3(9) 1147-57",
                "id": "15367709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e97f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Mutation of these phosphorylation sites on Claspin inhibited Claspin-Chk1 interaction in vivo, impaired Chk1 activation, and induced premature chromatin condensation in cells, indicating a defect in replication checkpoint.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 3 281(44) 33276-82",
                "id": "16963448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e943"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jul 4 278(27) 24644-50",
                "id": "12714602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e93f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Oct 1 65(19) 8613-6",
                "id": "16204026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e931"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We also show that senescent cells contain activated forms of the DNA damage checkpoint kinases CHK1 and CHK2",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2003 Nov 13 426(6963) 194-8",
                "id": "14608368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e90e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": " Chk1, a fission yeast kinase involved in the DNA damage checkpoint response, phosphorylated Cdc25C in vitro on serine-216",
              "citation": {
                "type": "PubMed",
                "name": "Science 1997 Sep 5 277(5331) 1501-5",
                "id": "9278512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": " Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 3 284(27) 18085-95",
                "id": "19416980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The DNA-bound 9-1-1 complex then facilitates ATR-mediated phosphorylation and activation of Chk1, a protein kinase that regulates S-phase progression, G2/M arrest, and replication fork stabilization. ",
              "citation": {
                "type": "PubMed",
                "name": "DNA Repair (Amst) 3(8-9) 1009-14",
                "id": "15279787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "CHK1 heterozygosity modestly enhances the tumorigenesis phenotype of WNT-1 transgenic mice. Chk1 plays an essential role in the mammalian DNA damage checkpoint, embryonic development, and tumor suppression",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Jun 15 14(12) 1448-59",
                "id": "10859164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Here we show that the oncogenic p53-induced serine/threonine phosphatase, PPM1D (or Wip1), dephosphorylates two ATM/ATR targets, Chk1 and p53. PPM1D binds Chk1 and dephosphorylates the ATR-targeted phospho-Ser 345, leading to decreased Chk1 kinase activity. PPM1D also dephosphorylates p53 at phospho-Ser 15",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2005 May 15 19(10) 1162-74",
                "id": "15870257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "activation of ATM and ATR in turn activates CHK2 and CHK1, respectively",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e896"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "We show that caffeine's ability to inhibit ATR (but not ATM) causes PCC, that ATR (but not ATM) prevents PCC, and that ATR prevents PCC via Chk-1 regulation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Jul 31 98(16) 9092-7",
                "id": "11481475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e87d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Consistent with this, we discovered that endogenous p73alpha interacts with Chk1 and is phosphorylated by Chk1 at serine 47 in vitro and in vivo. In contrast, Chk2 does not phosphorylate p73alpha in vitro. Moreover, mutation of serine 47 abolishes both Chk1-dependent phosphorylation of p73alpha upon DNA damage in vivo and the ability of Chk1 to upregulate the transactivation capacity of p73alpha. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(22) 8161-71",
                "id": "14585975"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e86c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "from full text - Fig. 3 BRCA1 activates Chk1 kinase activity. a, Endogenous Chk1 was immunoprecipitated from parental and transfected HCC1937 cell extracts",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2002 Mar 30(3) 285-9",
                "id": "11836499"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e850"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Phosphorylation by Chk1 and Cds1/Chk2 down-regulates Cdc25A levels in response to genotoxic stresses",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 22 278(34) 31838-42",
                "id": "12801928"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e801"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Both Chk1 and Chk2/Cds1 have been shown to localize to the nucleus and to phosphorylate serine 216 of Cdc25C in vitro (13, 15) (18–21).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e800"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Here we demonstrate that ARF induces the ATR- and Chk1-dependent phosphorylation of the RelA transactivation domain at threonine 505, a site required for ARF-dependent repression of RelA transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 23 24(6) 1157-69",
                "id": "15775976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Using a small interfering RNA that enables the specific elimination of Chk1 expression, we show that the observed proteolysis of Cdc25A is mediated through Chk1. Moreover, Cdc25A overexpression abrogates the Chk1-mediated degradation and overcomes the doxorubicin-induced G2 arrest through dephosphorylation and activation of Cdc2/Cdk1 in a dose-dependent manner ... from full text, H1299 cells and tyrosine 15 phosphorylation of CDC2",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jun 13 278(24) 21767-73",
                "id": "12676925"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Finally, we show that bypass of the G2/M checkpoint by the CHK1 kinase inhibitor UCN-01 results in the activation of Aurora-A and phosphorylation of CDC25B on S353.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2005 Sep 4(9) 1233-8",
                "id": "16082213"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e746"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "phosphorylation of Cdc25A on Ser-75 by Chk1 and its subsequent degradation is required to delay cell cycle progression in response to UV-induced DNA lesions.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 8 278(32) 29824-9",
                "id": "12759351"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e724"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "The ubiquitination of Chk1 is mediated by E3 ligase complexes containing Cul1 or Cul4A. Treatment of cells with the anticancer agent camptothecin (CPT) triggers Chk1 destruction, which blocks recovery from drug-induced S phase arrest and leads to cell death.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Sep 2 19(5) 607-18",
                "id": "16137618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6fb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(21) 7488-97",
                "id": "14559997"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Our results suggest that Chk1 associates with BAD and phosphorylates the BAD protein at serine-155",
              "citation": {
                "type": "PubMed",
                "name": "Anticancer Res 24(6) 3907-10",
                "id": "15736430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "In vitro Chk1 bound to and phosphorylated the dual-specificity protein phosphatases Cdc25A, Cdc25B, and Cdc25C",
              "citation": {
                "type": "PubMed",
                "name": "Science 1997 Sep 5 277(5331) 1497-501",
                "id": "9278511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "CDC25B interacts at a low level with 14-3-3beta, epsilon, zeta, eta, and Theta isoforms. This interaction is not increased upon phosphorylation of CDC25B by CHK1 and is not abolished by dephosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Mar 2 19(10) 1257-65",
                "id": "10713667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Figure 5. Centrosome?targeted inhibition of Chk1 abrogates G2/M arrest after DNA damage. U2OS cells conditionally expressing wild?type or kinase?dead GFP?Chk1?PACT(AKAP) were induced to express the transgene by tetracycline for 72 h, irradiated with 20 J/m2 UV and harvested 1 h after UV.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2007 Oct 15 6(20) 2541-8",
                "id": "17726372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Conversely, BRCA1 itself controls subsequent steps in checkpoint activation through regulation of kinases such as CHK1 (REF. 50) and PLK1 (REF. 51).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e694"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "Depletion of beta-TRCP stabilizes Cdc25A, leading to hyperactive Cdk2 activity. SCFbeta-TRCP promotes Chk1-dependent Cdc25A ubiquitination in vitro, and this involves serine 76, a known Chk1 phosphorylation site. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Dec 15 17(24) 3062-74",
                "id": "14681206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e682"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1) actsIn kin(p(HGNC:CHEK1))",
              "summary_text": "In both the MT-1 and HCC1937/BRCA1wt cell lines, the suppression of PLK mRNA expression 6 h after IR exposure was completely abolished by UCN-01 (Figure 5).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Dec 4 22(55) 8952-5",
                "id": "14654792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e665"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATR)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:ATR))",
        "directed": false,
        "label": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b1",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Fractionation of HeLa nuclear extracts and biochemical analyses indicate that this kinase is distinct from the DNA-dependent protein kinase (DNA-PK) and corresponds to the human cell cycle checkpoint protein ATR. Immunoprecipitation studies of recombinant ATR reveal that catalytic activity of this polypeptide is required for DNA-stimulated phosphorylation of p53 on serine-15.  These data suggest that ATR may function upstream of p53 in a signal transduction cascade initiated upon DNA damage and provide a biochemical assay system for ATR activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Jul 8 18(27) 3989-95",
                "id": "10435622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "inhibition of ERK1/2 signaling resulted in marked attenuation in IR-induced ATR activity with little, if any, effect on IR-induced ATM activation. Furthermore, inhibition of ERK1/2 signaling resulted in >/=85% attenuation in IR-induced G2/M arrest and concomitant diminution of IR-induced activation of ataxia telangiectasia mutated- and rad3-related (ATR), Chk1 and Wee1 kinases as well as phosphorylation of Cdc25A-Thr506, Cdc25C-Ser216 and Cdc2-Tyr15.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4689-98",
                "id": "17297454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In this report we provide evidence that the ATM-Rad3-related protein ATR regulates phosphorylation of Ser-15 in DNA-damaged cells. Overexpression of catalytically inactive ATR (ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to gamma-irradiation and UV light. In gamma-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner. ATR phosphorylated p53 at Ser-15 and Ser-37 in vitro, suggesting that p53 is a target for phosphorylation by ATR in DNA-damaged cells.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jan 15 13(2) 152-7",
                "id": "9925639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The nuclear staining pattern of BRCA1 is consistent with its nuclear functions in different types of DNA repair pathways,( 19,20) cell cyle control(2) and transcriptional activation.(21) The use of cell fractionation coupled withWestern blot analysis has revealed that BRCA1 is most frequently detected in the nuclear compartment, but that a portion of it can also be detected in the cytoplasm in different cell lines.(27,35,36) Immunohistochemistry has generally disclosed a loss of BRCA1 in breast tumour of increasing grade and from patients carrying germ-line BRCA1 mutations,(37) although, in many instances, the use of N-terminal antibodies such as Ab1 provide a non-specific cellular profile, in that they cross-react with other naturally occurring forms of BRCA1, such as the exon-11 splice variants(31) and possibly the novel truncated form of BRCA1, BRCA1-IRIS.(38) All forms of BRCA1 so far identified, except for the naturally occuring truncated form BRCA1-IRIS, have been detected in nuclear dots at Sphase (33,39) and in DNA-damage induced nuclear foci.(35,40) BRCA1-IRIS was found to associate with chromatin directly and, unlike wild-type BRCA1, it did not associate with BARD1 in vitro or in vivo in immunoprecipitation assays.(38) In meiotic cells, BRCA1 is detectable at the sex chromsomes and has been implicated in recruiting the ATR kinase to XY chromatin at the onset of the pachytene stage of meiotic prophase during mammalian spermatogenesis.(41) It was proposed that ATR then phosphorylates H2AX to signal meiotic sex chromosome inactivation.(41)",
              "citation": {
                "type": "PubMed",
                "name": "Bioessays 2005 Sep 27(9) 884-93",
                "id": "16108063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In this report we provide evidence that the ATM-Rad3-related protein ATR regulates phosphorylation of Ser-15 in DNA-damaged cells. Overexpression of catalytically inactive ATR (ATRki) in human fibroblasts inhibited Ser-15 phosphorylation in response to gamma-irradiation and UV light. In gamma-irradiated cells, ATRki expression selectively interfered with late-phase Ser-15 phosphorylation, whereas ATRki blocked UV-induced Ser-15 phosphorylation in a time-independent manner. ATR phosphorylated p53 at Ser-15 and Ser-37 in vitro, suggesting that p53 is a target for phosphorylation by ATR in DNA-damaged cells.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1999 Jan 15 13(2) 152-7",
                "id": "9925639"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In response to genotoxic stress (i.e. DNA-damaging agents), the E2F1 protein is stabilized through distinct mechanisms including: (i) direct phosphorylation by ataxia-telangiectasia- mutated (ATM) kinase, ATM- and RAD3-related (ATR) kinase and checkpoint 2 (CHK2) kinase and (ii) acetylation through p300/CREB-binding-proteinassociated factor (P/CAF)",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eabb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Initiation of these checkpoints is dependent on the transient recruitment of the MRE11/RAD50/NBS1 (MRN) complex at DSB sites, followed by the recruitment/activation of ataxia–telangiectasia mutated (ATM) a member of the family of phosphoinositide-3-kinase-related kinases (PIKKs) (Su, 2006). In addition, two other PIKKs, DNA-dependent protein kinase (DNA–PK) and ATR (ATM and Rad3 related), are also activated and involved in the response to DSBs.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In this study, we show that BRCA1 phosphorylation is only partially ATM dependent in response to IR and ATM independent in response to treatment with UV light, or the DNA replication inhibitors hydroxyurea (HU) and aphidicolin (APH) We provide evidence that the kinase responsible for this phosphorylation is the ATM-related kinase, ATR. ATR phosphorylates BRCA1 on six Ser/Thr residues, including Ser 1423, in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Dec 1 14(23) 2989-3002",
                "id": "11114888"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Sep 2 19(5) 607-18",
                "id": "16137618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e83e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Significantly, ATR activity is also required for ARF-induced p53 activity and inhibition of proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Mar 23 24(6) 1157-69",
                "id": "15775976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": " ATR activation requires several factors, including the BRCT repeat-containing TopBP1 protein and the 9-1-1 clamp protein",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Sep 15 8(18) 2877-84",
                "id": "19652550"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaaa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Phosphorylation on Chk1(Ser-345), Chk2(Thr-68), and p53(Ser-15)following oxidative damage by IR involved both ATM and ATR. phosphorylation on Chk1, Chk2, and p53 was found to be ATM-dependent, whereas ATR also contributed to Chk1 phosphorylation ... from full text, A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1186-92",
                "id": "15533933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea88"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Oct 29 323(4) 1197-202",
                "id": "15451423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea56"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31251-8",
                "id": "15159397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea06"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": " Treatment with estrogen can block DNA damage-induced senescence. Moreover, WRN is suppressed by ATR that is activated by DNA damage, whereas WRN can be induced by ATR elimination. ",
              "citation": {
                "type": "PubMed",
                "name": "Horm Res Paediatr 2010 74(1) 33-40",
                "id": "20395656"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Jul 15 15(14) 1833-44",
                "id": "11459832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show that recombinant TopBP1 induces a large increase in the kinase activity of both Xenopus and human ATR",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2006 Mar 10 124(5) 943-55",
                "id": "16530042"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Interestingly, this function of the FA-protein nuclear complex might be mediated through FANCD2, which is phosphorylated by ATR using a mechanism that requires FANCC79.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In the present study, we identify two novel DNA damage-inducible phosphorylation sites on FANCD2, threonine 691 and serine 717. ATR phosphorylates FANCD2 on these two sites, thereby promoting FANCD2 monoubiquitination and enhancing cellular resistance to DNA cross-linking agents",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Sep 26(18) 7005-15",
                "id": "16943440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Nov 6 98(23) 13102-7",
                "id": "11687627"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The ATM (23) and ATR (24) protein kinases play key roles in p53 activation in response to IR and UV, respectively. Bulky chemical adducts have also been shown to induce stabilization and nuclear accumulation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e99d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e980"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": " Here we describe the FA protein FANCI, identified as an ATM/ATR kinase substrate required for resistance to mitomycin C.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Apr 20 129(2) 289-301",
                "id": "17412408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e976"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 41656-60",
                "id": "11514540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e953"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "ATR phosphorylates Chk2 on Thr68 in vitro, and phosphorylation of Thr68 in response to IR occurs later in cells lacking ATM (data not shown).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10389-94",
                "id": "10973490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e949"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "ATM and Rad3-related (ATR) is a regulatory kinase that, when activated by hydroxyurea, UV, or human immunodeficiency virus-1 Vpr, causes cell cycle arrest through Chk1-Ser(345) phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Mar 9 282(10) 7287-98",
                "id": "17210576"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e93a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "these kinases phosphorylate CDC25C, the molecule that is responsible for activating CDK1",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Thr-26 is evidently a good ATR substrate in vitro (34).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Mar 7 278(10) 8468-75",
                "id": "12493754"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We previously reported that compared with Fhit+/+ cells, Fhit-/- cells with an overactivated ATR/CHK1 pathway show increased mutation frequency and resistance to DNA damage-induced killing, indicating that Fhit and the CHK1 pathway have opposing roles in cells responding to DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Oct 1 65(19) 8613-6",
                "id": "16204026"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b1"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hum Genet 105(1-2) 17-27",
                "id": "10480350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Phosphorylation of ATM/ATR substrates and H2AX in VSMCs increased with disease severity in vivo (Figure 1A), reaching 70% to 90% of intimal VSMCs in advanced disease.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Sep 26 103(7) 717-25",
                "id": "18723444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e86b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show for the first time that MRN is required for ATR-dependent phosphorylation of structural maintenance of chromosomes 1 (Smc1)",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2005 Sep 15 14(18) 2685-93",
                "id": "16087684"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e85f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "ATR phosphorylates Chk1 at Ser317 and Ser345 in vitro, and phosphorylation of these sites in human cells in response to UV and hydroxyurea is ATR-dependent [16–19].",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Jun 1 388(Pt 2) 705-12",
                "id": "15707391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e85c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "heterogeneous nuclear ribonucleoprotein K (hnRNP K) as being rapidly induced by DNA damage in a manner that requires the DNA-damage signaling kinases ATM or ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Dec 16 123(6) 1065-78",
                "id": "16360036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e853"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show that Rad9's role in Chk1 activation is to bind TopBP1, which stimulates ATR-mediated Chk1 phosphorylation via TopBP1's activation domain (AD), a domain that binds and activates ATR. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Jun 15 21(12) 1472-7",
                "id": "17575048"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e84b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "The ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) kinases regulate cell cycle checkpoints by phosphorylating multiple substrates including the CHK1 and -2 protein kinases and p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37139-45",
                "id": "12847089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e828"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Thus, stimuli that activate these kinases, including exposure to pro-inflammatory cytokines, UV irradiation, DNA damage or change in ROS, are among the classic inducers of ATF2 transcriptional activity (van Dam et al., 1995).ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e812"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Evasion from apoptosis is a hallmark of cancer, and recent success using targeted therapeutics underscores the importance of identifying anti-apoptotic survival pathways. Here we utilize RNA interference (RNAi) to systematically screen the kinase and phosphatase component of the human genome.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Jun 7(6) 591-600",
                "id": "15864305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "In response to stress, Atr participates in the down-regulation of FRAG1 expression, leading to the induction of apoptosis through the release of Rad9 from damaged chromatin during the S phase of the cell cycle, allowing Rad9-Bcl2 association and induction of proapoptotic Bax protein.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jul 5 102(27) 9655-60",
                "id": "15983387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "UV transiently increased GSK-3beta activity, and this increase could be blocked by caffeine or by ATR small interfering RNA, indicating ATR-dependent activation of GSK-3beta.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Apr 27(8) 3187-98",
                "id": "17283049"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "15073328;16293623",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show that pure ATR is a protein kinase which is activated by circular single-stranded, double-stranded or linear DNA.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 18 18(48) 6707-13",
                "id": "10597277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "TRF2 represses ATM, whereas POT1 prevents activation of ATR. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2007 Aug 30 448(7157) 1068-71",
                "id": "17687332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Fhit overexpression leads to apoptosis in many cancer cell lines. We report in this study that Fhit-/- cells derived from gene knockout mice show much stronger S and G2 checkpoint responses than their wild type counterparts. The strong checkpoint responses are regulated by the ATR/CHK1 pathway",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Physiol 2005 Feb 202(2) 518-23",
                "id": "15389587"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": " Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 3 284(27) 18085-95",
                "id": "19416980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We show that caffeine's ability to inhibit ATR (but not ATM) causes PCC, that ATR (but not ATM) prevents PCC, and that ATR prevents PCC via Chk-1 regulation.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Jul 31 98(16) 9092-7",
                "id": "11481475"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e77a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "We demonstrate that activating ATR is sufficient to promote cell cycle arrest",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2008 Feb 1 22(3) 297-302",
                "id": "18245444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e745"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Using chemical inhibitors and small interfering RNA of the signaling kinases, we show that a MMR-mediated 6-TG-induced G2 arrest is ATR/CHK1 dependent but ATM/CHK2 independent and that ATR/CHK1 signaling is responsible for both initiation and maintenance of the G2 arrest. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Ther 2004 Sep 3(9) 1147-57",
                "id": "15367709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e715"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "ATR-dependent activation of Chk1 is mediated by Claspin. Phosphorylation of Claspin at two sites (Thr916 and Ser945 in humans) in response to DNA replication arrest or DNA damage recruits Chk1 to Claspin.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2008 May 9 369(3) 973-6",
                "id": "18331829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e713"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Taken together, our data indicate that S407 phosphorylation of Mdm2 by ATR reduces Mdm2-dependent export of p53 from nuclei to cytoplasm",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Dec 4 22(55) 8870-80",
                "id": "14654783"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "When ATM and ATR are recruited to sites of damage, they target many substrates, including checkpoint kinase-2 (CHK2) and CHK1, respectively (FIG. 2; BOX 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "Here, we show that ATRIP contains a TopBP1-interacting region that is necessary for the association of TopBP1 and ATR, for TopBP1-mediated activation of ATR, and for cells to survive and recover DNA synthesis following replication stress.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2008 Jun 1 22(11) 1478-89",
                "id": "18519640"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6aa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATR) actsIn kin(p(HGNC:ATR))",
              "summary_text": "caffeine, a widely used inhibitor to ATM/ATR",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jun 15 184(12) 6901-9",
                "id": "20488792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e68c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:CSNK1D))",
        "relation": "increases",
        "target": "p(HGNC:PER2,pmod(P))",
        "directed": false,
        "label": "kin(p(HGNC:CSNK1D)) increases p(HGNC:PER2,pmod(P))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051395",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:CSNK1D)) increases p(HGNC:PER2,pmod(P))",
              "summary_text": "both hCKIdelta and hCKIepsilon phosphorylated and caused protein instability of human period 2 protein (hPER2)",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 159-65",
                "id": "11165242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RB1)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:RB1))",
        "directed": false,
        "label": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ab",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "<E7> E2F-DP dimers, complexed with pRb, p107, or p130, can bind and inhibit E2 promoter elements (Dyson, 1998; Mayol and Grana, 1998). In quiescent cells, the predominant complexes contain E2F4 and p130. E2F1_DP:RB1-|taof(E2F1_DP) E2F2_DP:RB1-|taof(E2F2_DP) E2F3_DP:RB1-|taof(E2F3_DP) E2F4_DP:RB1-|taof(E2F4_DP) E2F1_DP:RBL1-|taof(E2F1_DP) E2F2_DP:RBL1-|taof(E2F2_DP) E2F3_DP:RBL1-|taof(E2F3_DP) E2F4_DP:RBL1-|taof(E2F4_DP) E2F1_DP:NOLC1-|taof(E2F1_DP) E2F2_DP:NOLC1-|taof(E2F2_DP) E2F3_DP:NOLC1-|taof(E2F3_DP) E2F4_DP:NOLC1-|taof(E2F4_DP)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e94f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "MEK1 and MEK2 contain a proline-rich sequence that enables recognition and activation by Raf.125,146-153 This sequence, which is not present in other MAPKKs, may explain why Raf preferentially activates MEK1 and MEK2, whereas the dualspecificity p38MAPK kinases (MKK3 and MKK6) and JNK kinases (MKK4 and MKK7) phosphorylate p38MAPK and JNK, respectively. Although both A-Raf and C-Raf are capable of activating other signaling elements independent of MAPK pathway activation, such as nuclear factor-kappa B (NF-kB), Rb, and Bcl-2",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e893"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Table1: Down-regulation by progesterone (fold) Gene\t\t\tPRA \t\tPRB  Fibronectin \t\tNone \t\t2.8 Integrin a3 \t\tNone \t\t2.8 Integrin B1 \t\tNone \t\t>10 Integrin B3 \t\t8 \t\t5.6 Cadherin 6\t\t6 \t\t8 Differences between the PR isoforms were evident: in general, PRB had a greater inhibitory effect on cellular adhesion molecule expression compared with PRA. Only PRB significantly inhibited the expression of fibronectin and the integrins 3 and B1, but both PR isoforms inhibited cadherin 6 and integrin B3.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Feb 1 62(3) 881-6",
                "id": "11830547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "carcinoma of endometrium",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "TGF-beta1 increased retinoblastoma protein phosphorylation at both Ser807/811 and Ser780. Silencing Nox4 prevented TGF-beta1-mediated retinoblastoma protein phosphorylation, proliferation, and cell hypertrophy. TGF-beta1 also increased phosphorylation of eukaryotic translation initiation factor 4E binding protein-1 at Thr37/46, and this was likewise blocked by silencing Nox4",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Lung Cell Mol Physiol 2007 Jun 292(6) L1543-55",
                "id": "17369289"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e692"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Besides p53, several other proteins that interact with BRCA1 have been identified, including c-myc, BAP-1 (48), and retinoblastoma susceptibility gene RB1 (49). cancers. It was recently shown that the product of the RB1 gene, Rb, regulates the expression of both the murine Brca1 and human BRCA1 genes (49).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Sep 15 60(18) 4993-5001",
                "id": "11016617"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea22"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "pllORb phosphorylated by cyclin D1/Cdk4 was significantly impaired in its ability to block S-phase entry. The percentage of cells that remained in G1 (29%) was similar to that observed with IgG, and the extent of pllORb inactivation correlated with the extent of phosphorylation by Cdk4 (Figure 3, A and B).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1997 Feb 8(2) 287-301",
                "id": "9190208"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Mammalian SNF5 is essential for normal cell viability, and loss or mutation of the human SNF gene is the molecular basis for familial malignant rhabdoid tumorigenesis. Previous studies have suggested that SNF5 suppresses cancer by signaling through the p16Ink4a and retinoblastoma tumor suppressors to negatively regulate cell cycle progression from G0/G1 into S phase.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2005 Apr 7(4) 294-5",
                "id": "15837618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "When compared to control cells, plaque VSMCs have increased expression of p16 and p21, a reduction in pRB phosphorylation, and increased levels of E2F-1/pRB complex [40].",
              "citation": {
                "type": "PubMed",
                "name": "Cardiovasc Res 2006 Oct 1 72(1) 9-17",
                "id": "16824498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "In this study, we show that expression of the FGF receptor-2 (FGFR-2) protein is induced in the mid-to-late G1 phase of the cell cycle in serum-starved mouse NIH3T3 cells released from starvation. Transcription of mouse FGFR-2 was activated by E2F-1. Analysis of various mouse FGFR-2 promoter mutant constructs showed that a sequence located +57/+64 downstream of the transcriptional initiation site, related to the consensus E2F-responsive sequence, is necessary for the activation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Aug 28 22(36) 5630-5",
                "id": "12944911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e936"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "there are a few other proteins that have been demonstrated to upregulate the transcriptional activity of the PR. Chromatin highmobility group protein 1, chromatin high-mobility group protein 2, TIP60 (Tat-interacting protein), proline-rich nuclear receptor coregulatory protein 1, proline-rich nuclear receptor coregulatory protein 2, Cdc25B, and GT198 all function as PR coactivators,",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2002 4(5) 182-6",
                "id": "12223121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e82d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Nicotine activates survivin gene transcription in A549 NSCLC cells by increasing the recruitment of E2F1 and the concomitant dissociation of Rb from the survivin promoter (7).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2008 Aug 29(8) 1614-22",
                "id": "18635526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Retinoblastoma and Wilms' tumor are rare childhood embryonic tumors associated with loss or inactivation of tumor suppressor genes, RB1 l",
              "citation": {
                "type": "PubMed",
                "name": "Am J Med Genet A 2003 Jul 1 120A(1) 105-9",
                "id": "12794701"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "table 1 - pRB pathway target genes cluster 1 - up-regulated by E2F and down-regulated by pRB and p16",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Nov 14 278(46) 46124-37",
                "id": "12923195"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea93"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Active Cyclin D ? Cdk6 then phosphorylates and inactivates Rb , thereby enhancing the expression of Cyclin A and Cyclin E , and thereby promoting G1-to-S transition . ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2007 6 65",
                "id": "17941990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea92"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 24 277(21) 19122-30",
                "id": "11889133"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea8b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "As a consequence, one of the targets of Cdk2, Rb1 , is hypophosophorylated, leading to sequestration of the E2F transcription factors, a family of proteins that are essential for G1/S progression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Oct 22(20) 7066-82",
                "id": "12242286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea71"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "The two, nearly identical, isoforms of human progesterone receptors (PR), PR-B and PR-A, share activation functions (AF) 1 and 2, yet they possess markedly different transcriptional profiles, with PR-B being much stronger transactivators.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 2006 Jun 8",
                "id": "16762974"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea68"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "loss of neurofibromin induced the accumulation of p53 and the activation of Rb, as demonstrated by reduced levels of hyperphosphorylated Rb (Figure 2A).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2006 Dec 10(6) 459-72",
                "id": "17157787"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea66"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "E2F-responsive sequence in the vicinity of the transcription initiation site is necessary for the E2F1-induced activation of MCM10 and TopBP1 gene transcription, which is further suppressed by pRb",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Aug 19 23(37) 6250-60",
                "id": "15195143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea4a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "K10-induced inhibition is hampered by cotransfection with viral oncoproteins which interfere with pRb but not with p53;",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Apr 19(4) 3086-94",
                "id": "10082575"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea30"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Several lines of evidence implicate pRb in osteogenesis. Viral oncoproteins that target the pocket proteins inhibit osteoblast differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Aug 8(2) 303-16",
                "id": "11545733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "These results suggest that Fas-mediated inactivation of Rb is mediated via the p38 kinase, independent of cdks",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Mar 15 18(6) 1559-70",
                "id": "10075927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "expression of CDK4/cyclin D1, which stimulated RB phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2000 Jul 11(7) 361-72",
                "id": "10939590"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Table I: Genes regulated by progesterone",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 15 277(7) 5209-18",
                "id": "11717311"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "In myometrial SMC, both isoforms of the progesterone receptor, PR-B and PR-A, caused a ligand-dependent activation of PGDH-2368/luc3. Transcriptional activity of PR-B was further enhanced by the addition of 8-bromo-cAMP",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2000 Feb 141(2) 581-97",
                "id": "10650939"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e994"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Progesterone (PG) increased IGFBP-5 expression in normal human osteoblasts and increased IGFBP-5 transcription in U2 human osteosarcoma cells...Using a luciferase reporter construct containing base pairs -252 to +24 of the IGFBP-5 promoter, we found that both PR(A) and PR(B) isoforms mediated PG stimulation of promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Sep 10 274(37) 26431-8",
                "id": "10473602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e963"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "osteoblast",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "The phosphorylation levels of RB at serine residues 780 and 795 were decreased in LNCaP cells treated with androgens.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 18 23(12) 2161-76",
                "id": "14676836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e960"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "These convergent studies have revealed the central role played by the pathway that controls the activity of the retinoblastoma tumor suppressor protein (Rb), which in turn regulates the E2F transcription factor.",
              "citation": {
                "type": "PubMed",
                "name": "Hum Mol Genet 2001 Apr 10(7) 699-703",
                "id": "11257102"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e95e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Research has identified the transcription factors Sp1, Rb, TEF4, Ets-1 and E2F as enhancing the expression of the cytidylyltransferase and Net as a factor that represses cytidylyltransferase expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Prog Lipid Res 2008 May 47(3) 204-20",
                "id": "18295604"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e941"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "We found that Id-1 expression induced phosphorylation of RB and down-regulation of p16(INK4a) but not p21(Waf1)or p27(Kip1)",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2002 May 23(5) 721-5",
                "id": "12016143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e92a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 May 15(5) 2536-46",
                "id": "7739537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e903"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "swi/snf activity is necessary to repress RB targets and activates GR targets, both events can induce a cessation of cellular proliferation (cell cycle arrest and/or apoptosis)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Aug 15 278(33) 30605-13",
                "id": "12775722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "GCIP, a newly identified cyclin D-interacting protein, was found to reduce the phosphorylation of retinoblastoma protein and inhibit E2F1-mediated transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2000 Dec 20 279(2) 732-7",
                "id": "11118353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ec"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "As shown in Figure 3A, exposure to CSE induced activation of ATM, p53, and pRb, a marked increase in p53 and p21, and a mild increase in p16 accumulation.  ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Dec 35(6) 681-8",
                "id": "16840774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "These are promoter-specific events because Rb binds to the mitogenic cdc25A promoter upon TNF-alpha stimulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 10 279(37) 38762-9",
                "id": "15210709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "pRB can enforce a G1 block by repressing E2F-responsive promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Jun 10 18(6) 623-35",
                "id": "15949438"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Id2 is a natural inhibitor of the basic helix-loop-helix transcription factors and the retinoblastoma tumor suppressor protein.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Mar 28 103(13) 4976-81",
                "id": "16549780"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1994 Feb 25 269(8) 6083-8",
                "id": "8119953"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "in addition, both pRb and its relative p107 inhibited transcription from the Htf9-a promoter. These results link the control of Htf9-a/RanBP-1 expression to the cell cycle progression.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1995 Oct 6(10) 1213-24",
                "id": "8845298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "As shown in Fig. 4A, both HG and TNF-alpha phosphorylated Rb in VSMC, and the maximal phosphorylation was observed at 6 and 3 h, respectively. The increase in phosphorylation of Rb was significantly inhibited by AR inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2010 May 151(5) 2140-50",
                "id": "20308528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ce"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "we demonstrated that both HBP1 and RB were involved in the activation of H1(0) gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Sep 20(18) 6627-37",
                "id": "10958660"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e89a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1991 Apr 15 88(8) 3052-6",
                "id": "1901652"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e88d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Jul 13 19(30) 3352-62",
                "id": "10918592"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e88a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Although the receptor-selective retinoids induce minimal amounts of apoptosis in T47D breast cancer cells, the predominant factor that leads to growth arrest is G1 cell cycle blockade. Our data indicate that this blockade results from the downregulation of Cyclin D1 and Cyclin D3, which in turn causes Rb hypophosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res Treat 2006 Mar 96(2) 147-57",
                "id": "16273314"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e889"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Furthermore, activated Rac and Cdc42, but again not Rho, are capable of inducing cyclin D1 accumulation and pRB hyperphosphorylation in serum-deprived cells, outlining one route leading to enhanced E2F-mediated transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Jul 24 273(30) 18812-8",
                "id": "9668055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e86d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "PD 0183812 blocks phosphorylation on pRb in tumor cells PD 0183812 inhibits phosphorylation of pRb at serine 780",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 18 276(20) 16617-23",
                "id": "11278443"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e85d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": " In HeLa cells, luciferase activity of the promoter for RB1, p16 and p21 increased significantly upon transfection of plasmid expressing RB1CC1 (RB1CC1wt) ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(6) e11404",
                "id": "20614030"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e843"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "from full text - Stimulation of quiescent cells with bombesin/insulin, PDB/insulin or forskolin/ insulin caused the initial appearance of pRb hyperphosphorylation 15 h after treatment, whilst bombesin alone first caused hyperphosphorylation of pRb after 21 h (Figure 1).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Apr 17 14(15) 1759-66",
                "id": "9150381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e83c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Endostatin decreased the hyperphosphorylated retinoblastoma gene product and down-regulated cyclin D1 mRNA and protein",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 16464-9",
                "id": "11815623"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e833"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "While E2F1-induced activation of human Cdt1 gene transcription was suppressed by pRb, but not by p107 or p130, its E2F4-induced activation was suppressed by pRb, p107, and p130.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 May 6 23(21) 3802-12",
                "id": "14990995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e82a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Rb is a transcriptional repressor of cyclin E gene",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 May 28 20(24) 3134-8",
                "id": "11420730"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "SMRT TRAC2 Represses unliganded TR, RAR, ER and PR",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "# Ariadne: Instead, BRG1 activates pRB by inducing its hypophosphorylation through up-regulation of the cdk inhibitor p21. [Regulation]",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(3) 1188-99",
                "id": "14729964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "sites. pRb associated with both the proximal and distal osteocalcin and osteopontin promoters, and these inter- actions were reduced by E7 (Figure 4B). CBFA1 bound to both osteocalcin and osteopontin fragments, and this was not consistently altered by E7 with the promoters tested. Neither pRb nor CBFA1 was associated with the",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Aug 8(2) 303-16",
                "id": "11545733"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e79d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Unliganded PR-B disrupted the DNA-binding activity of BTEB1 in gel retardation assays, and this effect was enhanced by the presence of PR ligand.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2002 Jan 143(1) 62-73",
                "id": "11751593"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e78b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Treatment of VSMC with AR inhibitor sorbinil prevented HG- as well as TNF-alpha-induced phosphorylation of retinoblastoma protein and activation of E2F-1.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2010 May 151(5) 2140-50",
                "id": "20308528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e788"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "This is strikingly illustrated by the observation that the expression of the constitutively active T320A mutant of PP1-alpha, but not that of the wild-type PP1-alpha, prevented the Rb phosphorylation in late G1 and caused cell cycle arrest (35).",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Rev 2004 Jan 84(1) 1-39",
                "id": "14715909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e752"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "These results indicate that (a) PRB preferentially regulates VEGF expression in breast cancer cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Mar 15 64(6) 2238-44",
                "id": "15026368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e744"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Progesterone also has two receptors, PRA and PRB. they function as ligand-dependent nuclear transcription factors.",
              "citation": {
                "type": "PubMed",
                "name": "Breast Cancer Res 2002 4(5) 197-201",
                "id": "12223124"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e73c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Rb inactivation is found in f90% of SCLC, whereas p16INK4a is inactivated by deletion and/or promoter hypermethylation in f50% of NSCLC (3)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Jun 15 68(12) 4487-90",
                "id": "18559489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e723"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma, Small Cell",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Raf-1 can inactivate Rb function and can reverse Rb-mediated repression of E2F1 transcription and cell proliferation efficiently",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Dec 18(12) 7487-98",
                "id": "9819434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e711"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "We also found that Suv39H1 and Rb cooperate to repress E2F activity and that Suv39H1 could be recruited to E2F1 through its interaction with Rb.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Oct 21(19) 6484-94",
                "id": "11533237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Suv39H1 bound the so-called 'core histone deacetylase complex', composed of HDAC1, HDAC2 and the Rb-associated proteins RbAp48 and RbAp46.  Taken together, our results suggest that a complex containing both the Suv39H1 histone methyl transferase and histone deacetylases could be involved in heterochromatin silencing or transcriptional repression by Rb.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2002 Jan 15 30(2) 475-81",
                "id": "11788710"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "HBP1 inhibited transcriptional activation by the MyoD family members. The inhibition of MyoD family function by HBP1 required binding to RB and/or p130. HBP1 probably blocked differentiation by disrupting Myf5 function, thus preventing expression of MyoD and myogenin.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1998 Aug 18(8) 4732-43",
                "id": "9671483"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Full text: Overexpression of wild-type FRK/RAK showed a majority of the protein in the nucleus where it bound pRB during G1 and S phases of the cell cycle and inhibited cell growth [55].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Mol Med 2003 Jun 3(4) 313-24",
                "id": "12776987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Therefore, we evaluated the state of the latter in DHEA-treated HUVEC and found that DHEA decreased the percentage of phosphorylated RB protein (19% vs. 35% in control cells) (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "FEBS J 2005 Mar 272(6) 1343-53",
                "id": "15752352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "umbilical vein endothelial cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "In addition, HDAC1 overexpression led to senescence through both an accumulation of hypophosphorylated active retinoblastoma protein (pRb) and an increase in the protein level of protein phosphatase 2A catalytic subunit (PP2Ac).",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2011 Apr 15 407(3) 587-92",
                "id": "21420382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6be"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "RB stimulated the expression of a differentiation-related gene, the surfactant protein D (SP-D), which plays important roles in innate host defense and the regulation of surfactant homeostasis. We demonstrated that RB specifically stimulated the activity of human SP-D gene promoter",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biochem 83(3) 414-25",
                "id": "11596110"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Wild-type Rb also enhanced the binding of C/EBP to cognate DNA sequences in vitro and the transactivation of a C/EBPbeta-responsive promoter in cells",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1996 Nov 1 10(21) 2794-804",
                "id": "8946919"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e69e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Arrest in G1 phase of the cell cycle is associated with decreased levels of cyclins D1 and E RNA and protein, resulting in dramatically reduced Rb phosphorylation.",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2004 Jan 22 5 5",
                "id": "14736338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e68a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "We had found previously that growth factor stimulation of quiescent cells lead to the direct binding of Raf-1 kinase to Rb, leading to its inactivation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Nov 24(21) 9527-41",
                "id": "15485920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e673"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": " Blocking the functions of the Rb protein family or adding back E2Fs to PML-expressing cells can rescue their defects in E2F-dependent gene expression and cell proliferation, inhibiting  the senescent phenotype. ",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2011 Jan 1 25(1) 41-50",
                "id": "21205865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e66a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "Che-1 has a viral factor-like S phase promoting role in counteracting Rb repression to facilitate E2F-dependent transactivation during G1-S transition",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Cell Biol 2007 Aug 85(4) 477-83",
                "id": "17713582"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e669"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RB1) actsIn tscript(p(HGNC:RB1))",
              "summary_text": "It was observed that low levels of E2F1 and high levels of Rb were bound to the cdc6 and cdc25A promoters in quiescent A549 cells. Stimulation with 1 ?M nicotine caused the dissociation of Rb from both the promoters, while there were increased amounts of E2F1 bound to them (Figure 1H, top 2 panels).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2006 Aug 116(8) 2208-2217",
                "id": "16862215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e660"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:E2F1)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:E2F1))",
        "directed": false,
        "label": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513af",
          "evidences": [
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Furthermore, we investigated the effect of E2F1 overexpression to cyclin D1 and cyclin E expression. Because we previously reported that the regulation of G1 cyclins is a key factor in the G1/S transition phase in mesangial cells, we showed that overexpression of E2F1 induced protein expression of cyclin D1 and cyclin E and increased promoter activity. Thus, we conclude that E2F1 plays an important role in the G1/S transition phase and acts on the mesangial cell cycle through two distinct pathways: (1) E2F1 directly transcribes an S-phase gene, and (2) E2F1 promotes cell cycle progression via the induction of cyclin D1 and cyclin E.",
              "citation": {
                "type": "PubMed",
                "name": "Kidney Int 1999 Oct 56(4) 1238-41",
                "id": "10504464"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The transcription factors driving MYCN expression in neuroblastomas are unknown. In transient-transfection assays, E2F-1, E2F-2, and E2F-3 activate a MYCN reporter construct dependent on the presence of several putative E2F-binding sites. Using chromatin immunoprecipitation, we show that E2F-1, E2F-2, and E2F-3 bind to the proximal MYCN promoter in vivo, specifically in neuroblastoma cell lines expressing MYCN.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Jan 31 278(5) 2983-9",
                "id": "12438307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea7a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Through isolation and analysis of the SIVA promoter, we have identified response elements for both p53 and E2F1. Like p53, E2F1 is another tumor suppressor gene involved in the regulation of apoptosis, including neuronal injury models. We have identified E2F consensus sites in the promoter region, whereas p53 recognition sequences were found in intron1. Sequence analysis has shown that these consensus sites are also conserved between mouse and human SIVA genes. Electrophoretic mobility shift assays reveal that both transcription factors are capable of binding to putative consensus sites, and luciferase reporter assays reveal that E2F1 and p53 can activate transcription from the SIVA promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 2 279(27) 28706-14",
                "id": "15105421"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea67"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "o examine whether E2F8 is an E2F-target gene, we used U2OS cells stably expressing E2F1 fused to the estrogen receptor ligand-binding domain (ER-E2F1), which has been characterized previously (16,17). Briefly, in the presence of 4-hydroxytamoxifen (OHT) ER-E2F1 is translocated from the cytosol to nucleus of the cells and E2F-regulated genes are induced. After 4 h of OHT induction in the presence or absence of cycloheximide (CHX), total RNA was isolated and the levels of E2F8 transcripts were determined by qPCR (Figure 4A). An ~10-fold up-regulation of E2F8 mRNA levels was observed. The magnitude of induction was comparable with that of E2F7.",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2005 33(17) 5458-70",
                "id": "16179649"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea48"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Here we show that NPAT transcription is up-regulated at the G(1)/S-phase boundary in growth-stimulated cells and that the NPAT promoter responds to activation by E2F proteins.....e cloned various DNA fragments from the 5' end of the NPAT  gene into a luciferase reporter plasmid and tested their activation by E2F1 in transient transfection assays (Fig. 2B). Several NPAT promoter constructs were strongly activated by E2F1. Deletion of nucleotides 5' to the putative E2F binding sites in the NPAT promoter did not impede the activation of the NPAT promoter by E2F1. In contrast, a deletion that removes  one putative E2F binding site (pGL-N86) significantly impaired  the activation of the promoter by E2F1, and deletion of both  putative E2F binding sites (pGL-N30) abolished the activation  of the promoter by E2F1 (Fig. 2B). These results suggest that NPAT transcription is regulated by E2F, presumably through the E2F recognition sites in the promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Apr 23(8) 2821-33",
                "id": "12665581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea46"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Figure 5. Regulation of the core cell-death machinery by E2F-1 and the p53 family. E2F-1 can regulate apoptosis in many ways. It can induce cell death by stabilizing the levels of p53 through activating the ARF tumor suppressor, which suppresses Mdm2, a negative regulator of p53. The p53 protein regulates the transcription of several celldeath genes including BH3-only proteins, proapoptotic Bcl-2 protein Bax and the caspase-9 adaptor Apaf-1. In cells lacking p53, E2F-1 can act through p73, a member of p53 family that activates some of the same target genes as p53. E2F-1 can also directly regulate the transcription of several different caspases and suppress cell survival pathways by suppressing Mcl-1 expression or by inhibiting NFkB-mediated antiapoptotic signaling.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Biochem Sci 2004 Apr 29(4) 193-9",
                "id": "15082313"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "researchers explored the possibility that E2F regulators play a broader role by identifying additional genes bound by E2F in living human cells the promoters of 127 genes were bound by the E2F4 transcription factor in primary fibroblasts a subset of these target was also bound by E2F1 need to somehow include that E2F4 and E2F5 usually are acting as repressors, in G0 and G1 and that their ability to be in the nucleus may depend on posttranslational modification, association with RB family members, or heterodimerization with DP2 E2F4 bound to living quiescent cells coincides with recruitment of p130, diminished acetylation of histones at the promoter and gene repression E2F4 and E2F5 could activate transcription under some circumstances, because E2F4 has been detected on certain mouse promoters in late G1/S phase",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 Jan 15 16(2) 245-56",
                "id": "11799067"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": ". Here we show that mice deficient in E2F1 exhibit enhanced angiogenesis. The proangiogenic phenotype in E2F1 deficiency is the result of overproduction of vascular endothelial growth factor (VEGF) and is prevented by VEGF blockade. Under hypoxic conditions, E2F1 down-regulates the expression of VEGF promoter activity by associating with p53 and specifically down-regulating expression of VEGF but not other hypoxia-inducible genes, suggesting a promoter structure context-dependent regulation mechanism. We found that the minimum VEGF promoter mediating transcriptional repression by E2F1 features an E2F1- binding site with four Sp-1 sites in close proximity. These data disclose an unexpected function of endogenous E2F1: regulation of angiogenic activity via p53-dependent transcriptional control of VEGF expression.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Jul 18 103(29) 11015-20",
                "id": "16835303"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e993"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Endothelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Ectopic expression of E2F1 protein was found to increase E2F6 mRNA levels and significantly upregulate E2F6 promoter activity. Deletion or mutation of the putative E2F binding sites nullified the effects of E2F1 on the E2F6 promoter activity. Studies on the temporal induction of E2F family members demonstrated that the activating E2Fs, and most notably E2F1, were upregulated before E2F6 during cell cycle progression at the G1/S phase, and this coincided with the time course of induction experienced by the E2F6 promoter during the course of the cell cycle. EMSAs indicated the specific binding of nuclear complexes to the E2F6 promoter that contained E2F1-related species whose binding was specifically competed by the consensus E2F binding site. Chromatin immunoprecipitation assays with anti-E2Fs demonstrated the association of E2F family members with the E2F6 promoter in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Cell Physiol 2006 Jan 290(1) C189-99",
                "id": "16107498"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e96d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The interaction of RB and E2F transcription factors represents a functional interaction that has been the predominant focus in the field. RB and the related family members p107 and p130 can each bind E2F to repress genes that are otherwise important for progression from G1 to S phase. The binding of RB, p107, or p130 has two simultaneous consequences: (1) binding prevents E2F from interacting with transcriptional co-activators (e.g., p300); and (2) binding recruits chromatin-modifying enzymes [e.g., histone deacetylases (HDACs)] to silence transcription. E2F itself is a family of transcription factors that include six E2F and three DP proteins, which together form the heterodimeric complex that comprises E2F transcriptional activity (reviewed in Trimarchi and Lees, 2002 and Yee and Wang, 2003). While there is considerable complexity, gene repression in G1 phase utilizes RB and E2Fs 1, 2, 3, and 4, while gene repression in G0 utilizes primarily p130 and E2Fs 4 and 5. binding prevents E2F from interacting with transcriptional co-activators (e.g., p300); and",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2004 Jul 7 336(1) 1-13",
                "id": "15225871"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e94c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "E2F-1 enhanced the expression of Apaf-1 without the cytosolic accumulation of cytochrome c. Apaf-1-deficient melanoma cell lines were resistant to E2F-1, indicating that Apaf-1 is an essential element of E2F-1-mediated apoptosis. Finally, we isolated the promoter region of the Apaf-1 gene and found a putative binding site for E2F. A chromatin immunoprecipitation assay revealed that E2F-1 bound to Apaf-1 promoter upon E2F-1 overexpression, suggesting that Apaf-1 is under transcriptional regulation of E2F-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39760-8",
                "id": "12149244"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e91a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Here we show that NPAT transcription is up-regulated at the G(1)/S-phase boundary in growth-stimulated cells and that the NPAT promoter responds to activation by E2F proteins.....e cloned various DNA fragments from the 5' end of the NPAT  gene into a luciferase reporter plasmid and tested their activation by E2F1 in transient transfection assays (Fig. 2B). Several NPAT promoter constructs were strongly activated by E2F1. Deletion of nucleotides 5' to the putative E2F binding sites in the NPAT promoter did not impede the activation of the NPAT promoter by E2F1. In contrast, a deletion that removes  one putative E2F binding site (pGL-N86) significantly impaired  the activation of the promoter by E2F1, and deletion of both  putative E2F binding sites (pGL-N30) abolished the activation  of the promoter by E2F1 (Fig. 2B). These results suggest that NPAT transcription is regulated by E2F, presumably through the E2F recognition sites in the promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Apr 23(8) 2821-33",
                "id": "12665581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "MCM10 and TopBP1 function in the initiation of DNA replication, by regulating the chromatin binding of the DNA polymerase alpha loading factor, CDC45. TopBP1 is also known as a DNA damage response protein. In this study, we showed that the transcription of human MCM10 and TopBP1 is activated by transcription factors E2F1-3, but not by factors E2F4-7. Analysis of various MCM10 and TopBP1 promoter constructs showed that an E2F-responsive sequence in the vicinity of the transcription initiation site is necessary for the E2F1-induced activation of MCM10 and TopBP1 gene transcription, which is further suppressed by pRb. The promoter activities of human MCM10 and TopBP1 were demonstrated to be growth dependent via the E2F-responsive sequence. Although E2F1 was stabilized by ultraviolet (UV) irradiation, the mRNA expression level of TopBP1 was suppressed in HCT116 human diploid colon cancer cells. We showed, by performing chromatin immunoprecipitation that, in response to UV irradiation but not doxorubicin treatment, E2F4 accumulated on the MCM10 and TopBP1 promoters. Our data suggest a model in which UV irradiation-induced DNA damage depends, at least in part, on the accumulation of the E2F4 transcription factor on the MCM10 and TopBP1 promoters, which results in suppression of DNA replication.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Aug 19 23(37) 6250-60",
                "id": "15195143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e81b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "During hypoxia (CoCl(2), 800 microM)-induced human embryonic kidney 293 cell apoptosis, E2F6 expression was down-regulated with concurrent increases in E2F1 expression and transactivation. E2F6 overexpression abrogated hypoxia-induced apoptosis and alteration of E2F1. Conversely, specific knockdown of E2F6 by small interfering RNA had opposite effects. Chromatin immunoprecipitation assay confirmed that E2F6 regulated E2F1 expression through the transrepression of E2F1 promoter. Interestingly, E2F1 transactivation and apoptosis induced by hypoxia in cells stably expressing E2F1 were inhibited by E2F6 overexpression, suggesting that the inhibitory effects of E2F6 are not only mediated by the repression of E2F1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2008 Sep 19(9) 3691-700",
                "id": "18562691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "ICBP90, inverted CCAAT box-binding protein of 90 kDa, has been reported as a regulator of topoisomerase IIalpha expression. We present evidence here that ICBP90 binds to methyl-CpG when at least one symmetrically methylated-CpG dinucleotides is presented as its recognition sequence. A SET and RING finger-associated (SRA) domain accounts for the high binding affinity of ICBP90 for methyl-CpG dinucleotides. This protein constitutes a complex with HDAC1 also via its SRA domain, and bound to methylated promoter regions of various tumor suppressor genes, including p16INK4Aand p14ARF, in cancer cells. It has been reported that expression of ICBP90 was upregulated by E2F-1, and we confirmed that the upregulation was caused by binding of E2F-1 to the intron1 of ICBP90, which contains two E2F-1-binding motifs. Our data also revealed accumulation of ICBP90 in breast-cancer cells, where it might suppress expression of tumor suppressor genes through deacetylation of histones after recruitment of HDAC1. The data reported here suggest that ICBP90 is involved in cell proliferation by way of methylation-mediated regulation of certain genes.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Oct 7 23(46) 7601-10",
                "id": "15361834"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We found that overexpression of E2F1-3, which acts mainly in late G(1), inhibits promoter activity and endogenous expression of the urokinase-type PA (uPA) and PA inhibitor 1 (PAI-1) genes. This effect is dose dependent and conserved in evolution. Mutation analysis indicated that both the DNA-binding and transactivation domains of E2F1 are necessary for this regulation. Interestingly, an E2F1 mutant lacking the pRB-binding region strongly repressed the uPA and PAI-1 promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Mar 20(6) 2014-22",
                "id": "10688648"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e791"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "(From full text)  In another approach to indirectly activate endogenous E2F, we employed mutant SAOS2 cells expressing temperature-sensitive pRB [47]. Shift of the culture to permissive temperature, allows the formation of pRB-E2F1 complexes, which would prevent the function of E2F resulting in the derepression of the PAI-1 gene. Accordingly, we found that shift of the culture to the permissive temperature induced PAI-1 mRNA (Fig. 3)Go. In contrast, the temperature shift had no effect on PAI-1 gene expression in control SAOS-2 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 Sep 268(18) 4969-78",
                "id": "11559366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e74e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Cyclin E2 induction by estrogen was accompanied by recruitment of E2F1 to the cyclin E1 and E2 promoters, and cyclin D1 induction was sufficient for E2F1 recruitment. siRNA-mediated knockdown of the chromatin remodelling factor CHD8 prevented cyclin E2 upregulation. Together, these data indicate that cyclin E2-Cdk2 activation by estrogen occurs via E2F- and CHD8-mediated transcription of cyclin E2 downstream of cyclin D1. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2009 Sep 29(17) 4623-39",
                "id": "19564413"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e742"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The ASPP2/53BP2L promoter was identified and ectopic expression of transcription-competent E2F-1 (E2F-2 and E2F-3) stimulated an ASPP2/53BP2L promoter-luciferase reporter. Mutational analysis of the ASPP2/53BP2L promoter identified E2F-binding sites that cooperate for E2F-1 induction and basal repression of ASPP2/53BP2L. Moreover, endogenous ASPP2/53BP2L levels increased after E2F-1 expression, and E2F-1 bound the endogenous ASPP2/53BP2L promoter after chromatin immunoprecipitation. Typical for an E2F target, ASPP2/53BP2L expression was maximal in early S-phase. Thus, ASPP2/53BP2L is downstream of E2F",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2005 Apr 12(4) 358-68",
                "id": "15592436"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We found that activity deprivation induces cdc2 transcription in neurons via an E2F-binding element (EBE) within the cdc2 promoter. The transcription factor E2F1 that is expressed in granule neurons was found in DNA binding assays to bind to the EBE of the cdc2 gene. In chromatin immunoprecipitation analysis, endogenous E2F1 forms a complex with the promoter of the endogenous cdc2 gene in granule neurons, indicating that endogenous E2F1 is poised to activate transcription of the endogenous cdc2 gene in neurons. Consistent with this conclusion, a dominant interfering form of E2F, when expressed in granule neurons, blocked activity deprivation-induced cdc2 transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "J Neurosci 2003 Mar 1 23(5) 1649-58",
                "id": "12629169"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "neuron",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway — for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-D–Cdk4 from phosphorylating Rb — unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 4–6,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e67c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "These reported that overexpression of E2F1 suppresses the expression of two apoptotic antagonists, BCL-2 and its family member MCL-1 (myeloid leukaemia cell differentiation protein 1), thereby leading to apoptosis.In both cases, transcriptional repression is direct and dependent on the DNA-binding domain of E2F1.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eabd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We now report that miR-20a, a member of the mir-17-92 cluster, modulates the translation of the E2F2 and E2F3 mRNAs via binding sites in their 3'-untranslated region. We also found that the endogenous E2F1, E2F2, and E2F3 directly bind the promoter of the mir-17-92 cluster activating its transcription, suggesting an autoregulatory feedback loop between E2F factors and miRNAs from the mir-17-92 cluster.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Jan 26 282(4) 2135-43",
                "id": "17135249"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Third, HBP1 can function as a transcriptional repressor of the promoter for N-MYC, which is a critical cell cycle and developmental gene. Fourth, because the activation of the N-MYC promoter in cycling cells required the E2F transcription factor, we show that E2F-1 and HBP1 represent opposite transcriptional signals that can be integrated within the N-MYC promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1997 Feb 1 11(3) 383-96",
                "id": "9030690"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e989"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Several E2F binding sites were detected in the genomic sequence and E2F1 induced Chk1 promoter activity in co-transfection experiments. This induction was abolished when a mutated form of E2F1, not able to bind DNA, was used. Over-expression of E2F1 sustained an increased Chk1 promoter activity, whereas overexpression of Rb protein, which binds E2F factors, decreased Chk1 promoter activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2(6) 604-9",
                "id": "14504477"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e986"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "aurora B promoter activity was upregulated during M phase, and its cell cycle-dependent element (CDE) and cell cycle-gene homology region (CHR) upstream of the transcription initiation sites regulated the cell cycle-dependent promoter activity. binding of E2F-1, E2F-4, and DP-2, but not of DP-1, to the CDE was detected.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Apr 9 316(3) 930-6",
                "id": "15033491"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e983"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Bcl-2 homology 3 (BH3)-only proteins are pro-apoptotic members of the Bcl-2 protein family that trigger apoptosis in response to diverse stimuli. We show here that E2F1 up-regulates the expression of the pro-apoptotic BH3-only proteins PUMA, Noxa, Bim, and Hrk/DP5 through a direct transcriptional mechanism.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Mar 5 279(10) 8627-34",
                "id": "14684737"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e96f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Gel shift, supershift assay, and ChIP analysis demonstrated the specific binding of NFY and E2F1 proteins to the mouse PNRC2 promoter. Transient transfections and luciferase assays further revealed that overexpression of NFY enhanced-promoter activity of PNRC2 gene in a dose-dependent manner while overexpression of E2F1 strongly repressed the activity of the PNRC2 promoter",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2005 Nov 21 361 89-100",
                "id": "16181749"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e894"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "In this study, we show that expression of the FGF receptor-2 (FGFR-2) protein is induced in the mid-to-late G1 phase of the cell cycle in serum-starved mouse NIH3T3 cells released from starvation. Transcription of mouse FGFR-2 was activated by E2F-1. Analysis of various mouse FGFR-2 promoter mutant constructs showed that a sequence located +57/+64 downstream of the transcriptional initiation site, related to the consensus E2F-responsive sequence, is necessary for the activation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Aug 28 22(36) 5630-5",
                "id": "12944911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e75f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "On the other hand, E2F1 elevates the ATM promoter activity and induces an increase in ATM at both the RNA and protein levels that is accompanied by an E2F-induced increase in p53 phosphorylation. Since E2F-1 is a critical downstream target of the tumor suppressor retinoblastoma protein (RB), ATM may thus provide a link between RB/E2F and p53 (70).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Oct 24(10) 1571-80",
                "id": "12919958"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e75d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "To test whether this site is functional, we cotransfected PCNA-CAT genes with E2F-1 and DP-1 expression plasmids. Expression of the E2F-1/DP-1 heterodimer activated the CAT gene with the PCNA intron. Therefore, this intron region, involved in transcriptional activation at the cell cycle G1/S boundary, is also E2F inducible.",
              "citation": {
                "type": "PubMed",
                "name": "Gene Expr 1995 4(3) 95-109",
                "id": "7734951"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e753"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "In a first step toward elaborating the mechanism for cyclin D1-mediated induction of p21 gene expression we show that co-expression of E2F-1 and DP-1 can specifically transactivate the p21 promoter. In support of these findings and a direct effect of E2F on induction of p21 gene expression a putative E2F binding site was identified within the p21 promoter. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 May 29 14(21) 2533-42",
                "id": "9191053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e709"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "glioblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We also show that LRBA promoter activity and endogenous LRBA mRNA levels are reduced by p53 and increased by E2F1, indicating that mutations in the tumor suppressors p53 and Rb could contribute to the deregulation of LRBA",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 May 20 23(23) 4089-97",
                "id": "15064745"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Jul 15 15(14) 1833-44",
                "id": "11459832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Nicotine activates survivin gene transcription in A549 NSCLC cells by increasing the recruitment of E2F1 and the concomitant dissociation of Rb from the survivin promoter (7).",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2008 Aug 29(8) 1614-22",
                "id": "18635526"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "ribonucleotide reductase 2 (RR2) and cyclin A are stimulated by both E2F1 and E2F2",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2002 Jun 21 1602(2) 131-50",
                "id": "12020800"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea90"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "JNK1 phosphorylates E2F1 in vitro, and co-transfection of JNK1 reduces the DNA binding activity of E2F1;",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Mar 15 18(6) 1559-70",
                "id": "10075927"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea73"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "While E2F1-induced activation of human Cdt1 gene transcription was suppressed by pRb, but not by p107 or p130, its E2F4-induced activation was suppressed by pRb, p107, and p130.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 May 6 23(21) 3802-12",
                "id": "14990995"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea6f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Among the members of the E2F family, E2F1 to E2F5, but not E2F6, activated the ASF1B reporter construct.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2007 Feb 26(2) 91-9",
                "id": "17328667"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea6e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "ectopic expression of E2F1 repressed the plasminogen activator inhibitor type 1 (PAI-1) promoter",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 2001 Sep 268(18) 4969-78",
                "id": "11559366"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea5d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "glioblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Necdin and MAGE-G1 interacted with the transcription factor E2F1 via its transactivation domain, repressed E2F1-dependent transcription, and antagonized E2F1-induced apoptosis of N1E-115 neuroblastoma cells.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jan 16 279(3) 1703-12",
                "id": "14593116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea51"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "neuroblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Through an expression cloning approach, we identified E2F-1 as a repressor of the hTERT gene in human tumor cells.",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Dec 16(14) 1943-5",
                "id": "12368233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea4c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "tumor"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "upregulation of p21WAF1 and inhibition of E2F-stimulated transcription accompanied inhibition of cell growth by IFI 16 in prostate cancer cell lines.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jul 31 22(31) 4831-40",
                "id": "12894224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea42"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "<p42> E2F1 directly activates the p19ARF gene promoter and induces the expression of p19ARF",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea3a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Regulation of E2F1-mediated apoptosis is essential for proper cellular growth. This control requires TopBP1, a BRCT (BRCA1 carboxyl-terminal) domain-containing protein, which interacts with E2F1 but not other E2Fs and represses its proapoptotic activity.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2006 Oct 18 25(20) 4795-807",
                "id": "17006541"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea2d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Second, all of the growth-stimulatory members of the E2F family (E2F1, -2, and -3A) potently activate a cyclin D3 promoter reporter, whereas growth-restraining members of the family (E2F4, -5, and -6) have little effect. Third, recombinant E2F1 binds with high affinity to the cyclin D3 promoter in vitro. Fourth, chromatin immunoprecipitation assays demonstrate that endogenous E2F1 is associated with the cyclin D3 promoter in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 9 278(19) 16770-6",
                "id": "12611887"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea2c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "we found that two important downstream target genes of estrogen and heregulin-beta1 that are regulated through E2F-1, cyclin E and NPAT, were both regulated in a similar fashion by all-trans retinoic acid, and these effects were antagonized by dominant-negative HES-1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Nov 18 23(54) 8826-33",
                "id": "15467735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea27"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Using CAT reporter co-transfection assays we show here that transcription from the MYC P2 promoter is induced efficiently by E2F-1, but repressed by RB.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1994 Jul 9(7) 2029-36",
                "id": "8208548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea0f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1560-9",
                "id": "14749372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea0d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The results show that the cytochrome c\\\" promoter is modulated by both E2F1 and E2F6; being activated by the former and suppressed by the latter.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2000 Oct 1 351(Pt 1) 251-6",
                "id": "10998368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea0c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Activation of HsOrc1 transcription following growth stimulation requires G1 cyclin-dependent kinase activity, and forced E2F1 expression can bypass this requirement.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Dec 16(12) 6977-84",
                "id": "8943353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea0a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "In contrast, the Cdc45 protein, another RC component, which turned out to be a transcriptional target of E2Fs, was induced to express and subsequently bound to chromatin in response to E2F-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 3 275(9) 6337-45",
                "id": "10692433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea09"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "This report shows that the cell-cycle and apoptosis regulator E2F1 induces SirT1 expression at the transcriptional level",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2006 Sep 8(9) 1025-31",
                "id": "16892051"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The mechanism for the cell cycle downregulation appeared to be a transcriptional downregulation of E2F-1, a transcription factor that regulates genes required for cell cycle progression beyond the G1/S interphase.",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 2000 Jan 10 1495(1) 51-68",
                "id": "10634932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "E2F can activate both transcription of cyclin A and the hEmi1-dependent stabilization of APC(Cdh1) targets, such as cyclin A, to promote S phase entry",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2002 May 4(5) 358-66",
                "id": "11988738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Furthermore, phosphorylation of retinoblastoma protein by cyclin D-dependent protein kinase was reduced and E2F1-mediated transcription activity was inhibited in cells transfected with GCIP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 7 275(27) 20942-8",
                "id": "10801854"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We have found that E2F1 and E2F3, transcription factors that activate genes required for cell cycle progression, are strong activators of the p21 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Dec 31 17(26) 3463-9",
                "id": "10030670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "E2F promoter and RT-PCR assay clearly demonstrated that proteasome inhibitors could reduce E2F transcriptional activation.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jun 11 318(4) 868-72",
                "id": "15147952"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "In this study, we show that E2F1 up-regulates the expression of axin2.",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 2005 Feb 1 303(1) 32-46",
                "id": "15572025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e996"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "In this study, we demonstrate that IKKalpha, but not IKKbeta, is important for estrogen-induced cell cycle progression by regulating the transcription of the E2F1 gene as well as other E2F1-responsive genes, including thymidine kinase 1, proliferating cell nuclear antigen, cyclin E, and cdc25A. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Mar 10 281(10) 6699-706",
                "id": "16407216"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e967"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Furthermore, we demonstrated that activation of cytochrome c oxidase genes occurs during the development of hypertrophy and that cytochrome c oxidase IV is a direct transcriptional target of E2F-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 15 279(42) 43625-33",
                "id": "15304485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e964"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Furthermore, CDC25A is defined as a novel E2F target whose expression can be directly regulated by E2F-1. Data showing that CDC25A is an essential target for E2F-1, since its activity is required for efficient induction of S phase by E2F-1, are provided. Finally, our results show that expression of two E2F target genes, namely CDC25A and cyclin E, is sufficient to induce entry into S phase in quiescent fibroblasts. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Sep 19(9) 6379-95",
                "id": "10454584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e95c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "we provided evidence that the androgenic effect is mediated by E2F1 protein through a putative E2F-binding site in the promoter",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 18 23(12) 2161-76",
                "id": "14676836"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e954"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "E2F1 activated the p53 promoter through E2F1 binding site.",
              "citation": {
                "type": "PubMed",
                "name": "IUBMB Life 2002 Jun 53(6) 309-17",
                "id": "12625370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e94e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "In contrast to the repressor function of E2F-1 in human tumor cells, we demonstrated that E2F-1 is an activator of the hTERT gene in normal human somatic cells. Ectopically expressed E2F-1 activated the hTERT promoter through a noncanonical DNA binding site. ",
              "citation": {
                "type": "PubMed",
                "name": "FASEB J 2002 Dec 16(14) 1943-5",
                "id": "12368233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e948"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "MCK promoter activity is also inhibited by ectopic E2F1 expression, but this inhibition is not reversed by the co-expression of p21.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Jan 10 272(2) 791-7",
                "id": "8995365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e935"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Here we report that E2F1 can directly bind to and activate the promoter of Smac/DIABLO..., E2F1 has been shown to upregulate the Smac/DIABLO expression at both mRNA and protein levels",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2006 34(7) 2046-55",
                "id": "16617145"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e932"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We also found that Suv39H1 and Rb cooperate to repress E2F activity and that Suv39H1 could be recruited to E2F1 through its interaction with Rb.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Oct 21(19) 6484-94",
                "id": "11533237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e92f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "overexpressed E2F proteins up-regulate p18 expression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 30 277(35) 31679-93",
                "id": "12077144"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e919"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "This analysis showed that the activation of E2F1-3 dramatically increased the levels of the three PRC2 genes (EZH2, EED and SUZ12) (Figure 1A)",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Oct 15 22(20) 5323-35",
                "id": "14532106"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e916"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Direct repression of the Mcl-1 promoter by E2F1",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Feb 21 21(9) 1359-69",
                "id": "11857079"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e90a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "By overexpressing E2F1 in Huh-7 cells, transcriptional activity of dbpA was significantly increased",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Sep 10 322(1) 297-302",
                "id": "15313206"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "# Ariadne: TopBP1 recruits Brg1/Brm, a central component of the SWI/SNF chromatin-remodeling complex, to E2F1-responsive promoters and represses the activities of E2F1, but not E2F2 or E2F3. [Binding]",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2004 Mar 15 18(6) 673-86",
                "id": "15075294"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Thus, E2F-1 promotes the transcription of Bid, a molecule that links death receptor signaling to the activation of apoptotic mechanisms in mitochondria. It also promotes the transcription of caspase-8, the enzyme that cleaves and activates Bid.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Jul 15 173(2) 1111-7",
                "id": "15240700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "t-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Expression of either E2F1 or E2F2 can induce postmitotic lens fiber cells to re-enter the cell cycle.",
              "citation": {
                "type": "PubMed",
                "name": "Invest Ophthalmol Vis Sci 2000 Dec 41(13) 4223-31",
                "id": "11095619"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e864"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Subsequent gel-mobility shift and supershift experiments involving the CTCCGCGC site in the bcl-2 promoter showed that E2F-1 bound Bcl-2. Transactivation experiments consistently showed that ectopic E2F-1 activated responsive elements located in the -1448/-1441 region in the P1 promoter region of the bcl-2 gene.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Sep 15 61(18) 6693-7",
                "id": "11559537"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e860"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Glioma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "From table 1. Genes whose expression is increased by E2F family proteins ans whose promoter is bound by E2F family proteins, indicating direct regulation (references to previously published work).",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Nov 15 62(22) 6587-97",
                "id": "12438254"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e859"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "E2F1 could transactivate the p21 promoter via cis-acting elements between -119 to +16 bp of the p21 gene",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Feb 17 19(7) 961-4",
                "id": "10702805"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e858"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "As shown in Fig. 3B, inhibition of AR significantly prevented HG and/or TNF-alpha- induced transcriptional activation of E2F-1.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2010 May 151(5) 2140-50",
                "id": "20308528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e849"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "It was observed that low levels of E2F1 and high levels of Rb were bound to the cdc6 and cdc25A promoters in quiescent A549 cells. Stimulation with 1 ?M nicotine caused the dissociation of Rb from both the promoters, while there were increased amounts of E2F1 bound to them (Figure 1H, top 2 panels).",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Invest 2006 Aug 116(8) 2208-2217",
                "id": "16862215"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e847"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "we localized the E2F1-specific binding site and demonstrated that it was required for E2F1-mediated transcription of the carboxylesterase promoter. we demonstrated that the DNA binding domain of E2F1 is necessary for E2F1-mediated activation of the carboxylesterase promoter.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Oct 29 279(44) 46343-9",
                "id": "15328355"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e81e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Knockdown of endogenous E2F1 impaired the LPS inducibility of the proinflammatory cytokines CCL3(MIP-1alpha), IL23A(p19), TNF-alpha, and IL1-beta. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2007 Aug 17 27(4) 622-35",
                "id": "17707233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e81d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We have previously demonstrated that Bok mRNA is up-regulated following E2F1 overexpression.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Aug 11 281(32) 22729-35",
                "id": "16772296"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e819"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Knockdown of endogenous E2F1 impaired the LPS inducibility of the proinflammatory cytokines CCL3(MIP-1alpha), IL23A(p19), TNF-alpha, and IL1-beta. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2007 Aug 17 27(4) 622-35",
                "id": "17707233"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e80f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Monocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The p21 protein primarily acts by the inhibition of cyclin/CDK complexes upstream of pRb. This inhibition leads to a reduction in pRb phosphorylation, increased association of pRb with E2F1-3 and repression of E2F target genes.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2011 Jun 30 30(26) 2901-11",
                "id": "21383691"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e807"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We find that many of the genes encoding S-phase-acting proteins previously suspected to be E2F targets, including DNA polymerase alpha, thymidylate synthase, proliferating cell nuclear antigen, and ribonucleotide reductase, are indeed induced by E2F1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 Aug 15(8) 4215-24",
                "id": "7623816"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "When activated, E2F-1 induces cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jan 16 22(2) 161-7",
                "id": "12527885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We further characterized the putative promoter regions of Emi1 and Emi2 genes, and these could be regulated by activators E2F and E2F1-E2F4, respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "J Genet Genomics 2008 Apr 35(4) 215-24",
                "id": "18439978"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Recent studies have shown that putative E2F1 and signal transducer and activator of transcription (Stat)3 binding sites are present on the survivin promoter (35, 36). [Ref36 PMID15271987] - shows that E2F1 increases RNA expression of BIRC5 in rat embryonic fibroblasts]...However, nicotine stimulation caused the increased recruitment of E2F1 to proximal site, whereas Rb was dissociated.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Apr 18 103(16) 6332-7",
                "id": "16601104"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7dc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "expression of Topoisomerase IIalpha and subunit IV of DNA polymerase alpha is also up-regulated upon E2F-1 induction.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Mar 15 20(11) 1379-87",
                "id": "11313881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "GCIP, a newly identified cyclin D-interacting protein, was found to reduce the phosphorylation of retinoblastoma protein and inhibit E2F1-mediated transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2000 Dec 20 279(2) 732-7",
                "id": "11118353"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7bc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The results of YY1-silencing and E2F1-silencing alone revealed that both factors are involved in the doxorubicin-induced activation of p73 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2008 Jan 4 365(1) 75-81",
                "id": "17980704"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The repressive effects of prohibitin on the YY1 promoter were mediated through E2F binding sites, as seen by mutational analysis and chromatin immunoprecipitation assays. Further, depletion of E2F1 prevented prohibitin from repressing the YY1 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2007 Jan 1 401(1) 155-66",
                "id": "16918502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We identified 33 new E2F1-inducible genes, including checkpoint genes Claspin and Rad51ap1, and four genes with unknown function required for cell cycle progression.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Nov 14",
                "id": "16288221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Accompanying this is a reduction in the E2F-1-regulated expression of cell cycle genes such as c-myc, cyclin D1, cyclin A and cyclin B1.",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2001 Oct 22(10) 1727-31",
                "id": "11577016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The Brca1 gene is identified as an in vivo target of E2F1 in a transgenic mouse model. The Brca1 promoter contains E2F DNA-binding sites that mediate transcriptional activation by E2F1 and repression by Rb",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Feb 11 275(6) 4532-6",
                "id": "10660629"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e781"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We also show that the E2F activators (E2F1, E2F2, and E2F3) can bind to the survivin promoter and induce survivin transcription.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 24 279(39) 40511-20",
                "id": "15271987"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e774"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Consequently, the results in this study indicate the physiological function of AhR as a potent transcriptional coactivator of E2F1-dependent transcription and implicate the AhR-E2F1 interaction as a part of the mechanism by which AhR/Arnt promotes cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Biol Pharm Bull 2010 33(3) 389-97",
                "id": "20190398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e74f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The effect of overexpression of E2F-1 is more efficient on ICBP90 and TopoIIalpha expression in noncancer cells (IMR90, WI38) than in cancer cells (U2OS, SaOs)",
              "citation": {
                "type": "PubMed",
                "name": "Br J Cancer 2003 Jul 7 89(1) 120-7",
                "id": "12838312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e73d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Since the levels of E2F1 but not DP-1 mRNA correlated with changes in transcription from the dhfr promoter, we examined whether E2F1 could activate various growth-regulated promoters. We found that E2F1 could activate some (dhfr, thymidine kinase, and DNA polymerase alpha) but not all (thymidylate synthase, cad, and c-myc) of these promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Mar 14(3) 1861-9",
                "id": "8114719"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e733"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Nicotine also promotes binding of E2F1, E2F2 and E2F3 on proliferative promoters, causing their transcription and entry into S phase [16].",
              "citation": {
                "type": "PubMed",
                "name": "Trends Pharmacol Sci 2008 Mar 29(3) 151-8",
                "id": "18262664"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e719"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Aberrant mitogenic signals enable the activating forms of E2F to bind to the ARF promoter to induce its expression.",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e70a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "An LXCXE motif on ASK1 was required for Rb binding; this correlated with increased E2F1 transcriptional activity and up-regulation of the proapoptotic protein p73.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Sep 10 279(37) 38762-9",
                "id": "15210709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Subsets of E2Fs were specifically bound to the Dmp1 promoter upon mitogenic signaling and E2Fs 1-4 inhibited the Dmp1 promoter in a reporter assay.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Dec 14 25(59) 7703-13",
                "id": "16878159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Finally, we demonstrate that CDK4 is activated by glucose through the insulin pathway, ultimately resulting in E2F1 activation and consequently in Kir6.2 increased expression.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2009 Aug 11(8) 1017-23",
                "id": "19597485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "we show that human metallothionein 1G (hMT1G) promoter is upregulated by E2F1 upon VEGF stimulation of human aortic endothelial cells. hMT1G promoter could be induced by E2F1 in transient transfections",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Mar 24 24(13) 2204-17",
                "id": "15735762"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6cb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "In case of c-myc a sequence near the P2-promoter, which gives rise to ~75-90% of c-myc mRNA, was used for the TFO approach by McGuffie et al. to prevent binding of E2F, MAZ and ets transcription factors",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2003 Jun 3(3) 163-75",
                "id": "12769686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "PD 0183812 blocks phosphorylation on pRb in tumor cells PD 0183812 inhibits phosphorylation of pRb at serine 780",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 18 276(20) 16617-23",
                "id": "11278443"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Wild-type E2F-1 and E2F-4 transactivation of the E2F-1 promoter was stimulated by TRRAP overexpression (Fig. 4 B). TRRAP overexpression did not significantly influence the basal level of the reporter. However, E2F-1- and E2F-4-mediated transcription was stimulated 2- and 3.1-fold, respectively, by co-expression of TRRAP.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 31 276(35) 32627-34",
                "id": "11418595"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e69a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "We have studied the interaction of E2F-1 with the Rb and adenovirus E4 proteins and show that phosphorylation of E2F-1 on serine residues 332 and 337 prevented its interaction with Rb but was a prerequisite for interaction with E4. (PhosphoElm data from PMID 15212693)",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1994 Sep 9 78(5) 799-811",
                "id": "8087847"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e695"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "E2F-1 binds to specific sites in the FoxO1 and FoxO3 promoters (Nowak et al., 2007), indicating that these two FoxO genes are transcriptional targets of E2F-1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 7 27(16) 2276-88",
                "id": "18391970"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e68e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "The human axin2 gene allows transcription of messages with three different 5' untranslated regions and in the first mechanism E2F1 directly activates the transcription of only one of these species by acting at canonical E2F binding sites.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Apr 22 329(4) 1267-74",
                "id": "15766563"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e689"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "DP1, the DNA binding partner of the E2F family of factors (E2Fs)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Sep 25(18) 8024-36",
                "id": "16135794"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e681"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:E2F1) actsIn tscript(p(HGNC:E2F1))",
              "summary_text": "Treatment of VSMC with AR inhibitor sorbinil prevented HG- as well as TNF-alpha-induced phosphorylation of retinoblastoma protein and activation of E2F-1.",
              "citation": {
                "type": "PubMed",
                "name": "Endocrinology 2010 May 151(5) 2140-50",
                "id": "20308528"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e66b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER3)",
        "relation": " hasModification",
        "target": "p(HGNC:PER3,pmod(P))",
        "directed": false,
        "label": "p(HGNC:PER3)  hasModification p(HGNC:PER3,pmod(P))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513dc",
          "evidences": [

          ]
        }
      },
      {
        "source": "p(HGNC:CHEK1,pmod(P,S,345))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:CHEK1))",
        "directed": false,
        "label": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d7",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e845"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns. Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Jul 21(13) 4129-39",
                "id": "11390642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eacb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "Here we show that the oncogenic p53-induced serine/threonine phosphatase, PPM1D (or Wip1), dephosphorylates two ATM/ATR targets, Chk1 and p53. PPM1D binds Chk1 and dephosphorylates the ATR-targeted phospho-Ser 345, leading to decreased Chk1 kinase activity. PPM1D also dephosphorylates p53 at phospho-Ser 15",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2005 May 15 19(10) 1162-74",
                "id": "15870257"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea89"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CHEK1,pmod(P,S,345)) directlyIncreases kin(p(HGNC:CHEK1))",
              "summary_text": "Here, we report that replicative stress induces the polyubiquitination and degradation of Chk1 in human cells. This response is triggered by phosphorylation of Chk1 at Ser-345, a known target site for the upstream activating kinase ATR. These findings indicate that ATR-dependent phosphorylation of Chk1 delivers a signal that both activates Chk1 and marks this protein for proteolytic degradation.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Sep 2 19(5) 607-18",
                "id": "16137618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ATM)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:ATM))",
        "directed": false,
        "label": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513fa",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show that, upon DNA damage, RASSF1A is phosphorylated by ATM on Ser131 and is involved in the activation of both MST2 and LATS1, leading to the stabilization of p73....As shown previously, expression of RASSF1A  enhances the stability of p73 [7], but this stabilization was further enhanced when combined with DNA damage (Figure 4C, left). In agreement with a role for the ATM phosphorylation site in pathway signaling, RASSF1A-S131A blocked the stabilization of p73 in response to cisplatin-mediated DNA damage (Figure 4C, right).",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2009 Dec 15 19(23) 2020-5",
                "id": "19962312"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The basal turnover of Cdc25A operating in unperturbed S phase required Chk1-dependent phosphorylation of serines 123, 178, 278, and 292. IR-induced acceleration of Cdc25A proteolysis correlated with increased phosphate incorporation into these residues generated by a combined action of Chk1 and Chk2 kinases. Finally, phosphorylation of Chk1 by ATM was required to fully accelerate the IR-induced degradation of Cdc25A ... from full text, U2OS cells and ATM-dependent CHEK1 phosphorylation at S317 and S345",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 247-58",
                "id": "12676583"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea8a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Abrogation of cyclin G enhances p53 accumulation and phosphorylation of p53 at the Ser-15 residue, resulting in cell cycle arrest. Ectopically expressed cyclin G significantly reduces the steady-state levels of p53 as well as that of phosphorylated p53 at Ser-15 after DNA damage in normal human dermal fibroblasts containing normal ATM. However, cyclin G does not cause similar reductions in p53 levels in ATM-mutated cells. We also show that translocation of cyclin G to the nucleus requires functional ATM.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Jul 8 23(31) 5405-8",
                "id": "15077171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea4f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway — for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-D–Cdk4 from phosphorylating Rb — unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 4–6,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea07"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - To study the effects of SOCS1 in normal cells, we infected the human diploid fibroblast strain IMR90 with a retroviral vector encoding SOCS1 or a control vector. Expression of SOCS1 inhibited cell growth (Figure 3A) and induced senescence, characterized by senescence-associated ?-galactosidase staining (Figure S3A) and the accumulation of PML bodies (Figure S3B). In addition, SOCS1 induced high levels of p53 and its target, p21; a reduction in Rb phosphorylation; and the inhibition of E2F target genes such as Mcm6 (Figure 3B). Intriguingly, during SOCS1-induced senescence, the increase in p53 levels was accompanied with serine 15 phosphorylation of p53 (Figure 3B) and activation of the DNA damage-regulated kinases ATM and Chk2 (Figure 3C). Staining of SOCS1-expressing cells with an antibody against ?H2AX revealed numerous DNA damage foci (Figure S3C).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2009 Dec 11 36(5) 754-67",
                "id": "20005840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "<s8> Human RPA2 can be phosphorylated at several Ser/Thr sites within the N-terminal 33 amino acids (Henricksen et al., 1996). At least five phosphorylation states have been resolved (Zernik-Kobak et al., 1997). In unirradiated cells, RPA2 is phosphorylated primarily at Ser23 and Ser29 (Dutta and Stillman, 1992; Pan and Hurwitz, 1993). DNA damage by UV, IR, camptothecin, or etoposide induces phosphorylation of additional sites (Zernik-Kobak et al., 1997; Shao et al., 1999). These hyperphosphorylations are attributable to DNA-PK (Shao et al., 1999) and independently to ATM (Gately et al., 1998). <s12>  ATM (or an ATM-associated kinase other than DNA-PK or ATM-related protein) hyperphosphorylates RPA2 on serine and threonine residues in response to DNA damage; the reaction is dependent on both ssDNA and linear dsDNA (Gately et al., 1998). <s13> DNA damage-induced hyperphosphorylation of RPA2 prevents the binding of RPA to p53 (Abramova et al., 1997).",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Depletion of ATM also decreased NF-kB reporter activity— to roughly the same level as p38MAPK inhibition (Figure 5E, Po0.001). Although increased concentrations of SB203580 had no additional effect on NF-kB reporter output (data not shown), the combined treatment of SB203580 and ATM depletion had a synergistic effect, lowering NF-kB transcriptional activity to PRE control levels (Figure 5E, SBþshATM).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2011 Apr 20 30(8) 1536-48",
                "id": "21399611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e89d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The main downstream targets (of BRCA1) identified so far are p53-responsive genes, including p21 and BcIX13. BRCA1 binds to BRCA2, p53, RAD51 and many other proteins involved in cell cycling and DNA-damage response14,15 (Fig. 2a). The involvement of BRCA1 in response to DNA damage is supported by extensive data, including evidence that BRCA1 is phosphorylated by the ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (CHK2) proteins in response to DNA damage16,17, that cells without functional BRCA1 do not arrest in G2 after DNA damage and are deficient in transcription-coupled repair18,19, and that BRCA1 is part of the RAD50-MRE11-p95 complex, an essential component of recombination- mediated repair of DNA double-stranded breaks20.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2001 May 7(5) 552-6",
                "id": "11329055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": " In the presence of CPT, topo I forms a covalent intermediate with the 3'-phosphate end of the broken DNA strand (5) . This single-strand nick lesion is believed to convert into an irreversible double-strand break after it encounters the replication fork machinery in S phase. This unusual form of DNA damage induces a signaling cascade that is propagated by ATM-family kinases in human cells (6) , which phosphorylate numerous targets involved in transcription, DNA repair, cell cycle arrest, and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Mar 15 64(6) 2096-104",
                "id": "15026349"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e78d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "KAP-1 is phosphorylated in an ATM-dependent manner on Ser 824. KAP-1 is phosphorylated exclusively at the damage sites, from which phosphorylated KAP-1 spreads rapidly throughout the chromatin. Ablation of the phosphorylation site of KAP-1 leads to loss of DSB-induced chromatin decondensation and renders the cells hypersensitive to DSB-inducing agents. Knocking down KAP-1, or mimicking a constitutive phosphorylation of this protein, leads to constitutive chromatin relaxation. These results suggest that chromatin relaxation is a fundamental pathway in the DNA-damage response and identify its primary mediators.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2006 Aug 8(8) 870-6",
                "id": "16862143"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e684"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "There is evidence that FANCD2,like BRCA1, participates in the events that are triggered by DNA damage during S and G2 phases and that lead to cell-cycle arrest. As well as modifying BRCA1, the ATM protein kinase can phosphorylate FANCD2 on several residues, including serine 222, following exposure to ionizing radiation77. Ser222 phosphorylation is required for the intra-S-phase arrest and is, in turn, dependent on the protein kinase NBS1, which is a component of the trimeric MRE11-RAD50-NBS1 complex78. FANCD2 can also be phosphorylated in an ATM-independent manner by the ATR kinase79,which signals an intra-S-phase arrest that is triggered by ultraviolet radiation or DNA-crosslinking agents46.Here, too, FANCD2 phosphorylation depends on NBS1, which is required to fully enforce the S-phase checkpoint. The participation of FANCD2 in ionizingradiation- activated checkpoint responses through phosphorylation on Ser222 seems to be independent78 of its mono-ubiquitylation on Lys561, which promotes the translocation of FANCD2 to damage-induced nuclear foci that contain BRCA1 and RAD51, and that are presumed sites of DNA repair. Similarly, FANCD2 foci do not require ATR-dependent phosphorylation79.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Apr 4(4) 266-76",
                "id": "15057286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e66e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Figure 3 Nbs1 modulates ATMactivation after low doses of IR. Human NBS-Tert cells expressing different Nbs1 mutant forms and the cells infected with empty vector were irradiated with 2Gy and lysed at the indicated times (5 min to 8 h) after irradiation. Phosphorylation of S1981 of ATMand S966 of SMC1 and the total level of SMC1 were examined by immunoblotting as described in Figure 1",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Apr 15 23(17) 3122-7",
                "id": "15048089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The consequential loss of CDC25A results in G1/S arrest, due to the inefficient loading of CDC45 at the origin of replication. In addition, activated ATM, ATR, DNA–PK, Chk2, and Chk1 all aid in the phosphorylation and activation of p53, a key player in DNA-damage checkpoints. Activated p53 transactivates p21, which inhibits two G1/S-promoting cyclin-dependent kinases (CDKs), CDK2 and CDK4.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea4e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Here we show that efficient damage-induced degradation of human Hdmx depends on functional ATM and at least three sites on the Hdmx that are phosphorylated in response to DSBs. One of these sites, S403, is a direct ATM target. Accordingly, each of these sites is important for Hdm2-mediated ubiquitination of Hdmx after DSB induction",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Apr 5 102(14) 5056-61",
                "id": "15788536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e997"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Exposure of ES cells to genotoxins caused an ATM-dependent nuclear accumulation of Abl but not Abl muNLS. ES cells expressing Abl muNLS exhibited delayed Bax activation, reduced cytochrome c release and decreased caspase-9 activity in response to DNA damage. These results provide a genetic proof that Abl nuclear entry contributes to DNA damage-induced activation of the intrinsic apoptotic pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2007 Jun 14(6) 1139-48",
                "id": "17363963"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e991"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "preincubation of cells with the hydroxyl radical scavenger, N-acetylcysteine, significantly attenuated the doxorubicin-mediated phosphorylation and accumulation of p53, p53-DNA binding, and the phosphorylation of H2AX, Nbs1, SMC1, Chk1, and Chk2, suggesting that hydroxyl radicals contribute to the doxorubicin-induced activation of ATM-dependent pathways.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Dec 17 279(51) 53272-81",
                "id": "15489221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e98f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We observed that in response to DNA damage, ATM phosphorylated COP1 on Ser387 and stimulated a rapid autodegradation mechanism. Ionizing radiation triggered an ATM-dependent movement of COP1 from the nucleus to the cytoplasm, and ATM-dependent phosphorylation of COP1 on Ser387 was both necessary and sufficient to disrupt the COP1-p53 complex and subsequently to abrogate the ubiquitination and degradation of p53.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2006 Aug 25 313(5790) 1122-6",
                "id": "16931761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e966"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "3-Phosphoinositide- dependent protein kinase (PDK) 1 has been identified as a primary kinase that will phosphorylate Akt at Thr308. Kinases that activate Ser473 are known as PDK2, which include mitogen-activated protein kinase (MAPK)-activated protein kinase (PK)-2, integrin-linked kinase, p38 MAPK, PKCa, PKCbII, rictor-mTOR complex (mTORC2), double-stranded DNA-dependent PK, autophosphorylation, and ataxia telangiectasia- mutated gene product (Brazil et al., 2004; Manning and Cantley, 2007).",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2009 Dec 17(6) 800-10",
                "id": "20059950"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e945"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Thus, stimuli that activate these kinases, including exposure to pro-inflammatory cytokines, UV irradiation, DNA damage or change in ROS, are among the classic inducers of ATF2 transcriptional activity (van Dam et al., 1995).ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. ",
              "citation": {
                "type": "PubMed",
                "name": "Pigment Cell Res 2007 Dec 20(6) 498-506",
                "id": "17935492"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e93e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The three major phosphatidylinositol 3-kinase-like kinases ATM, ATR, and DNA-dependent protein kinase have the ability to phosphorylate the C-terminal tail of the histone variant H2AX on serine 139. Whereas this phosphorylation is carried out exclusively by ATM or DNA-dependent protein kinase after ionizing irradiation (38), ATR is responsible for the reaction in response to replication stress (44)",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Aug 26(16) 6056-64",
                "id": "16880517"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e87f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "To study the expression of CDX transcription factors, we used qRT-PCR to measure the expression level of CDX1 (MIM 600746) and CDX2 (MIM 600297) in lymphoblastoid cells from noncarriers, AT carriers, and AT patients. Results showed that the CDX1 level is similar in individuals with different ATM genotypes (data not shown); however, the CDX2 level is significantly higher in AT carriers and AT patients compared to noncarriers (Figure 4A).",
              "citation": {
                "type": "PubMed",
                "name": "Am J Hum Genet 2008 Aug 83(2) 243-53",
                "id": "18674748"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "immune cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1999 Nov 1 59(21) 5456-60",
                "id": "10554017"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eacc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In the cells exposed to CS, there is strong and rather uniform IF revealing the presence of activated ATM throughout the nucleus (Fig. 7C).",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cell Biol 2007 8 26",
                "id": "17594478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Immunoprecipitates of ATM collected from IGF-1-stimulated cells also caused the phosphorylation of the AMPK-alpha subunit in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Nov 19 324(3) 986-92",
                "id": "15485651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In cultured cardiac myocytes, doxorubicin induced oxidative stress, DNA damage, ATM activation, and p53 induction. ...Doxorubicin treatment in vivo also induced oxidative stress, DNA damage, ATM activation, and p53 accumulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Cell Cardiol 2009 Nov 47(5) 698-705",
                "id": "19660469"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "cardiomyocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": " Here we describe the FA protein FANCI, identified as an ATM/ATR kinase substrate required for resistance to mitomycin C.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2007 Apr 20 129(2) 289-301",
                "id": "17412408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea9b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show that doses of gamma-radiation (IR) as low as 0.25 Gy, which generate vast numbers of SSBs but only a few DSBs per cell (<8), promptly activate ATM kinase and induce the phosphorylation of the ATM substrates p53-Ser15, Nbs1-Ser343 and Chk2-Thr68. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Oct 7 23(46) 7691-700",
                "id": "15361830"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea99"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 May 11 276(19) 16580-6",
                "id": "11278446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea86"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Dec 1 368(Pt 2) 507-16",
                "id": "12234250"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea79"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We and others have recently shown that a cluster of repeated consensus ATM phosphorylation sites in MDC1 is crucial for the recruitment of BRCA1 and 53BP1 to IRIF, but not for NBS1 focus formation. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2008 Aug 9(8) 795-801",
                "id": "18583988"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea6c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We therefore conclude that threonine 68 is the preferred site of phosphorylation in vitro and that other sites (possibly a combination of several) are phosphorylated at lower stoichiometry.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Oct 2(10) 762-5",
                "id": "11025670"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea6b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Hum Genet 105(1-2) 17-27",
                "id": "10480350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea5e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Apr 13 276(15) 11783-90",
                "id": "11278277"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea59"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Figure 2 Comparison of gene expression (induction fold) obtained from microarray data and real-time RT-PCR analysis for 11 genes selected from the set of Atm-dependent, putatively NF-kB-mediated responding genes",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2006 Mar 9 25(10) 1584-92",
                "id": "16314843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea53"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "immune cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Thr383 (Fig. 5C) or Thr387 (data not shown). This suggests that ATM phosphorylation of Thr68 is required for the subsequent phosphorylation of Thr383 and Thr387 in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 10 276(32) 30537-41",
                "id": "11390408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea3c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Consistent with a role of ATM in the phosphorylation of Chk2, Thr68 phosphorylation and Chk2 activation were not detected in ATM-deficient FT169A cells after IR, while Chk2 was phosphorylated and activated in the isogenic, wild-type ATM-reconstituted YZ5 cells ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 47755-8",
                "id": "11668173"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea38"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "ATM had intrinsic protein kinase activity and phosphorylated p53 on serine-15 in a manganese-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Sep 11 281(5383) 1677-9",
                "id": "9733515"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea35"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 30 278(22) 19579-82",
                "id": "12697768"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea2a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In other studies, at 6 and 12 h after UVB irradiation, we observed a moderate serine 139 phosphorylation of H2A.X (Fig. 6D), which is shown to be one of the substrates of DNA-PK as well as ATM/ATR (37).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 27 280(21) 20375-83",
                "id": "15792956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea05"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Moreover, induction of both apoptosis and p53 phosphorylation by E2F1 is abolished by caffeine; this is an inhibitor of the ATM and ATR kinases [33], supporting the notion that E2F1 uses the ATM signaling pathway to induce p53 and CHK2 phosphorylation and thereby apoptosis",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2006 Apr 12(4) 177-85",
                "id": "16530485"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "However, no such activation was found in A-T cells indicating that caffeine inhibited the ATM-dependent Chk2/Cds1 activation (Fig. 3A, lanes 6 and 8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "9295339;9139719;14872059",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In vitro substrates included the translation repressor PHAS-I and the p53 protein. ATM phosphorylated p53 in vitro on a single residue, serine-15, which is phosphorylated in vivo in response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Science 1998 Sep 11 281(5383) 1674-7",
                "id": "9733514"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "ATM phosphorylates Nbs1 on Ser343",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Dec 15 63(24) 8586-91",
                "id": "14695167"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jun 23 95(13) 7664-9",
                "id": "9636207"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Aug 3 276(31) 29282-91",
                "id": "11375976"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "caffeine, a widely used inhibitor to ATM/ATR",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2010 Jun 15 184(12) 6901-9",
                "id": "20488792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Macrophages",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "As shown in Figure 3A, exposure to CSE induced activation of ATM, p53, and pRb, a marked increase in p53 and p21, and a mild increase in p16 accumulation.  ",
              "citation": {
                "type": "PubMed",
                "name": "Am J Respir Cell Mol Biol 2006 Dec 35(6) 681-8",
                "id": "16840774"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Here, we pinpoint a single ATM-phosphorylated residue in 53BP1--Ser25--that is required for binding of 53BP1 to hPTIP",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2007 35(16) 5312-22",
                "id": "17690115"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Furthermore, inhibition of ATM/ATR kinases abolishes both induction of Rad51 and phosphorylation of p53 and reduced the level of apoptosis induced by coexpression of oncogenes and ARF (Pauklin et al., 2005).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 41656-60",
                "id": "11514540"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e99b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Nov 5 286(5442) 1162-6",
                "id": "10550055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e972"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2002 Aug 15 62(16) 4588-91",
                "id": "12183412"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e965"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Interestingly, oxidative stress induced the translocation of PP2A-C, an ATM inhibitor, into caveolar membranes, away from ATM, and promoted the interaction between PP2A-C and caveolin- 1 (supplemental Fig. 2, A and B, respectively).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Feb 27 284(9) 5462-6",
                "id": "19103597"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e94d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Here, we observe that UVA, unlike UVC, triggers ATM kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Feb 1 277(5) 3124-31",
                "id": "11723137"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e94b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Sep 12 97(19) 10389-94",
                "id": "10973490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e946"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "these kinases phosphorylate CDC25C, the molecule that is responsible for activating CDK1",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2004 Aug 4(8) 592-603",
                "id": "15286739"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e942"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "heterogeneous nuclear ribonucleoprotein K (hnRNP K) as being rapidly induced by DNA damage in a manner that requires the DNA-damage signaling kinases ATM or ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2005 Dec 16 123(6) 1065-78",
                "id": "16360036"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e937"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In vitro kinase assay indicated that ATM phosphorylates IKK-alpha at Ser-473. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Feb 14 27(8) 1183-8",
                "id": "17700524"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e92c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": ". ATM-phosphorylated p300 in vitro and in vivo, in response to DNA damage. Phosphorylation of p300 proteins was observed upon gamma-irradiation in ATM(+) cells but not ATM(-) cells.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2010 Jul 9 397(4) 637-43",
                "id": "20471956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e924"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Fig 2 and 3 - ATM kinase activates c-Abl kinase.  Serine-465 of c-Abl is required for tyrosine kinase activation by ionizing radiation and ATM.  3T3 cells",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 May 29 387(6632) 516-9",
                "id": "9168116"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e922"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show that the Mre11-Rad50-Nbs1 (MRN) complex acts as a double-strand break sensor for ATM and recruits ATM to broken DNA molecules. Inactive ATM dimers were activated in vitro with DNA in the presence of MRN",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Apr 22 308(5721) 551-4",
                "id": "15790808"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e91d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39527-33",
                "id": "12890678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e918"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Activation of ATM induces Sp1 phosphorylation with kinetics similar to H2AX; inhibition of ATM activity blocks Sp1 phosphorylation; depletion of Sp1 sensitizes cells to DNA damage and increases the frequency of double strand breaks. We have identified serine 101 as a critical site phosphorylated by ATM;",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer Res 2007 Dec 5(12) 1319-30",
                "id": "18171990"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e902"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 42462-7",
                "id": "11571274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation of the ATM kinase and its downstream effectors, such as histone H2AX, were impaired in the myc null cell line HO15.19, compared to the myc positive TGR-1 and HOmyc3 cells. Nuclear foci formation of the Nijmegen Breakage Syndrome (Nbs) 1 protein, essential for efficient ATM activation, was also reduced in absence of myc",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2010 5(1) e8924",
                "id": "20111719"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8fb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Nov 1 60(21) 5934-6",
                "id": "11085506"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Following exposure to ionizing radiation (IR), the BRCA1-c-Abl complex is disrupted in an ATM-dependent manner, which correlates temporally with ATM-dependent phosphorylation of BRCA1 and ATM-dependent enhancement of the tyrosine kinase activity of c-Abl. In vivo, BRCA1 is phosphorylated at tyrosine residues in an ATM-dependent, radiation-dependent manner",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jun 22(12) 4020-32",
                "id": "12024016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Wild-typeATMincreases TonEBP/OREBP transcriptional activity both at 300 and 500 mosmol/kg, whereas ATMS1981A does not (Fig. 3D).....anti-ATM antibody coimmunoprecipitates TonEBP/OREBP and ATM both at 300 and 500 mosmol/kg (Fig. 4A Lower).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Jun 8 101(23) 8809-14",
                "id": "15173573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2000 Dec 2(12) 893-8",
                "id": "11146653"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "ATM is one of the major kinases that phosphorylate p53 at Ser15 after IR and that ATM also phosphorylates and activates Chk2 after IR, which then phosphorylates p53 at Ser20",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Jan 28(1) 448-56",
                "id": "17967874"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The immunoprecipitated ATM efficiently phosphorylated recombinant H2AXin vitro (Fig. 3  c, lane 1).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 42462-7",
                "id": "11571274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e883"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The ataxia-telangiectasia-mutated (ATM) and ATM- and Rad3-related (ATR) kinases regulate cell cycle checkpoints by phosphorylating multiple substrates including the CHK1 and -2 protein kinases and p53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37139-45",
                "id": "12847089"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e875"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show that oxidation of ATM directly induces ATM activation in the absence of DNA DSBs and the MRN complex.",
              "citation": {
                "type": "PubMed",
                "name": "Science 2010 Oct 22 330(6003) 517-21",
                "id": "20966255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e870"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The serine/threonine protein kinase ATM signals to cell cycle and DNA repair components by phosphorylating downstream targets such as p53, CHK2, NBS1, and BRCA1.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Dec 15 64(24) 9152-9",
                "id": "15604286"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e86e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e84e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - S395 of Mdm2 is phosphorylated in vitro by ATM",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 May 1 15(9) 1067-77",
                "id": "11331603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e841"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Science 2006 Feb 24 311(5764) 1141-6",
                "id": "16497931"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e838"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Apr 20 101(16) 5898-903",
                "id": "15073328"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e82c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2001 Sep 3 154(5) 913-23",
                "id": "11535615"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e82b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Nov 11 18(47) 6411-8",
                "id": "10597242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e815"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 23 276(12) 8898-903",
                "id": "11114307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We have demonstrated that ionizing radiation-associated DNA double-strand breaks (DSBs) induce phosphorylation of at least Ser-56 and Ser-101 residues on Sp1 in an ATM-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Signal 2008 Oct 20(10) 1795-803",
                "id": "18619531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Substitution of threonine 68 by alanine in the full-length kinase-dead Chk2 dramatically reduced but did not abolish the ATM phosphorylation of Chk2/Cds1 in vitro (Fig. 4B; threonine 68 accounts for approximately 70% of the total phosphorylation).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Apr 7 275(14) 10342-8",
                "id": "10744722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Jul 15 15(14) 1833-44",
                "id": "11459832"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Moreover, Chk1 phosphorylated by PKB fails to undergo activating phosphorylation on serine 345 by ATM/ATR.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2004 May 3(5) 634-7",
                "id": "15107605"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Evasion from apoptosis is a hallmark of cancer, and recent success using targeted therapeutics underscores the importance of identifying anti-apoptotic survival pathways. Here we utilize RNA interference (RNAi) to systematically screen the kinase and phosphatase component of the human genome.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Jun 7(6) 591-600",
                "id": "15864305"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e79b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "IR-inducible phosphorylation of threonine 691 and serine 717 is also dependent on ATM and is more strongly impaired when both ATM and ATR are knocked down",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Sep 26(18) 7005-15",
                "id": "16943440"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e79a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We also discovered that the phosphorylation of NBS1 by ATM is required for the phosphorylation of SMC1, establishing the role of NBS1 as an adaptor in the ATM/NBS1/SMC1 pathway.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 Mar 1 16(5) 571-82",
                "id": "11877377"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e790"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation of ATM/ATR substrates and H2AX in VSMCs increased with disease severity in vivo (Figure 1A), reaching 70% to 90% of intimal VSMCs in advanced disease.",
              "citation": {
                "type": "PubMed",
                "name": "Circ Res 2008 Sep 26 103(7) 717-25",
                "id": "18723444"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e787"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Myocytes, Smooth Muscle",
                "tissue": "vascular tissue"
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "MRN stimulates the kinase activity of ATM in vitro toward its substrates p53, Chk2, and histone H2AX. MRN makes multiple contacts with ATM and appears to stimulate ATM activity by facilitating the stable binding of substrates .. phospho-sites from Figs 1-2",
              "citation": {
                "type": "PubMed",
                "name": "Science 2004 Apr 2 304(5667) 93-6",
                "id": "15064416"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e77d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": " These observations indicate that ATM-mediated phosphorylation of S1189 is required for BRCA1 functions in the modulation of DNA damage response and in the suppression of tumor formation by regulating p53 and apoptosis.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2009 Dec 15 69(24) 9291-300",
                "id": "19996295"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e764"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Mar 23 276(12) 8898-903",
                "id": "11114307"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e763"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Apr 6 404(6778) 613-7",
                "id": "10766245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e75e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation on Chk1(Ser-345), Chk2(Thr-68), and p53(Ser-15)following oxidative damage by IR involved both ATM and ATR. phosphorylation on Chk1, Chk2, and p53 was found to be ATM-dependent, whereas ATR also contributed to Chk1 phosphorylation ... from full text, A549 cells",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Jan 14 280(2) 1186-92",
                "id": "15533933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e714"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "C-terminal domain harbors three known phosphorylation sites (S325, T366 and S428), the latter two of which are targeted by ATM (ataxia telangiectasia mutated), and protein kinase A (PKA), ribosomal protein S6 kinase 90 kDa or protein kinase C z, respectively (Collins et al., 2000; Xie et al., 2006; Sapkota et al. 2002a, b).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Nov 24 27(55) 6908-19",
                "id": "19029933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Our results show that despite the presence of higher than normal levels of DNA-PK kinase activity, c-Abl fails to become activated after IR exposure in ATM-deficient cells. Conversely, normal activation of both ATM and c-Abl occurs in DNA-PKcs-deficient cells, indicating that ATM but not DNA-PK is required for activation of Abl in response to IR treatment.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Sep 29 275(39) 30163-8",
                "id": "10906134"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6fd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2001 Mar 21(5) 1719-29",
                "id": "11238909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "When ATM and ATR are recruited to sites of damage, they target many substrates, including checkpoint kinase-2 (CHK2) and CHK1, respectively (FIG. 2; BOX 2).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2008 Apr 9(4) 297-308",
                "id": "18285803"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ee"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Further analysis on the impact of MCT-1 in DNA damage signaling cascades revealed that autophosphorylation of ATM (Ser1981) and phosphorylation of NBS1 (Ser343) mediated by ATM kinase were induced approximately twofold, while phospho-H2AX (Ser136) has more than a 10-fold induction (Figure 2c).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jul 21 24(31) 4956-64",
                "id": "15897892"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ea"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "We show here that E2F-1 elevates ATM promoter activity and induces an increase in ATM mRNA and protein levels. This is accompanied by an E2F-induced increase in p53 phosphorylation ... ATM activates the tumor suppressor p53",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Jan 16 22(2) 161-7",
                "id": "12527885"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2002 May 17 109(4) 459-72",
                "id": "12086603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 17 275(11) 7803-10",
                "id": "10713094"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6db"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "ATM-mediated phosphorylation of p53 stabilizes this tumor suppressor protein by reducing constitutive interactions with MDM2, which usually promotes the degradation of p53 (Figure 1) (Giaccia and Kastan, 1998; Chin et al., 1999).",
              "citation": {
                "type": "PubMed",
                "name": "Biol Chem 2008 Mar 389(3) 211-20",
                "id": "18208352"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6da"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Dec 31 274(53) 37538-43",
                "id": "10608806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Reconstitution of the AT cells with wild-type ATM increases TonEBP/OREBP transactivating activity both at 300 and 500 mosmol/kg, but the inactive mutant, ATM S1981A, does not (Fig. 3E). We conclude that ATM regulates transactivating activity of TonEBP/OREBP.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2004 Jun 8 101(23) 8809-14",
                "id": "15173573"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The essential elements of this checkpoint are ATM/ATR kinases that indirectly lead to the phosphorylation and inhibition of the mitosis-promoting factor (Cdc2/cyclin B1).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2003 Nov 13 22(51) 8283-92",
                "id": "14614452"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Phosphorylation of histone H2AX on serine 139 and p53 on serine 15 in Parp-1 knockout (Parp-1(-/-)) mouse embryonic fibroblasts (MEF) was significantly induced by NCS treatment compared with MEF derived from wild-type (Parp-1(+/+)) mouse.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jun 25 319(2) 596-602",
                "id": "15178448"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2003 Jan 33(1) 80-4",
                "id": "12447371"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Feb 16 276(7) 5296-302",
                "id": "11076947"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Silencing of ATR or ATM and inhibition of ATM activity by KU-55933 blocked Chk1 activation and RRM2 up-regulation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2009 Jul 3 284(27) 18085-95",
                "id": "19416980"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e699"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Jul 13 406(6792) 210-5",
                "id": "10910365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e690"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 10 278(41) 39527-33",
                "id": "12890678"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e688"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "from full text - Figure 6. ATF2 Is Important for IR-Induced Activation of ATM and Chk2 (A) ATF2 is important for activation of ATM. U2OS cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 May 27 18(5) 577-87",
                "id": "15916964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e683"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "TRF2 represses ATM, whereas POT1 prevents activation of ATR. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2007 Aug 30 448(7157) 1068-71",
                "id": "17687332"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e67a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "we show that ATM interacts with BRCA1, and this association is enhanced by radiation. We also demonstrate that BRCA1 is a substrate of ATM kinase in vitro and in vivo. Using phospho-specific antibodies against serines 1387, 1423, and 1457 of BRCA1, we demonstrate radiation-induced, ATM-dependent phosphorylation of BRCA1 at these sites ... from full text, A-T lymphoblastoid cells",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jun 15 60(12) 3299-304",
                "id": "10866324"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e678"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "In this report, we utilized small interfering RNA to deplete BRCA1 and BARD1 to demonstrate that the BRCA1-BARD1 complex is required for ATM/ATR (ataxia-telangiectasia-mutated/ATM and Rad3-related)-mediated phosphorylation of p53(Ser-15) following IR- and UV radiation-induced DNA damage.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Jul 23 279(30) 31251-8",
                "id": "15159397"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e66c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Jan 18 97(2) 889-94",
                "id": "10639175"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e668"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "the ATM cDNA expression vector pMAT1 (16) was transiently transfected into Atm?/? spontaneously immortalized fibroblasts. The ectopic expression of ATM in the transfected cells resulted in restoration of H2AX phosphorylation upon irradiation",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Nov 9 276(45) 42462-7",
                "id": "11571274"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e662"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ATM) actsIn kin(p(HGNC:ATM))",
              "summary_text": "The ATM (23) and ATR (24) protein kinases play key roles in p53 activation in response to IR and UV, respectively. Bulky chemical adducts have also been shown to induce stabilization and nuclear accumulation of p53",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2003 Feb 24(2) 225-34",
                "id": "12584171"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e65f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:PER2)",
        "relation": "decreases",
        "target": "p(HGNC:WEE1)",
        "directed": false,
        "label": "p(HGNC:PER2) decreases p(HGNC:WEE1)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405141e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:PER2) decreases p(HGNC:WEE1)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eacd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:PER1),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:TIMELESS)",
        "directed": false,
        "label": "complex(p(HGNC:PER1),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051399",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:PER1),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "in vitro",
              "citation": {
                "type": "PubMed",
                "name": "Neuron 1998 Nov 21(5) 1101-13",
                "id": "9856465"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea82"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:PER1),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e693"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY2),p(HGNC:PER1))",
        "relation": "decreases",
        "target": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "directed": false,
        "label": "complex(p(HGNC:CRY2),p(HGNC:PER1)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513b8",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY2),p(HGNC:PER1)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e851"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CRY1),p(HGNC:PER1))",
        "relation": "decreases",
        "target": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "directed": false,
        "label": "complex(p(HGNC:CRY1),p(HGNC:PER1)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405141c",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CRY1),p(HGNC:PER1)) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:WEE1)",
        "relation": "actsIn",
        "target": "kin(p(HGNC:WEE1))",
        "directed": false,
        "label": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513a9",
          "evidences": [
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Cables enhanced cdk2 tyrosine 15 phosphorylation by the Wee1 protein kinase, an inhibitory phosphorylation, which led to decreased cdk2 kinase activity. The gene encoding Cables is located on human chromosome 18q11-12, a site that is frequently lost in squamous, colon, and pancreas cancers. We found that Cables was strongly expressed in normal human epithelial cells including squamous and glandular mucosa.",
              "citation": {
                "type": "Other",
                "name": "cancer res 2001 oct 1 61(19) 7325-32",
                "id": "11585773"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54e132d589e362035c319d82"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Cables enhanced cdk2 tyrosine 15 phosphorylation by the Wee1 protein kinase, an inhibitory phosphorylation, which led to decreased cdk2 kinase activity",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Oct 1 61(19) 7325-32",
                "id": "11585773"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Fig. (1). Regulation of CDK1 by phosphorylation in the S phase. Cyclin B dimerizes with CDK1, and this complex is phosphorylated by CDK activity (CAK on Threonine161). wee1 and mik1 phosphorylate tyrosine15 and threonine14, which inactivates the complex. The G2/M transition cdc25 phosphatase dephosphorylates tyrosine15 and threonine14, but phosphorylation of threonine161 is retained, resulting in an active CDK1. Upon the completion of M phase, cyclin B is ubiquitinated and targeted for degradation. (reproduced with permission [64])",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea02"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "p53 also contributes to the G2/M checkpoint through its transactivation of p21 and 14-3-3. P21 effectively blocks the phosphorylation of CDC2, initiating the onset of the G2/M cell-cycle arrest. 14-3-3 sequesters CDC25C in the cytoplasm and promotes the activation ofWee1, a tyrosine kinase that negatively regulates CDC2, thus blocking entry into mitosis.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2008 Feb 20 27(4) 589-605",
                "id": "18285820"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "inhibition of ERK1/2 signaling resulted in marked attenuation in IR-induced ATR activity with little, if any, effect on IR-induced ATM activation. Furthermore, inhibition of ERK1/2 signaling resulted in >/=85% attenuation in IR-induced G2/M arrest and concomitant diminution of IR-induced activation of ataxia telangiectasia mutated- and rad3-related (ATR), Chk1 and Wee1 kinases as well as phosphorylation of Cdc25A-Thr506, Cdc25C-Ser216 and Cdc2-Tyr15.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jul 12 26(32) 4689-98",
                "id": "17297454"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Antibody depletion experiments demonstrate that WEE1 accounts for most of the activity that phosphorylates CDC2 on Tyr15 in an in vitro assay of HeLa cell lysates ... inhibitory tyrosine phosphorylation",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 May 15 14(10) 2166-75",
                "id": "7774574"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea78"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "In this study we defined the function of Myt1 by overexpression studies in both S. pombe and a human osteosarcoma cell line. Similar to Wee1, overexpression of human Myt1 prevented entry into mitosis in both cell types",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Sci 1999 Oct 112 ( Pt 19) 3361-71",
                "id": "10504341"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea72"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "from full text - As shown in Fig.1 A, addition of Wee1 lysates effectively inhibited Cdc2·cyclin B1 kinase activation. The Wee1 inhibitory activity was dependent on the presence of the Tyr15 residue in Cdc2, since both Cdc2-F15 (Tyr15 replaced with phenylalanine) and Cdc2-AF (Thr14 and Tyr15 replaced with alanine and phenylalanine) proteins complexed to cyclin B1 retained full activity in the presence of Wee1 lysates. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1997 Aug 29 272(35) 22300-6",
                "id": "9268380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea52"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "<C27> p45Skp2 inhibits Cdk2 kinase activity and blocks phosphorylation of Cdk2 by Wee1 or CAK (Yam et al., 1999). Similarly to p21Cip1, two molecules of p45Skp2 seem to be required to inhibit Cdk2. Binding to p45Skp2 is mutually exclusive with p21cip1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Cables is a novel cell cycle regulatory protein that interacts with cdk2, cdk3, and cdk5. Cables inhibits cdk2 activity by enhancing cdk2 tyrosine 15 phosphorylation by Wee1, which consequently leads to inhibition of cell growth.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Biol Ther 2005 Nov 4(11) 1211-5",
                "id": "16177568"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8fd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Inhibitory phosphorylation of adjacent threonine and tyrosine residues (T14/Y15 in CDK1) is mediated by dualspecificity kinases (such as WEE1 and MYT1). This inhibition is relieved when the CDC25 phosphatases (CDC25A,CDC25B and CDC25C) dephosphorylate these residues, which triggers entry into mitosis",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2001 Dec 1(3) 222-31",
                "id": "11902577"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "cdc2 had inactivating phosphorylation on Thr(14) or Tyr(15), and possibly both, due to an increase in the responsible Wee1 and Myt1 kinases",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2011 Apr 29 286(17) 15473-82",
                "id": "21321122"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Jun 9 95(12) 6785-90",
                "id": "9618490"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e891"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e852"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "96108162;7743995;15592455;16083285;15964826",
              "citation": {
                "type": "PubMed",
                "name": "BMC Bioinformatics 2004 Jun 22 5 79",
                "id": "15212693"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e844"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Cdc2 regulation also involves positive feedback, with active Cdc2-cyclin B stimulating its activator Cdc25 (refs 5-7) and inactivating its inhibitors Wee1 and Myt1 (refs 8-11)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2003 Apr 5(4) 346-51",
                "id": "12629549"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7cc"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "from full text - The wee1 gene product phosphorylates Cdc2 on Tyr-15 [p-Cdc2(Tyr 15)] and keeps it in an inactive form",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Oct 10 302(5643) 255-9",
                "id": "12934012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e78f"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "PhosphoElm data from PMID 15212693",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2005 Oct 1 391(Pt 1) 17-24",
                "id": "16083423"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e729"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:WEE1) actsIn kin(p(HGNC:WEE1))",
              "summary_text": "Wee1 expression prevents cancer cells from undergoing apoptosis in response to DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jun 2 24(24) 3875-85",
                "id": "15735666"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e71b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:PER3),p(HGNC:TIMELESS))",
        "relation": "hasComponent",
        "target": "p(HGNC:TIMELESS)",
        "directed": false,
        "label": "complex(p(HGNC:PER3),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f1",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:PER3),p(HGNC:TIMELESS)) hasComponent p(HGNC:TIMELESS)",
              "summary_text": "from full text - Table 1",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e759"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ARNTL)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:ARNTL))",
        "directed": false,
        "label": "p(HGNC:ARNTL) actsIn tscript(p(HGNC:ARNTL))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513ee",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ARNTL) actsIn tscript(p(HGNC:ARNTL))",
              "summary_text": "overexpression of dominant-negative CKI-epsilon leads to decreased BMAL1-driven transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 10 277(19) 17248-54",
                "id": "11875063"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e84f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ARNTL) actsIn tscript(p(HGNC:ARNTL))",
              "summary_text": "Coinduction of NPAS2 and BMAL1 activated transcription of the endogenous Per1, Per2, and Cry1 genes which encode negatively activating components of the circadian regulatory apparatus, and repressed transcription of the endogenous BMAL1 gene",
              "citation": {
                "type": "PubMed",
                "name": "Science 2001 Jul 20 293(5529) 506-9",
                "id": "11441147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eace"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ARNTL) actsIn tscript(p(HGNC:ARNTL))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Sep 20(17) 6269-75",
                "id": "10938103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ARNTL) actsIn tscript(p(HGNC:ARNTL))",
              "summary_text": "Furthermore, CRY proteins stabilize the unphosphorylated forms of BMAL1(BMAL2) thereby shifting the phosphorylated/unphosphorylated ratio towards a predominantly unphosphorylated (transcriptionally inactive) form.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2007 Mar 15 402(3) 525-36",
                "id": "17115977"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ARNTL) actsIn tscript(p(HGNC:ARNTL))",
              "summary_text": "Forced expression of Clock/Bmal increased endogenous Dec1 mRNA level, and overexpression of Dec1 resulted in suppression of Dec2, Per2, and Dbp expression",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 2 313(1) 117-24",
                "id": "14672706"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e912"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:ARNTL) actsIn tscript(p(HGNC:ARNTL))",
              "summary_text": "At least dbp has been identified as a direct target gene of BMAL1::CLOCK (BMAL1=ARNTL) in a mouse liver model (Oishi et al., 2003Go). ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2006 Oct 93(2) 422-31",
                "id": "16870687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e911"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:MYC)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:MYC))",
        "directed": false,
        "label": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513bd",
          "evidences": [
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here we demonstrate that HIF-1alpha, even in the absence of hypoxic signal, induces cell cycle arrest by functionally counteracting Myc, thereby derepressing p21(cip1). The HIF-1alpha antagonism is mediated by displacing Myc binding from p21(cip1) promoter. ....",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2004 May 5 23(9) 1949-56",
                "id": "15071503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Recently shown to be essential for transformation via the c-Myc pathway",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cancer 2003 Dec 15 2 42",
                "id": "14675489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e65d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "N-Myc is a transcription factor that forms heterodimers with the protein Max and binds gene promoters by recognizing a DNA sequence, CACGTG, called E-box. The identification of N-myc target genes is an important step for understanding N-Myc biological functions in both physiological and pathological contexts. In this study, we describe the identification of N-Myc-responsive genes through chromatin immunoprecipitation and methylation-sensitive restriction analysis. Results show that N-Myc is a direct regulator of several identified genes, and that methylation of the CpG dinucleotide within the E-box prevents the access of N-Myc to gene promoters in vivo. Furthermore, methylation profile of the E-box within the promoters of EGFR and CASP8, two genes directly controlled by Myc, is cell type-specific, suggesting that differential E-box methylation may contribute to generating unique patterns of Myc-dependent transcription. This study illuminates a central role of DNA methylation in controlling N-Myc occupancy at gene promoters and modulating its transcriptional activity in cancer cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Aug 23 102(34) 12117-22",
                "id": "16093321"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea96"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "To investigate whether c-MYC mediated down-regulation of the H-ferritin gene was direct, we studied H-ferritin RNA levels in a rat fibroblast cell line engineered to express an inactive c-MYC-estrogen receptor fusion protein (MycER(TM)). By treating the cells with 4-hydroxytamoxifen (TM), which specifically activates MycER(TM) (13), and by simultaneous treatment with the protein synthesis inhibitor cycloheximide (CX), we examined whether expression of the H-ferritin gene could be downregulated upon activation of preexisting MycER(TM) in the absence of new protein synthesis. Treatment with TM (with or without CX treatment, but not CX alone) led to a -60% reduction in H-ferritin RNA expression within 12 hours (Fig. IE). Because the half-life of H-ferritin RNA is 10 to 12 hours (14), the kinetics of c-MYC-induced down-regulation and the independence of new protein synthesis are consistent with a direct effect of c-MYC on H-ferritin gene expression",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Jan 29 283(5402) 676-9",
                "id": "9924025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea1f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "To investigate whether Rac1 blocked the effects of Myc through PAK2, we introduced two 4OHT-inducible Myc mutants into cultured human keratinocytes: MycAER (T358A/S373A/T400A), which cannot be phosphorylated by PAK2, and MycDER (T358D/S373D/T400D), which mimics constitutive phosphorylation of PAK2 sites (17).  The effects of MycAER on epidermal differentiation (Fig. 4G) and {alpha}6 integrin expression (Fig. 4I) were similar to the effects of wild-type MycER (Fig. 4, G and H). In contrast, MycDER did not stimulate differentiation (Fig. 4G) and increased {alpha}6 integrin expression (Fig. 4J).",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Aug 5 309(5736) 933-5",
                "id": "16081735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea1e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Because MYC proteins function primarily as transcription factors, the consequences of these alterations result in the deregulation of MYC target genes and subsequent effects on cell behavior and in the inability to down-regulate MYC expression to levels sufficiently low for a cell to exit the cell cycle and enter a quiescent state or to differentiate in response to appropriate signals. MYC is a member of the MYC/MAX/MAD network of the basic region/helix-loop-helix/leucine zipper (bHLHZ) domain transcriptional regulators (for a summary of the domain structure see Fig. 1). MYC proteins form obligatory heterodimers with MAX, and these complexes bind to specific E-box DNA sequences with the consensus 5beta-CACGTG (7). The transactivation domain (TAD) is localized at theNterminus, containing two highly conserved elements, Myc box (MB) I and II, that are particularly relevant for MYC regulation and cofactor recruitment, respectively (Fig. 1). Within the MYC/MAX/MAD network, MYC proteins are antagonized by several bHLHZ proteins collectively referred to as MAD proteins (for an overview of the network see Fig. S2A) (8).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 34725-9",
                "id": "16987807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e988"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Myc oncoproteins promote cell cycle progression in part through the transcriptional up-regulation of the cyclin D2 gene. We now show that Myc is bound to the cyclin D2 promoter in vivo. Binding of Myc induces cyclin D2 expression and histone acetylation at a single nucleosome in a MycBoxII/TRRAP-dependent manner. Down-regulation of cyclin D2 mRNA expression in differentiating HL60 cells is preceded by a switch of promoter occupancy from Myc/Max to Mad/Max complexes, loss of TRRAP binding, increased HDAC1 binding, and histone deacetylation. Thus, recruitment of TRRAP and regulation of histone acetylation are critical for transcriptional activation by Myc.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Aug 15 15(16) 2042-7",
                "id": "11511535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "from full text - Box 2 | Bcl2 and the Rb/Arf/p53 network Inactivation of the retinoblastoma (Rb) pathway — for example, by loss of cell-cycle inhibitor Ink4a, which can prevent cyclin-D–Cdk4 from phosphorylating Rb — unleashes the transcription factor E2f1,which increases expression of Arf, a protein that is encoded by the same locus as Ink4a (REF. 136).Arf,which is also a transcriptional target of Myc, sequesters Mdm2, a negative regulator of p53. Raised p53 levels can either impose growth arrest, typically by inducing the Waf1 cell-cycle inhibitor, or promote apoptosis through targets such as Bax, Puma and Noxa. The apoptotic targets seem to also require the p53 relative p63 or p73 (REF. 152). Circles/ovals denote oncogene products; rectangles denote known or likely tumour suppressors. For more detail, see REFS 4–6,136.ATM, ataxia telengiectasia mutated; Chk2, checkpoint 2; NF-?B, nuclear factor-?B.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 Sep 2(9) 647-56",
                "id": "12209154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here we provide evidence that TGFbeta signalling prevents recruitment of Myc to the p15INK4b transcriptional initiator by Myc-interacting zinc-finger protein 1 (Miz-1). This relieves repression and enables transcriptional activation by a TGFbeta-induced Smad protein complex that recognizes an upstream p15INK4b promoter region and contacts Miz-1. Thus, two separate TGFbeta-dependent inputs - Smad-mediated transactivation and relief of repression by Myc - keep tight control over p15INK4b activation.  \t ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Apr 3(4) 400-8",
                "id": "11283614"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "To investigate whether c-MYC mediated down-regulation of the H-ferritin gene was direct, we studied H-ferritin RNA levels in a rat fibroblast cell line engineered to express an inactive c-MYC-estrogen receptor fusion protein (MycER(TM)). By treating the cells with 4-hydroxytamoxifen (TM), which specifically activates MycER(TM) (13), and by simultaneous treatment with the protein synthesis inhibitor cycloheximide (CX), we examined whether expression of the H-ferritin gene could be downregulated upon activation of preexisting MycER(TM) in the absence of new protein synthesis. Treatment with TM (with or without CX treatment, but not CX alone) led to a -60% reduction in H-ferritin RNA expression within 12 hours (Fig. IE). Because the half-life of H-ferritin RNA is 10 to 12 hours (14), the kinetics of c-MYC-induced down-regulation and the independence of new protein synthesis are consistent with a direct effect of c-MYC on H-ferritin gene expression",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Jan 29 283(5402) 676-9",
                "id": "9924025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": ", MEK1 and MEK2 are the only known substrates for B-Raf.154-157 A consistent theme in studies on MEK/ERK activation by Raf is that B-Raf is far more potent at activating downstream kinases than either A-Raf or C-Raf. Several lines of evidence also indicate that B-Raf has a much higher affinity for its substrate than the other Raf isoforms and is 50-fold more potent at phosphorylating MEK1 and MEK2 than either A-Raf or C-Raf.125,158 The respective downstream substrates of MEK1 and MEK2 are ERK1 (p44MAPK) and ERK2 (p42MAPK), which are translocated to the nucleus where they ultimately induce an array of cytoplasmic and nuclear regulatory proteins.50,159-162 Effectors include the nuclear transcription factors Elk-1, Fos, Jun, AP-1, and Myc, which regulate genes encoding proteins that play key roles in proliferation, angiogenesis, metastasis, and resistance to anticancer therapeutics.51",
              "citation": {
                "type": "PubMed",
                "name": "J Clin Oncol 2005 Sep 20 23(27) 6771-90",
                "id": "16170185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e890"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "From article: To determine whether the overexpression of c-Myc in the liver led to the long-term counteraction of diabetic alterations, control and transgenic mice were treated with STZ. in STZ-treated transgenic mice the expression of genes involved in the control of gluconeogenesis (phosphoenolpyruvate carbokykinase), ketogenesis (3-hydroxy-3-methylglutaryl-CoA synthase) and energy metabolism (uncoupling protein 2) had returned to normal. These findings were correlated with decreased expression of genes encoding the transcription factors hepatocyte nuclear factor 3gamma, peroxisome proliferator-activated receptor alpha and retinoid X receptor.% These results indicate that c- myc overexpression may counteract diabetic changes by controlling hepatic glucose metabolism, both directly by altering the expression of metabolic genes and through the expression of key transcription factor genes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2002 Dec 15 368(Pt 3) 931-7",
                "id": "12230428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e888"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Inhibition of either KPC1 or KPC2 by RNA interference or with dominant-negative mutants delays p27 degradation at the G0 G1 transition . These results indicate that the degradation of p27 is regulated by two distinct mechanisms: translocation-coupled cytoplasmic ubiquitylation by KPC at the G0 G1 transition and nuclear ubiquitylation by SKP2 during S and G2 phases (see Supplementary information S2 (figure)). Given that, in a subset of breast cancers (32 out of 84 samples)45, p27 levels were low despite SKP2 not being expressed, it remains possible that the expression of KPC might be elevated in such cases. Surprisingly, SKP2 also binds to MYC through its MB2 and helix loop helix leucine zipper (HLHZip) domains, and thereby mediates its ubiquitylation and degradation. However, SKP2 unexpectedly increases the transactivation activity of MYC, indicating that SKP2 is a transcriptional cofactor. Consistent with this notion, MYC accumulates, but its transcriptional activity is reduced, in mouse Skp2 ko cells.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2006 May 6(5) 369-81",
                "id": "16633365"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e884"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Within exon 1 of Raet1 epsilon exists an E-box (CACGTG), the canonical Myc-binding sequence. In addition, this region is within a CpG island, a highly permissive environment for Myc binding (43). We isolated B cells from wild-type, preneoplastic, and tumor-bearing animals and performed ChIP for both c-Myc and acetylated histone H3, a mark of both chromatin accessibility and transcriptional activation (43). We observed enhanced binding (8-fold enrichment over wild type) of Myc to the locus in tumor cells as well as increased histone H3 acetylation relative to wild-type B cells (Fig. 5).",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Feb 5 105(5) 1686-91",
                "id": "18223157"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ed"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In agreement with the role of S62 phosphorylation on reporter gene expression, the hTERT and Bmi-1 genes were repressed by IFN-? + TPA and by the Cdk2 inhibitor CVT-313 (Fig. 6D), whereas the p21 and p16Ink4A genes were strongly induced (Fig. 6E). The changes in gene expression are consistent with the ChIP results and indicate that cyclin E/Cdk2 enhances, whereas IFN-?, through the activation of p27, represses Myc-activated transcription (and vice versa for Myc-repressed transcription) of genes involved in cellular senescence. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2010 Jan 5 107(1) 58-63",
                "id": "19966300"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ca"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In addition to the influence on the protein kinase system, uPA can regulate gene expression. The binding of uPA to uPAR has been shown to stimulate downstream up-regulation of various transcription factors: AP1 in the HT-1080 cell line [54] and c-Jun, c-Myc, and c-fos factors in SaOS2 cells [55]. Recently, the possibility of signal transduction into the cell by the receptor systems associated with urokinase endocytosis was shown [56].",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry (Mosc) 2002 Jan 67(1) 119-34",
                "id": "11841347"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e758"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Myc oncoproteins promote cell cycle progression in part through the transcriptional up-regulation of the cyclin D2 gene. We now show that Myc is bound to the cyclin D2 promoter in vivo. Binding of Myc induces cyclin D2 expression and histone acetylation at a single nucleosome in a MycBoxII/TRRAP-dependent manner. Down-regulation of cyclin D2 mRNA expression in differentiating HL60 cells is preceded by a switch of promoter occupancy from Myc/Max to Mad/Max complexes, loss of TRRAP binding, increased HDAC1 binding, and histone deacetylation. Thus, recruitment of TRRAP and regulation of histone acetylation are critical for transcriptional activation by Myc.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Aug 15 15(16) 2042-7",
                "id": "11511535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e74d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "e hypothesized that in MCF-7 cells Smad3 and c-Myc interact directly to inhibit c-Myc transcriptional activation of the hTERT gene and that their interaction recruits Smad3 to the hTERT gene promoter for repression. To test this hypothesis, we determined if Smad3 binds to c-Myc in response to TGF-? treatment of MCF-7 cells by co-immunoprecipitation. Immunoprecipitation of c-Myc showed little co-immunoprecipitation of Smad3 in the presence of TGF-? stimulation, but after stimulation of the cells by TGF-? (4 ng/ml) for various periods of time, significant levels of Smad3 were detected in the c-Myc immunoprecipitates, with Smad3 detectable 15 min after TGF-? stimu-lation (Fig. 9A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Sep 1 281(35) 25588-600",
                "id": "16785237"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e74c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "This protein, Mxi1 (for Max interactor 1), contains a bHLH-Zip motif that is similar to that found in Myc family proteins. Mxi1 interacts specifically with Max to form heterodimers that efficiently bind to the Myc-Max consensus recognition site. When bound to DNA by a LexA moiety in yeast, Mxi1 does not stimulate transcription. mxi1 mRNA is expressed in many tissues, and its expression is elevated in U-937 myeloid leukemia cells that have been stimulated to differentiate. These facts are consistent with a model in which Mxi1-Max heterodimers indirectly inhibit Myc function in two ways: first, by sequestering Max, thus preventing the formation of Myc-Max heterodimers, and second, by competing with Myc-Max heterodimers for binding to target sites.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1993 Jan 29 72(2) 223-32",
                "id": "8425219"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e691"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The transcription factor E2F1 is an additional target of c-Myc that promotes cell cycle progression. We find that expression of E2F1 is negatively regulated by two miRNAs in this cluster, miR-17-5p and miR-20a. These findings expand the known classes of transcripts within the c-Myc target gene network, and reveal a mechanism through which c-Myc simultaneously activates E2F1 transcription and limits its translation, allowing a tightly controlled proliferative signal.",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2005 Jun 9 435(7043) 839-43",
                "id": "15944709"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e68b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Protein-protein interaction studies indicate that PRMT5 and mSin3A interact with the same hSWI/SNF subunits as those targeted by c-Myc. These observations prompted us to examine the expression profile of the c-Myc target genes, carbamoyl-phosphate synthase-aspartate carbamoyltransferase-dihydroorotase (cad) and nucleolin (nuc). We found that cad repression is altered in cells that express inactive Brg1 and in cells treated with the HDAC inhibitor depsipeptide.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(21) 7475-87",
                "id": "14559996"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea3d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Exposure to H2O2 enhances c-Myc recruitment to gamma-GCS regulatory regions through ERK-dependent phosphorylation. Phosphorylation at Ser-62 is required for c-Myc recruitment to gamma-GCS promoters and determines the cellular response to oxidative stress induced by different stimuli.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Feb 17 21(4) 509-19",
                "id": "16483932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "melanoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "These effects were dependent on GATA-1-mediated repression of the c-myc (Myc) proto-oncogene. GATA-1 inhibited Myc expression within 3 h, and chromatin immunoprecipitation studies indicated that GATA-1 occupies the Myc promoter in vivo, suggesting a direct mechanism for gene repression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Jul 23(14) 5031-42",
                "id": "12832487"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Next, the effect of c-Myc activation on mina53 mRNA was investigated (Fig. 2C). The mina53 mRNA level rose steadily for 9 h in OHT-treated T98Gmycer-2 cells, showing nearly 3-fold induction.....Treatment with cycloheximide had little effect on the mina53 mRNA level in T98G parent cells. These results indicate that the mina53 gene is a direct target of Myc.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 35450-9",
                "id": "12091391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "glioblastoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We now show that the cyclin B1 promoter is directly but oppositely regulated by c-Myc and p53. Enforced expression of cyclin B1 also induces tetraploidy, either after mitotic spindle inhibition or in the absence of such inhibition if cyclin B1 is coexpressed with c-Myc. Cyclin B1 represents a new class of c-Myc target genes that is also regulated by p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Sep 1 61(17) 6487-93",
                "id": "11522645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e982"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In this work we present evidence that v-Myc encoded by the avian retrovirus MC29 stimulates activating transcription factor 2 (ATF2)-dependent transcription. Analysis of the effect of Myc on ATF2 shows that v-Myc prolongs the half-life of ATF2 and induces the phosphorylation of N-terminal sites of ATF2 (Thr-69 and Thr-71) which have previously been identified as the target sites of stress-activated protein kinases and implicated in the regulation of ATF2 activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Dec 6 20(56) 8116-24",
                "id": "11781825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e979"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here we provide evidence that TGFbeta signalling prevents recruitment of Myc to the p15INK4b transcriptional initiator by Myc-interacting zinc-finger protein 1 (Miz-1). This relieves repression and enables transcriptional activation by a TGFbeta-induced Smad protein complex that recognizes an upstream p15INK4b promoter region and contacts Miz-1. (from Weinberg - Pathways in Human Cancer poster, SMAD = SMAD 2/3) (MIZ-1 = ZBTB17)",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Apr 3(4) 400-8",
                "id": "11283614"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e934"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Supplemental Data, genes whose expression was affected by induction of TFs were identified via pair-wise statistical comparison (FDR < 0.05 and expression changes > 2-fold) between microarray data for the same clone in Dox+ and Dox- conditions (NIA Mouse 44K Microarray v3.0 - whole genome 60-mer oligo arrays, Agilent Technology, design ID 015087)",
              "citation": {
                "type": "PubMed",
                "name": "Cell Stem Cell 2009 Oct 2 5(4) 420-33",
                "id": "19796622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e87a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "embryonic stem cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In primary cultures of lymphoid cells from Em-myc transgenic mice, MYC activation suppresses Bcl-X(L) RNA and protein, and Bcl-X(L) and Bcl-2 expression are inhibited by MYC in precancerous B cells from these mice. That suppression of Bcl-X(L) RNA levels by MYC requires de novo protein synthesis indicates that repression is indirect (Eischen et al., 2001a).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e821"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Up-regulation of functional nAChR {alpha}7 subunits has been shown in normal human bronchial epithelial cells (NHBE) upon exposure to nicotine (10). In SCLC cell lines, up-regulation of nAChR {alpha}7 has been shown in response to NNK stimulation, with overexpression and phosphorylation of serine-threonine protein kinase Raf-1 and extracellular signal regulated kinases 1 and 2 and activation of c-myc (27), leading to increased proliferation (1, 28). ",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 May 15 67(10) 4638-47",
                "id": "17510389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e779"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "To confirm the results, mRNA for mina53 was detected by Northern blotting in these 3Y1 cell lines (Fig. 3C). The mina53 mRNA level was stimulated by 1.5- and 3-fold in 3Y1MycA and 3Y1MycB, respectively. On the other hand, mina53 mRNA level was not stimulated in 3Y1Myc(dTAD)A and 3Y1Myc- (dTAD)B. These results suggest that c-Myc transactivates the expression of mina53.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 35450-9",
                "id": "12091391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e773"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": " We examined the promoter region of the Polycomb group (PcG) gene bmi-1, a known repressor of p16 transcription (16), and found a canonical c-Myc binding site (E-box) at position –182 relative to the transcriptional start site. Quantitative real-time RT-PCR (qPCR) showed that Bmi-1 mRNA levels were reduced {approx}2-fold in c-myc+/– cells (Fig. 2A). ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2006 Mar 7 103(10) 3645-50",
                "id": "16537449"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e767"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The Myc:Max interaction is essential for Myc-dependent transcriptional activation; however, we show that Max bound targets also include Myc-repressed genes. Moreover, we show that the interaction between Myc and Max is essential for gene repression to occur. Taken together, the identification and analysis of Myc bound target genes supports a model whereby Max plays an essential and universal role in the mechanism of Myc-dependent transcriptional regulation",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2003 May 13 13(10) 882-6",
                "id": "12747840"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e73e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The pro-differentiation genes downregulated by c-myc include those that encode p21, CDC2, and NCAM1, while the c-myc-activated pro-growth genes include those that encode prohibitin, cyclin D3, RAB40B, and TRAP1. Statistics: FDR included, fropm text \\\"For further analysis of fold changes, false discovery rate, and gene ontology, Genesifter software (VizX Labs, Seattle, WA) was used.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Dec 23(24) 9375-88",
                "id": "14645547"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e712"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Glucose increased c-Myc abundance and association with its heterodimer partner Max. Manipulations that prevented the formation of a functional c-Myc/Max heterodimer reduced the expression of the L-PK gene. In addition, glucose augmented the binding of ChREBP, c-Myc, and Max to the promoter of the L-PK gene in situ.  #[JL] Chrebp is MLXIPL, and is implicated as a glucose-responsive factor.  This is basically saying that glucose activates MLXIPL- activation of MYC",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Endocrinol Metab 2007 Mar 6",
                "id": "17341548"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e670"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1996 Jun 25 93(13) 6635-40",
                "id": "8692870"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 36017-26",
                "id": "12840021"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Myc is recruited to this promoter following STAT3 DNA binding. Moreover, small interfering RNA-mediated knockdown of Myc specifically inhibits the STAT3-mediated activation of Cdc25A",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Apr 22 280(16) 15673-81",
                "id": "15677471"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eac1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Cyclic stretch also significantly increased DNA-protein binding activity of Myc-Max.",
              "citation": {
                "type": "PubMed",
                "name": "Hypertension 2005 Sep 46(3) 614-21",
                "id": "16087782"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We now show that the cyclin B1 promoter is directly but oppositely regulated by c-Myc and p53. Enforced expression of cyclin B1 also induces tetraploidy, either after mitotic spindle inhibition or in the absence of such inhibition if cyclin B1 is coexpressed with c-Myc. Cyclin B1 represents a new class of c-Myc target genes that is also regulated by p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Sep 1 61(17) 6487-93",
                "id": "11522645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab4"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Science 1990 Nov 2 250(4981) 682-6",
                "id": "2237417"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eab0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1996 Nov 7 13(9) 1859-66",
                "id": "8934531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaaf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 2000 May 11(5) 269-77",
                "id": "10845428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "ARF negatively regulates the transcriptional activity of MYC by associating with and relocating MYC from the nucleoplasm to the nucleolus (Amente et al., 2006; Meyer et al., 2006; Sarker and Fisher, 2006),",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "lymphoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 1997 Jun 16(6) 737-47",
                "id": "9212167"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Sep 17(9) 5227-35",
                "id": "9271400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea9f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Expression of Myc in primary cells inhibits the accumulation of p15INK4b that is associated with cellular senescence; conversely, deletion of c-myc in an established cell line activates p15INK4b expression",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2001 Apr 3(4) 392-9",
                "id": "11283613"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea9e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Phosphorylation of downstream mitogen-activated protein kinase-targeted transcription factors including c-Myc, Elk-1, c-Jun, and activating transcription factor (ATF) 2 was also differentially enhanced",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 Jun 1 64(11) 3855-64",
                "id": "15172994"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea9c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "we show that TFRC1 expression is activated by c-Myc. Chromatin immunoprecipitation experiments reveal that c-Myc directly binds a conserved region of TFRC1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2006 Mar 26(6) 2373-86",
                "id": "16508012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea98"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Phosphorylation by Pak2 inhibits the ability of Myc to activate transcription",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1582-94",
                "id": "14749374"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea97"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1995 Dec 21 11(12) 2599-607",
                "id": "8545117"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea8f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea87"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1996 Aug 15 15(16) 4344-57",
                "id": "8861962"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea83"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Nov 10 95(23) 13887-92",
                "id": "9811896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea80"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Nov 15 60(22) 6318-25",
                "id": "11103792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea7f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Histochem J 1996 Jan 28(1) 45-52",
                "id": "8866647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea77"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Figure 1. c-Myc up-regulates eIF4E, eIF4AI, and eIF4GI mRNA and protein levels.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2008 Jul 1 68(13) 5326-34",
                "id": "18593934"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea74"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Aug 15 90(16) 7804-8",
                "id": "8356088"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea70"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1991 Jan 10(1) 133-41",
                "id": "1989881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea6a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Jan 17(1) 100-14",
                "id": "8972190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea63"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Aug 15 97(17) 9498-503",
                "id": "10920185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea60"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "the TCF-4 target gene c-MYC plays a central role in this switch by direct repression of the p21(CIP1/WAF1) promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 2002 Oct 18 111(2) 241-50",
                "id": "12408868"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea5f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Fig 4. Myc induces accumulation of cyclin d2 mrna",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Oct 1 18(19) 5310-20",
                "id": "10508164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea5b"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Exp Med 1999 Jan 18 189(2) 231-9",
                "id": "9892606"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea57"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The c-Myc oncoprotein is strongly induced during the G0 to S-phase transition and is an important regulator of cell cycle entry.",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2005 May 9 169(3) 405-13",
                "id": "15866886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea54"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Aug 15 15(16) 2069-82",
                "id": "11511539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea49"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mech Dev 1999 May 83(1-2) 39-52",
                "id": "10381566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea47"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 34815-25",
                "id": "12095979"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea45"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Inhibition of Sug1 expression by siRNA reduced transcription from a Myc target promoter to the same extent as c-Myc or Skp2 siRNA, implicating Sug1in this process.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2(5) 403-7",
                "id": "12963825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea3f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Jun 14(6) 3853-62",
                "id": "8196628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea3e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1987 Jun 1(4) 347-57",
                "id": "3678827"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea39"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-MYC negatively regulates p21/CIP by binding to and inhibiting the transcriptional activator Miz-1 (Wu et al., 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea37"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-MYC-mediated induction of PKA-Cbeta gene transcription occurs in multiple tissues, is independent of cell proliferation and is mediated by direct binding of c-MYC to the PKA-Cbeta gene promoter sequences.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Nov 7 21(51) 7872-82",
                "id": "12420224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea33"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We nowshow that p27 is rapidly and transiently sequestered by cyclin D2-Cdk4 complexesupon activation of Myc and that cyclin D2 is a direct target gene of Myc.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Oct 1 18(19) 5321-33",
                "id": "10508165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea31"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Aug 20(16) 6008-18",
                "id": "10913183"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea2b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jan 15 17(2) 240-55",
                "id": "12533512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea24"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1993 Feb 4(2) 57-65",
                "id": "8494784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea23"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 27 275(43) 33798-805",
                "id": "10931841"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea1d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1996 Nov 7 13(9) 1859-66",
                "id": "8934531"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea1c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6386-91",
                "id": "11983920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea1a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6386-91",
                "id": "11983920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea18"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Indeed, c-Myc transcriptionally regulates gamma-GCS by binding and activating the promoters of both gamma-GCS heavy and light subunits. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Feb 17 21(4) 509-19",
                "id": "16483932"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea16"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1991 Jan 10(1) 133-41",
                "id": "1989881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea14"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Taken together, these observations directly demonstrate that the amino-terminal repression domain of Mxi1-SR functions solely to recruit mSin3A and possibly other proteins like mSin3A and this association is necessary for the anti-Myc activity of Mxi1-SR.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1996 Mar 7 12(5) 1165-72",
                "id": "8649810"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea12"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Blood 1998 Dec 15 92(12) 4700-11",
                "id": "9845536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea0e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1993 Sep 15 53(18) 4337-42",
                "id": "7689933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea0b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Importantly, using promoter-reporter, chromatin immunoprecipitation, and quantitative real-time primary transcript RT-PCR assays, and an RNA interference approach, we demonstrate that Bmi-1 is a bona fide target of c-Myc oncoprotein.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 2007 Feb 18(2) 536-46",
                "id": "17151361"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea08"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We found that MYC induces DNA double-strand breaks (DSBs) independent of ROS production in murine lymphocytes in vivo as well as in normal human foreskin fibroblasts (NHFs)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Jul 1 66(13) 6598-605",
                "id": "16818632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea01"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Mar 29 20(14) 1688-702",
                "id": "11313917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9fb"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1992 Mar 24 1130(2) 166-74",
                "id": "1562593"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2003 Jun 1 372(Pt 2) 631-41",
                "id": "12646044"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f6"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Bim is induced by c-MYC in B cells and mediates apoptosis. Interestingly, inactivation of only one Bim allele was sufficient to accelerate MYCinduced development of tumors (Egle et al., 2004).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Antimicrob Chemother 1975 Mar 1(1) 55-65",
                "id": "1100584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ed"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Jul 22(14) 5054-63",
                "id": "12077335"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1997 Jun 24 94(13) 6658-63",
                "id": "9192621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-MYC expression downregulates both p21 and gadd45a expression as well as other growth arrest genes including gas1, p15, p27, gadd34 and gadd153 (Amundson et al., 1998; Seoane et al., 2002; Gartel and Shchors, 2003; Wu et al., 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9dc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Thus, recruitment of TRRAP and regulation of histone acetylation are critical for transcriptional activation by Myc.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Aug 15 15(16) 2042-7",
                "id": "11511535"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9d5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 21 275(29) 21797-800",
                "id": "10823814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9cd"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The effect of Pag on certain c-Myc-regulated biological functions occurs in the face of a significant loss of regulation of certain c-Myc target genes",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 8 277(45) 43175-84",
                "id": "12196529"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ca"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1994 May 1 152(9) 4328-35",
                "id": "8157956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 21 275(29) 21797-800",
                "id": "10823814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Overexpression of L11 inhibits c-Myc-induced transcription and cell proliferation, while reduction of endogenous L11 increases these c-Myc activities. ",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2007 Aug 6(22) 2735-41",
                "id": "18032916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 May 19(5) 3529-39",
                "id": "10207076"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "These data suggest that TRRAP is an essential cofactor for both the c-Myc and E1A/E2F oncogenic transcription factor pathways.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1998 Aug 7 94(3) 363-74",
                "id": "9708738"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ae"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The basic region/helix-loop-helix/leucine zipper (B-HLH-LZ) oncoprotein c-Myc is abundant in proliferating cells and forms heterodimers with Max protein that bind to E-box sites in DNA and stimulate genes required for proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jan 8 274(2) 595-606",
                "id": "9872993"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1998 Nov 19 1448(1) 115-25",
                "id": "9824682"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e99a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-MYC was shown to be directly recruited to the p21(Cip1) promoter by the DNA-binding protein Miz-1, blocking p21(Cip1) induction by p53 (Seoane et al., 2002; Wu et al., 2003).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e998"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 34997-5006",
                "id": "12110671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e995"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Fig 4. Myc induces accumulation of cyclin d2 mrna",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Oct 1 18(19) 5310-20",
                "id": "10508164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e992"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Using both chromatin immunoprecipitation and luciferase reporter analyses, c-MYC was shown to repress FLIP transcription, causing increased caspase-8 activation (Ricci et al., 2004).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e990"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here, we show that the induction of NOXA by bortezomib is directly dependent on the oncogene c-MYC. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Dec 4 104(49) 19488-93",
                "id": "18042711"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e98d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "tumor"
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Exposure of SCLC or PNECs to NNK or nicotine increased expression of the a7nAChR and caused influx of Ca2+, activation of PKC, Raf-1, ERK1/2, and c-myc, resulting in the stimulation of cell proliferation.",
              "citation": {
                "type": "PubMed",
                "name": "Mutat Res 659(3) 221-31",
                "id": "18495523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e98c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Reprod Dev 1997 May 47(1) 57-65",
                "id": "9110315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e98b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Regions of the c-myc protein required for induction of apoptosis overlap with regions necessary for cotransformation, autoregulation, and inhibition of differentiation, suggesting that the apoptotic function of c-myc protein is related to its other functions.",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1992 Apr 3 69(1) 119-28",
                "id": "1555236"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e987"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "A role for c-Myc in the hypoxic induction of VEGF was demonstrated by site-directed mutagenesis of the VEGF promoter and silencing of c-Myc by small interfering RNA.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 May 19 281(20) 13957-63",
                "id": "16543245"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e984"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Tmp promoter region and identified a putative c-Myc binding element  the c-Myc-Max protein complex can bind to this element  an inducible form of c-Myc, the MycER fusion protein, can activate the endogenous Tmp gene",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 May 19(5) 3529-39",
                "id": "10207076"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e981"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "# Pubmed:gene: Characterization of murine BCAT genes: Bcat1, a c-Myc target, and its homolog, Bcat2.",
              "citation": {
                "type": "PubMed",
                "name": "Mamm Genome 1998 Jul 9(7) 595-7",
                "id": "9657861"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e97e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Apr 15 90(8) 3685-9",
                "id": "8386381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e97c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 Oct 1 16(19) 2530-43",
                "id": "12368264"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e97b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Interestingly, NF-kappaB/rel-mediated activation of IEX-1 expression was synergized by p53, but strongly inhibited by c-Myc in a dose-dependent fashion.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Oct 3 21(44) 6819-28",
                "id": "12360408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e978"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "These findings support a model where Mnt represses Myc target genes and Myc functions as an oncogene by relieving Mnt-mediated repression.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Feb 24(4) 1560-9",
                "id": "14749372"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e977"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Apr 10 98(8) 4510-5",
                "id": "11274368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e973"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1997 Jun 24 94(13) 6658-63",
                "id": "9192621"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e970"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "supplementary table II: list of genes downregulated in MIZ kd cells # also downregulated by MYC",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Jan 7(1) 30-41",
                "id": "15580267"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e96e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Jun 12 14(23) 2825-34",
                "id": "9190899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e96b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "# Pubmed:gene: AMY-1 interacts with S-AKAP84 and AKAP95 in the cytoplasm and the nucleus, respectively, and inhibits cAMP-dependent protein kinase activity by preventing binding of its catalytic subunit to A-kinase-anchoring protein (AKAP) complex.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Dec 27 277(52) 50885-92",
                "id": "12414807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e95f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-MYC-mediated induction of PKA-Cbeta gene transcription occurs in multiple tissues, is independent of cell proliferation and is mediated by direct binding of c-MYC to the PKA-Cbeta gene promoter sequences.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Nov 7 21(51) 7872-82",
                "id": "12420224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e95d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Table 1. List of induced target genes with nucleolar localisation",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2003 Nov 1 31(21) 6148-56",
                "id": "14576301"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e95b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Aug 15 63(16) 4990-6",
                "id": "12941825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e959"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Sep 16(9) 4754-64",
                "id": "8756633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e957"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 May 31 277(22) 19998-20010",
                "id": "11909865"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e952"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Exp Cell Res 1999 Nov 25 253(1) 63-77",
                "id": "10579912"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e950"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Importantly, Myc acted as a strong and direct repressor for TSC2 expression because its loss increased TSC2 mRNA in myc-null and in HL60 shRNA experiments, activation of a mycER construct in myc(-/-) cells suppressed TSC2 induction in a myc box II-dependent manner, and mycER activation recruited Myc to the TSC2 promoter.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2007 Dec 1 67(23) 11209-17",
                "id": "18056446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e94a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1994 Sep 1 13(17) 4070-9",
                "id": "8076602"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e944"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Unlike HIF-1, HIF-2 promotes C-Myc-dependent activation of cyclin D2 and repression of p27 in RCC cells.74",
              "citation": {
                "type": "PubMed",
                "name": "Cell Death Differ 2008 Apr 15(4) 678-85",
                "id": "18259193"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e938"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1992 Dec 6(12B) 2513-23",
                "id": "1340466"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e930"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2002 Mar 27 21(13) 2097-101",
                "id": "11960382"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e923"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Curr Biol 2000 Oct 5 10(19) 1205-8",
                "id": "11050389"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e921"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-MYC-regulated genes identified by SAGE ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6274-9",
                "id": "11983916"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e91f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "JPO2 is closely related to JPO1, a Myc transcriptional target with transforming activity.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Jul 1 65(13) 5607-19",
                "id": "15994933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e91e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The Myc/Max heterodimer binds to elements in the cdc25A gene and activates transcription. Like myc, cdc25A, itself a proto-oncogene, can induce apoptosis in cells depleted of growth factor, and Myc-induced apoptosis also requires cdc25A. These findings indicate that cdc25A is a physiologically relevant transcriptional target of c-myc",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1996 Aug 8 382(6591) 511-7",
                "id": "8700224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e917"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Jan 17(1) 100-14",
                "id": "8972190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e914"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-Myc suppresses the Wnt inhibitors DKK1 and SFRP1",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Jul 27(14) 5135-46",
                "id": "17485441"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e910"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Sep 16(9) 4754-64",
                "id": "8756633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e90c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jan 1 60(1) 143-9",
                "id": "10646866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e90b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Mar 31 275(13) 9767-72",
                "id": "10734130"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e908"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Table 1 Genes differentially expressed in Myc-transformed versus parental colonocytes Activated by Myc",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2004 May 1 64(9) 3126-36",
                "id": "15126350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e901"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 May 15(5) 2527-35",
                "id": "7739536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e900"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 48285-91",
                "id": "11604407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1991 Apr 11(4) 2291-5",
                "id": "2005911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "the glucose-mediated induction of L-type pyruvate kinase and glucose-6-phosphatase mRNA levels was diminished by maneuvers involving recombinant adenoviral vectors that interfere with (i) c-Myc protein levels by antisense expression or (ii) c-Myc function through a dominant-negative Max protein. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 21 278(8) 6588-95",
                "id": "12480946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ef"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Aug 15 60(16) 4596-601",
                "id": "10969812"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ed"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "MycER activation caused accumulation of ARF and p53 in both Cdk2+/+ and Cdk2-/- MEFs, whereas p21Cip1 and p16INK4a were induced selectively in Cdk2-/- MEFs (Fig. 2a).",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2010 Jan 12(1) 54-9; sup pp 1-14",
                "id": "20010815"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2000 Jan 15 28(2) 446-53",
                "id": "10606642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8d3"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Cells transformed with MYC, but not cells transformed by a panel of other activated oncogenes, rapidly underwent apoptosis when treated with small-molecule CDK1 inhibitors. {Myc transformation and resistance to apoptosis is dependent on its transcriptional activity-SE}",
              "citation": {
                "type": "PubMed",
                "name": "Nat Med 2007 Jul 13(7) 820-7",
                "id": "17589519"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8cf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Aug 20(15) 5490-502",
                "id": "10891489"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8cc"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1998 Apr 29 1397(2) 189-201",
                "id": "9565685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8cb"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Beta Catenin",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2002 May 2(5) 331-41",
                "id": "12044009"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Apr 15 90(8) 3685-9",
                "id": "8386381"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In addition, small interfering RNA-mediated reduction in either PVT1 or MYC expression inhibited proliferation in breast and ovarian cancer cell lines in which they were both amplified and overexpressed but not in lines in which they were not amplified/overexpressed.",
              "citation": {
                "type": "PubMed",
                "name": "Clin Cancer Res 2007 Oct 1 13(19) 5745-55",
                "id": "17908964"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Jun 14(6) 3853-62",
                "id": "8196628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8ba"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Ectopic cdk3, but not cdk2, enhances Myc-induced proliferation and anchorage-independent growth associated with Myc activation, without effects on cyclin D1, E and A protein expression or kinase activities. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Oct 29 17(17) 2259-69",
                "id": "9811456"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": " BASP1 mRNA and protein expression is specifically suppressed in fibroblasts transformed by the v-myc oncogene, but not in cells transformed by other oncogenic agents. ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2009 Apr 7 106(14) 5604-9",
                "id": "19297618"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Activation by c-Myc, in turn, can promote LDH-A gene transcription",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 11 278(15) 12937-45",
                "id": "12562761"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8b0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Jan 1 60(1) 143-9",
                "id": "10646866"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 Nov 29 271(48) 30741-7",
                "id": "8940053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Oct 27 275(43) 33798-805",
                "id": "10931841"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e89f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Rock inhibition decreases c-myc gene expression without affecting the E2F and c-Jun pathways. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2007 Jan 8",
                "id": "17213802"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e899"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Oct 5 407(6804) 592-8",
                "id": "11034201"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e897"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1993 Feb 4(2) 57-65",
                "id": "8494784"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e88f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The Myc/Max heterodimer binds to elements in the cdc25A gene and activates transcription. Like myc, cdc25A, itself a proto-oncogene, can induce apoptosis in cells depleted of growth factor, and Myc-induced apoptosis also requires cdc25A. These findings indicate that cdc25A is a physiologically relevant transcriptional target of c-myc",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1996 Aug 8 382(6591) 511-7",
                "id": "8700224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e88c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2003 Sep 1 63(17) 5370-5",
                "id": "14500370"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e886"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 4 277(40) 36921-30",
                "id": "12145275"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e885"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 May 15(5) 2527-35",
                "id": "7739536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e882"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 Jun 12 14(23) 2825-34",
                "id": "9190899"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e881"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Table 1: Only those marked direct, as determined by experiment 3.  Time points are 4, 8, or 16 hours.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Apr 4 278(14) 12563-73",
                "id": "12529326"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e87c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Cell 2003 Mar 3(3) 219-31",
                "id": "12676581"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e879"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Fig 4. Myc induces accumulation of cyclin d2 mrna",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Oct 1 18(19) 5310-20",
                "id": "10508164"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e878"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "AKTactivates cell proliferation by inactivating p27 (Fujita et al., 2002) and inhibiting glycogen synthase kinase 3 (GSK3)- mediated Myc and cyclin D1 inhibition (Vivanco and Sawyers, 2002).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Sep 18 27(41) 5527-41",
                "id": "18794886"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e874"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Jul 21 275(29) 21797-800",
                "id": "10823814"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e873"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "FoxO transcription factors suppress Myc-driven lymphomagenesis",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2007 Nov 1 21(21) 2775-87",
                "id": "17974917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e871"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 1998 Jun 15 160(12) 5898-906",
                "id": "9637502"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e86a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In addition, c-myc AS ODN treatment down-regulated expression of Fas mRNA",
              "citation": {
                "type": "PubMed",
                "name": "Arthritis Rheum 1999 May 42(5) 954-62",
                "id": "10323451"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e869"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We demonstrate that SNIP1 functions as an important regulator of c-Myc activity, binding the N terminus of c-Myc through its own C terminus, and that SNIP1 enhances the transcriptional activity of c-Myc both by stabilizing it against proteosomal degradation and by bridging the c-Myc/p300 complex. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2006 Dec 8 24(5) 771-83",
                "id": "17157259"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e863"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Cell Growth Differ 1993 Nov 4(11) 879-83",
                "id": "8297793"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e862"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "from full text - Figure 3. Cells lacking WRN undergo rapid proliferative arrest and senescence upon c-myc overexpression.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jul 1 17(13) 1569-74",
                "id": "12842909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e85e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Fibroblasts",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-Myc represses the transcription of platelet-derived growth factor (PDGF) beta-receptor",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Oct 18 277(42) 39769-76",
                "id": "12167641"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e85a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "HIF1 also directly induces MXI1 (FIG. 1), which competes for and binds MAX, thereby antagonizing MYC function25,46.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Jan 8(1) 51-6",
                "id": "18046334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e857"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of kidney",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 48285-91",
                "id": "11604407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e855"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 Nov 10 95(23) 13887-92",
                "id": "9811896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e854"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-myc(-/-) cells express elevated levels of the Cdk inhibitor p27(Kip1) and reduced levels of Cdk7, the catalytic subunit of Cdk-activating kinase",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Aug 23 277(34) 31263-9",
                "id": "12070150"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e84c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Aug 15 97(17) 9498-503",
                "id": "10920185"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e842"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Therefore, through a combined upregulation of MYC, cyclin D1 and CDC25A, STAT3 induces S-phase progression through E2F activation and upregulation of DNA replication genes (Figure 1).",
              "citation": {
                "type": "PubMed",
                "name": "Trends Mol Med 2007 Jan 13(1) 4-11",
                "id": "17118707"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e83f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Biochemistry 2001 Mar 20 40(11) 3354-62",
                "id": "11258956"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e83b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "It has been reported that during the G1 to S transition of the cell cycle, Skp2 regulates the ubiquitinylation and stability of the transcription factor c-Myc, an oncoprotein that plays a major role in oncogenesis Skp2 enhances c-Myc-induced S phase transition and activates c-Myc transcriptional activity.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2004 Mar 15 23(11) 2037-49",
                "id": "15021891"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e839"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Sep 20(18) 6768-78",
                "id": "10958674"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e835"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In MCF-7 breast cancer cells, the induction of c-myc expression by estrogen was followed by the induction of all the Myc targets that we examined, indicating that those genes can serve as c-Myc targets in human oncogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Jul 16 17(2) 165-71",
                "id": "9674700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e832"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "These data suggest that the reciprocal E-box occupancy by c-Myc and Mad1 is responsible for activation and repression of the hTERT gene in proliferating and differentiated HL60 cells, respectively.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Mar 27 98(7) 3826-31",
                "id": "11274400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e82e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 48276-84",
                "id": "11598121"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e829"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We were able to detect the direct binding and in vivo association between c-Myc and Tiam1",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Feb 14 278(7) 5132-40",
                "id": "12446731"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e827"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1997 Nov 25 94(24) 12886-91",
                "id": "9371770"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e824"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here we provide several lines of evidence that Cdc25A cell cycle phosphatase, a direct transcriptional target for c-Myc, is a substrate for Pim-1 kinase and functions as an effector for Pim-1.  Pim-1 kinase activates the c-Myc-mediated apoptotic signaling through the direct activation of Cdc25A up-regulated by c-Myc.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1999 Jun 25 274(26) 18659-66",
                "id": "10373478"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e823"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1990 Apr 9(4) 1113-21",
                "id": "2182320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e81a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Recent studies have demonstrated that MYC activates all three RNA polymerases (10). In addition to its role as an activator, MYC also has the ability to repress genes (summarized in Fig. S2C) (11).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2006 Nov 17 281(46) 34725-9",
                "id": "16987807"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e818"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Sep 20(18) 6768-78",
                "id": "10958674"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e817"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Myc directly interacts with the hTERT promoter and activates its transcription both in vivo and in vitro.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1999 Sep 24 263(2) 361-5",
                "id": "10491298"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e814"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The failure of p21waf1 induction, despite increased expression of p53 and its binding to p21waf1 promoter, was mediated by the up-regulation of c-Myc, a negative regulator of p21waf1 transcription. Myc has been shown to bind to the p21waf1 promoter to block its activation on DNA damage",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2005 Oct 1 65(19) 8927-35",
                "id": "16204065"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e80c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2002 Aug 22(16) 5793-800",
                "id": "12138190"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e808"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6292-7",
                "id": "11983918"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e806"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The ability of USF to antagonize the transforming potential of c-Myc together with the similar binding preferences of Myc and USF suggest that these factors share a subset of common targets, and indeed, c-Myc and USF bind to some common promoters in vivo",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 26 278(39) 37231-40",
                "id": "12857727"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e803"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We report here that the expression of virtually all proposed c-Myc target genes is unchanged in cells containing a homozygous null deletion of c-myc. Two noteworthy exceptions are the gene cad, which has reduced log phase expression and serum induction in c-myc null cells, and the growth arrest gene gadd45, which is derepressed by c-myc knockout",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1998 Dec 15 12(24) 3797-802",
                "id": "9869632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7fa"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2001 Dec 21 276(51) 48285-91",
                "id": "11604407"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7f5"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2001 Apr 10 98(8) 4510-5",
                "id": "11274368"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ef"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We now show that the cyclin B1 promoter is directly but oppositely regulated by c-Myc and p53. Enforced expression of cyclin B1 also induces tetraploidy, either after mitotic spindle inhibition or in the absence of such inhibition if cyclin B1 is coexpressed with c-Myc. Cyclin B1 represents a new class of c-Myc target genes that is also regulated by p53.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2001 Sep 1 61(17) 6487-93",
                "id": "11522645"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e8"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Carcinogenesis 2001 Dec 22(12) 1965-70",
                "id": "11751426"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We demonstrated that p53-repression of eIF4E was regulated by c-myc. The wt-p53 can physically bind to c-myc, which inhibited binding of c-myc to eIF4E promoter and c-myc-stimulated promoter activity.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2005 Oct 7 335(4) 1272-9",
                "id": "16112647"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7e1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 May 15 14(19) 2301-11",
                "id": "9178906"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7dd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1991 Jan 10(1) 133-41",
                "id": "1989881"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Oct 1 18(19) 5321-33",
                "id": "10508165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7d1"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1998 Apr 29 1397(2) 189-201",
                "id": "9565685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ce"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We also found the collaborative induction of vascular endothelial growth factor (VEGF) by HIF-1 and dysregulated c-Myc.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2007 Nov 27(21) 7381-93",
                "id": "17785433"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7cd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1991 Apr 11(4) 2291-5",
                "id": "2005911"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c8"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "exogenous BAFF and APRIL up-regulate c-Myc, an inducer of cell proliferation; down-regulate p53, an inhibitor of cell proliferation; and increase Bcl-6, an inhibitor of B cell differentiation.",
              "citation": {
                "type": "PubMed",
                "name": "J Immunol 2004 Mar 1 172(5) 3268-79",
                "id": "14978135"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c7"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Array analyses and chromatin immunoprecipitation (ChIp) experiments suggest that several other genes that are repressed by Myc, including p57Kip2 (12) and C/EBP{alpha} (24), are directly repressed by Myc through interaction with Miz1 (V. Beuger and M. Eilers, unpublished observations). # miz1 = zbtb17 # p57KIP2 = CDKN1C # C/EBP{alpha} = CEPBA",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2003 Nov 23(21) 7648-57",
                "id": "14560010"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here we demonstrate that MYC directly stimulates transcription of the human Werner syndrome gene, WRN, which encodes a conserved RecQ helicase ... cell lines from Fig 2B",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jul 1 17(13) 1569-74",
                "id": "12842909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "cyclin-dependent kinase 4 (CDK4) gene as a transcriptional target of c-MYC. c-MYC induced a rapid increase in CDK4 mRNA levels ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Feb 29 97(5) 2229-34",
                "id": "10688915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c2"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1996 Oct 17 13(8) 1659-65",
                "id": "8895511"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7c0"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Mutational inactivation of the Myc p21 activated kinase 2 (PAK2) phosphorylation sites increased Myc activity and further enhanced epidermal differentiation. ",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Mol Med 2010 Jan 2(1) 16-25",
                "id": "20043278"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The Myc/Max heterodimer binds to elements in the cdc25A gene and activates transcription. Like myc, cdc25A, itself a proto-oncogene, can induce apoptosis in cells depleted of growth factor, and Myc-induced apoptosis also requires cdc25A. These findings indicate that cdc25A is a physiologically relevant transcriptional target of c-myc",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1996 Aug 8 382(6591) 511-7",
                "id": "8700224"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b9"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "^ MSSP, c-Myc and Max formed a ternary complex in vivo, although MSSP did not directly associate with Max.",
              "citation": {
                "type": "PubMed",
                "name": "Genes Cells 2000 Feb 5(2) 127-41",
                "id": "10672043"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The results show that multiple p53 target genes are downregulated when c-Myc is present, including p21WAF1, MDM2, PERP, NOXA, GADD45, DDB2, PIR121 and p53R2.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jun 30 24(28) 4559-71",
                "id": "15856024"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7b3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "These results suggest that c-Myc coordinates the activity of all three nuclear RNA polymerases, and thereby plays a key role in regulating ribosome biogenesis and cell growth.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Cell Biol 2005 Mar 7(3) 303-10",
                "id": "15723053"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7af"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1993 Sep 23 365(6444) 359-61",
                "id": "8377829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ae"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Consistent with this model, we also show that Skp2 is a transcriptional coactivator for Myc, recognizing an essential element within the Myc activation domain and activating Myc target genes....The ability of Skp2 to stimulate the transcriptional activity of Myc",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 May 11(5) 1177-88",
                "id": "12769843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7ab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "mimitin (Myc-induced mitochondrial protein), that encodes a mitochondrial protein with a molecular mass of 20 kDa. We demonstrated that the transcription of mimitin is directly stimulated by c-Myc",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 May 20 280(20) 19977-85",
                "id": "15774466"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here we show that the basic regions of Myc and Mad proteins are not functionally equivalent in oncogenesis, have separable E-box-binding activities and engage both common and distinct gene targets",
              "citation": {
                "type": "PubMed",
                "name": "Nat Genet 2000 Feb 24(2) 113-9",
                "id": "10655054"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7a2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2001 Mar 18(3) 541-8",
                "id": "11179484"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e798"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1991 Jan 11(1) 354-62",
                "id": "1670896"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e797"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "cyclin-dependent kinase 4 (CDK4) gene as a transcriptional target of c-MYC. c-MYC induced a rapid increase in CDK4 mRNA levels ",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Feb 29 97(5) 2229-34",
                "id": "10688915"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e796"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The effects of short interfering RNA (siRNA)-mediated downregulation of Id1 were the same as those following downregulation of c-Myc: decreased expression of cyclins D1 and E, reduced phosphorylation of pRb at Ser780 (a site targeted by cyclin D1-Cdk4) and reduced cyclin E-Cdk2 activity",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 Jan 13 24(3) 381-9",
                "id": "15489884"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e795"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1999 Oct 1 18(19) 5321-33",
                "id": "10508165"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e794"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Our results suggest that this activation may involve at least two Myc-dependent steps: the induction of cyclin E gene transcription followed by accumulation of cyclin E mRNA in a protein synthesis-independent manner and the inhibition of p27(Kip1) association with CycE/Cdk2 complexes containing newly synthesised CycE. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 May 22 14(20) 2373-81",
                "id": "9188852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e793"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "3-dimensional Matrigel culture system—has shown that polarity defects accompanying LKB1 inactivation unmask the oncogenic activity of c-Myc (Partanen et al., 2007).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Nov 24 27(55) 6908-19",
                "id": "19029933"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e789"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Epithelial Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1990 Mar 10(3) 1265-9",
                "id": "2406566"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e785"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "both Sp-1 and c-myc up regulate ID2 expression",
              "citation": {
                "type": "PubMed",
                "name": "Am J Physiol Endocrinol Metab 2005 Oct 18",
                "id": "16234270"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e77c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 May 23 278(21) 19286-91",
                "id": "12637527"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e772"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6386-91",
                "id": "11983920"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e76f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Surprisingly, Skp2 enhances c-Myc-induced S phase transition and activates c-Myc target genes in a Myc-dependent manner.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2003 May 11(5) 1189-200",
                "id": "12769844"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e76d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 May 22 387(6631) 422-6",
                "id": "9163430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e76c"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2002 Oct 1 16(19) 2530-43",
                "id": "12368264"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e76b"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Ornithine decarboxylase is a key regulatory enzyme in the biosynthesis of polyamines Sp1 and NF-ODC1, bind to this region in a mutually exclusive manner. ZBP-89, a DNA-binding protein, was identified as a candidate for the protein responsible for NF-ODC1 binding activity. From introduction over-expression of oncogenes such as myc, ras, fos, and mos result in elvated ODC expression",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1998 Aug 7 273(32) 19955-64",
                "id": "9685330"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e766"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "carcinoma"
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nature 312(5991) 280-2",
                "id": "6438521"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e765"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "A recent study suggests another mechanism by which HIF1? inhibits MYC function through binding MAX and thereby displacing MYC4,48.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Jan 8(1) 51-6",
                "id": "18046334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e760"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasm",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2001 Jul 8(1) 105-13",
                "id": "11511364"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e75a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1994 Jun 25 22(12) 2264-73",
                "id": "8036154"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e754"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2000 Jul 6 19(29) 3256-65",
                "id": "10918582"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e751"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1990 May 10(5) 2012-6",
                "id": "2183016"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e750"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Reprod Dev 1997 May 47(1) 57-65",
                "id": "9110315"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e74a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We report here that the expression of virtually all proposed c-Myc target genes is unchanged in cells containing a homozygous null deletion of c-myc. Two noteworthy exceptions are the gene cad, which has reduced log phase expression and serum induction in c-myc null cells, and the growth arrest gene gadd45, which is derepressed by c-myc knockout",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1998 Dec 15 12(24) 3797-802",
                "id": "9869632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e747"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Gene 2002 Jun 12 292(1-2) 91-9",
                "id": "12119103"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e743"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Mutation of a putative c-Myc/USF binding site in the region between -110 and -85 caused a decrease in the promoter activity by 2- to 3-fold.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2001 Mar 9 281(4) 1006-11",
                "id": "11237763"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e73b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "The analysis identified 160 genes, which were induced by twofold or more upon the addition of TGF-beta to control infected cells. ....... A second group of genes (n = 49), including Imo1, was inhibited by expression of both Myc and MycV394D (Fig. 2 A). ",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Biol 2006 Jan 2 172(1) 139-49",
                "id": "16391002"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e73a"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "Keratinocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Nov 15 277(46) 43763-70",
                "id": "12226097"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e739"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Biochim Biophys Acta 1998 Apr 29 1397(2) 189-201",
                "id": "9565685"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e738"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In addition, expression of eIF-4E and eIF-2 alpha was increased in myc-transformed rat embryo fibroblasts but was not increased in ras-transformed cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Jul 1 90(13) 6175-8",
                "id": "8327497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e734"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1993 Sep 23 365(6444) 359-61",
                "id": "8377829"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e72e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Table 1. Myc regulates different sets of genes Genes upregulated by Myc",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 2004 32(18) 5368-78",
                "id": "15477387"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e72d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6404-9",
                "id": "11983921"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e72c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Furthermore, when HL-60 myeloid leukemic cells were differentiated with phorbol ester (TPA), PBK/TOPK protein expression was strongly down-regulated by 24 h. Under these same conditions, phosphorylated c-Myc was rapidly down-regulated (by 4 h), while the levels of cyclin D1 and phosphorylated p38 were constant.",
              "citation": {
                "type": "PubMed",
                "name": "Blood Cells Mol Dis 32(1) 240-5",
                "id": "14757441"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e726"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Table 4. Examples of downregulated genes in skin of transgenic mice treated for 4 days with OHT",
              "citation": {
                "type": "PubMed",
                "name": "Development 2003 Jun 130(12) 2793-808",
                "id": "12736221"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e725"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Myc activation causes epidermal stem celldepletioninvivo",
              "citation": {
                "type": "PubMed",
                "name": "Science 2005 Aug 5 309(5736) 933-5",
                "id": "16081735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e71f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Stem Cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Jun 14(6) 3853-62",
                "id": "8196628"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e71d"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1994 Jun 14(6) 4032-43",
                "id": "8196642"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e718"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "in VHL-deficient renal cell carcinoma cells, HIF-1 can induce a decrease in respiration and mitochondrial biogenesis by negatively regulating c-myc activity and, thereby reducing the expression of the transcriptional coactivator protein PGC-1b, resulting in reduced cellular respiration [39].",
              "citation": {
                "type": "PubMed",
                "name": "Curr Opin Lipidol 2007 Oct 18(5) 508-14",
                "id": "17885420"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e716"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Carcinoma of kidney",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1999 Feb 13(2) 254-67",
                "id": "9973255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e710"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "hetero-dimerization of MAX with other HLH-LZ proteins, such as MAD, Mxi-1 and Mnt, which are antagonists of c-MYC-induced transformation",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2003 Jun 3(3) 163-75",
                "id": "12769686"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e70d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "CBX7 expression cooperated with c-Myc in rendering LNCaP cells insensitive to growth arrest by androgen receptor inhibition.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2005 May 9",
                "id": "15897876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e70b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Figure 1 | The ErbB signalling network.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Mol Cell Biol 2001 Feb 2(2) 127-37",
                "id": "11252954"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e708"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Oct 29 17(17) 2149-54",
                "id": "9811446"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e705"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 May 14 99(10) 6649-54",
                "id": "12011429"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e703"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Our results suggest that this activation may involve at least two Myc-dependent steps: the induction of cyclin E gene transcription followed by accumulation of cyclin E mRNA in a protein synthesis-independent manner and the inhibition of p27(Kip1) association with CycE/Cdk2 complexes containing newly synthesised CycE. ",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1997 May 22 14(20) 2373-81",
                "id": "9188852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e702"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6292-7",
                "id": "11983918"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e701"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Unexpectedly, IRF4 was itself a direct target of MYC transactivation, generating an autoregulatory circuit in myeloma cells. ",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2008 Jul 10 454(7201) 226-31",
                "id": "18568025"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e700"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In primary cultures of lymphoid cells from Em-myc transgenic mice, MYC activation suppresses Bcl-X(L) RNA and protein, and Bcl-X(L) and Bcl-2 expression are inhibited by MYC in precancerous B cells from these mice. That suppression of Bcl-X(L) RNA levels by MYC requires de novo protein synthesis indicates that repression is indirect (Eischen et al., 2001a).",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Oct 27 27(50) 6462-72",
                "id": "18955973"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6fa"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here, we report that c-MYC directly regulates the expression of AP4 via CACGTG motifs in the first intron of the AP4 gene.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2008 Sep 30 105(39) 15046-51",
                "id": "18818310"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1997 Jul 8 94(14) 7227-32",
                "id": "9207073"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f7"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We used oligonucleotide microarray analysis of 6,416 genes and expressed sequence tags to determine changes in gene expression caused by activation of c-MYC in primary human fibroblasts",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Mar 28 97(7) 3260-5",
                "id": "10737792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nature 1997 May 22 387(6631) 422-6",
                "id": "9163430"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "HIF-1alpha displaces the transcriptional activator Myc from Sp1 binding to repress MutSalpha expression in a p53-dependent manner; Sp1 serves as a molecular switch by recruiting HIF-1alpha to the gene promoter under hypoxia. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Mar 18 17(6) 793-803",
                "id": "15780936"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6f0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here we demonstrate that MYC directly stimulates transcription of the human Werner syndrome gene, WRN, which encodes a conserved RecQ helicase ... cell lines from Fig 2B",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2003 Jul 1 17(13) 1569-74",
                "id": "12842909"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6eb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1992 Dec 6(12B) 2513-23",
                "id": "1340466"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e9"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In addition, expression of eIF-4E and eIF-2 alpha was increased in myc-transformed rat embryo fibroblasts but was not increased in ras-transformed cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Jul 1 90(13) 6175-8",
                "id": "8327497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e5"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In MCF-7 breast cancer cells, the induction of c-myc expression by estrogen was followed by the induction of all the Myc targets that we examined, indicating that those genes can serve as c-Myc targets in human oncogenesis",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1998 Jul 16 17(2) 165-71",
                "id": "9674700"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Here, we identify the c-Myc transcription factor as a direct mediator of telomerase activation in primary human fibroblasts through its ability to specifically induce TERT gene expression.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 Feb 4 18(5) 1219-26",
                "id": "10022128"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1990 Apr 9(4) 1113-21",
                "id": "2182320"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 10 97(21) 11198-202",
                "id": "11005843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In support of our previous data, a minimal, functional, 403-nucleotide promoter region of eIF4E was found to contain CACGTG E box repeats, and this core eIF4E promoter was myc responsive in cotransfections with c-myc. A direct role for myc in activating the eIF4E promoter was demonstrated by cotransfections with two dominant negative mutants of c-myc (MycdeltaTAD and MycdeltaBR) which equally suppressed promoter function",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1996 Sep 16(9) 4754-64",
                "id": "8756633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "From GEO data: obvious genes increased after myc induction within 8 hours.  Data needs to be properly analyzed by Bill or Jefferson, which will likely cause inclusion of more genes.  Cutoff used was at least a 1.5X fold change during the 2-8 hour time points with no decrease at 24 hour time point more than 0.8X.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 May 1 66(9) 4591-601",
                "id": "16651409"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6d3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2001 Mar 29 20(14) 1688-702",
                "id": "11313917"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "induction of Myc in density-arrested fibroblasts triggers rapid hyperphosphorylation of the retinoblastoma protein and activation of both cyclin D1- and cyclin E-associated kinase activities in the absence of significant changes in the amounts of cyclin-cdk complexes.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1995 Oct 2 14(19) 4814-26",
                "id": "7588611"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c6"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Clin Exp Metastasis 1997 May 15(3) 228-38",
                "id": "9174124"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2001 Aug 15 15(16) 2069-82",
                "id": "11511539"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6c0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Int J Oncol 2001 Mar 18(3) 541-8",
                "id": "11179484"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b9"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "In addition, expression of eIF-4E and eIF-2 alpha was increased in myc-transformed rat embryo fibroblasts but was not increased in ras-transformed cells.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Jul 1 90(13) 6175-8",
                "id": "8327497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b8"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "c-Myc could repress TMEFF2 gene expression through its cognate site",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Biol 2003 May 16 328(5) 977-83",
                "id": "12729735"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "GeneRif: UBE2L3, the c-myc-regulated gene is involved in genotype-C-HBV-related HCC",
              "citation": {
                "type": "PubMed",
                "name": "J Cancer Res Clin Oncol 2006 Jul 132(7) 473-81",
                "id": "16703398"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "hepatocellular carcinoma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2000 Oct 10 97(21) 11198-202",
                "id": "11005843"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We also determined whether Myc could bind nonconserved canonical E boxes found in the remaining human glycolytic genes. Myc bound PFKM,",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2004 Jul 24(13) 5923-36",
                "id": "15199147"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6b1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "TABLE 1. Genes determined by ChIP to be Myc targets (www.myccancergene.org) and genes up-regulated by Myc in P493-6 cells as determined by microarray analysis",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Jul 25(14) 6225-34",
                "id": "15988031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ac"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Antimicrob Chemother 1975 Mar 1(1) 55-65",
                "id": "1100584"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a7"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nucleic Acids Res 1995 Jan 11 23(1) 1-9",
                "id": "7870572"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6a5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "When MYC is ectopically expressed (mimicking MYC overexpression in human tumours), we found that MYC cooperates with HIF1 to induce the expression of PDK1, hexokinase 2 (HK2, known to be a target of both HIF and MYC) and vascular endothelial growth factor (VEGFA) in human P493 B cells60.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Rev Cancer 2008 Jan 8(1) 51-6",
                "id": "18046334"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e69f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "b-cell",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "We found that MYC induces DNA double-strand breaks (DSBs) independent of ROS production in murine lymphocytes in vivo as well as in normal human foreskin fibroblasts (NHFs)",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2006 Jul 1 66(13) 6598-605",
                "id": "16818632"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e69c"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "lymphocyte",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 35450-9",
                "id": "12091391"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e697"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Reporter assays revealed increased c-MYC transcriptional activity in Pim1-expressing cells and mRNA expression profiling demonstrated that a large fraction of c-MYC target genes were also regulated by Pim1 expression.",
              "citation": {
                "type": "PubMed",
                "name": "BMC Cancer 2010 10 248",
                "id": "20515470"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e68f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1995 May 15(5) 2527-35",
                "id": "7739536"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e68d"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 27 277(39) 36671-7",
                "id": "12149248"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e686"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2002 Apr 30 99(9) 6410-5",
                "id": "11983922"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e685"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Nov 15 60(22) 6318-25",
                "id": "11103792"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e680"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Eur J Biochem 1995 Sep 1 232(2) 397-403",
                "id": "7556187"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e67e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 2000 Sep 1 14(17) 2185-91",
                "id": "10970882"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e676"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Sep 17(9) 5227-35",
                "id": "9271400"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e675"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Genes Dev 1998 Aug 1 12(15) 2424-33",
                "id": "9694806"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e672"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Mol Endocrinol 1999 Feb 13(2) 254-67",
                "id": "9973255"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e66f"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Furthermore, IL-6 up-regulated the expression of MYC via STAT3 phosphorylation and MYC bound to the promoter region of the CEBPA gene followed by the down-regulation of CEBPA expression.",
              "citation": {
                "type": "PubMed",
                "name": "Int J Hematol 2009 Apr 89(3) 310-8",
                "id": "19259613"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e66d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Multiple Myeloma",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 2000 Sep 15 60(18) 5244-53",
                "id": "11016654"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e664"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:MYC) actsIn tscript(p(HGNC:MYC))",
              "summary_text": "Not Available",
              "citation": {
                "type": "PubMed",
                "name": "Nature 2000 Oct 5 407(6804) 592-8",
                "id": "11034201"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e65e"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:RORA)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:RORA))",
        "directed": false,
        "label": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405138e",
          "evidences": [
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "activation of RORalpha, by means of the thiazolidinedione derivative CGP 52608 (the synthetic RORalpha activator), significantly reduces 5-LOX expression",
              "citation": {
                "type": "PubMed",
                "name": "Int J Cancer 2004 Oct 20 112(1) 87-93",
                "id": "15305379"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e80b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "Transient transfection experiments performed with human HepG2 hepatoma cells showed that overproduction of ROR alpha 4 stimulated the activity of the AFP enhancer in a dose-dependent manner, while that of Rev-erb alpha and Rev-erb beta had the opposite effect",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2000 Oct 19(10) 589-99",
                "id": "11058961"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e77b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "Overexpression of RORalpha1 and RORalpha4 also suppressed TNF-alpha-stimulated translocation of p50 and p65 to the nucleus. In contrast, dominant-negative deletion mutants of RORalpha1 and RORalpha4 failed to suppress the induction of VCAM-1 and ICAM-1 and translocations of p50 and p65. These results suggest that RORalpha1 and RORalpha4 regulate the inflammatory responses via inhibition of the nuclear factor-kappaB signaling pathway in endothelial cells.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Jan 16 557(1-3) 269-74",
                "id": "14741380"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "Arterioscler Thromb Vasc Biol 2004 Apr 24(4) 637-43",
                "id": "14751813"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e778"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "To obtain insight into the physiological functions of ROR receptors in liver, we compared the gene expression profiles from livers of WT, ROR{alpha}sg/sg, ROR{gamma}–/–, and DKO mice by microarray analysis. Because ROR{alpha}1 and ROR{gamma}1 expression displayed a circadian rhythmicity, the tissues were collected at CT19, a time at which receptor expression is at its zenith. Differentially expressed genes were considered for further analysis if they were induced or repressed at least 1.5-fold or more in one of the three knockout groups and if their P value was <0.001. ",
              "citation": {
                "type": "PubMed",
                "name": "Physiol Genomics 2007 Oct 22 31(2) 281-94",
                "id": "17666523"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e811"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "We utilize ectopic dominant negative RORalpha expression in skeletal muscle cells to understand the regulatory role of RORs in this major mass peripheral tissue. Exogenous dominant negative RORalpha expression in skeletal muscle cells represses the endogenous levels of RORalpha and -gamma mRNAs and ROR-dependent gene expression. Moreover, we observed attenuated expression of many genes involved in lipid homeostasis.  Furthermore, we show that the muscle carnitine palmitoyltransferase-1 and caveolin-3 promoters are directly regulated by ROR and coactivated by p300 and PGC-1.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2004 Aug 27 279(35) 36828-40",
                "id": "15199055"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7cf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "Retinoid-related receptor alpha (RORalpha) is an orphan nuclear receptor that constitutively activates transcription from its cognate response element. We show that RORalpha is Ca(2+ )responsive, and a Ca(2+)/calmodulin-independent form of Ca(2+)/calmodulin-dependent protein kinase IV (CaMKIV) potentiates RORalpha-dependent transcription 20- to 30-fold.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2000 Feb 15 19(4) 691-701",
                "id": "10675338"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea26"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "title := \\\"In vivo roles of RORalpha and Sp4 in the regulation of murine prosaposin gene.\\\" The deletion of RORE and Sp1/U sites did alter the increase of reporter activity in the brain and eye, but not in the spinal cord, of Sg(-/-) mice. These results indicate that Sp4 and RORalpha play minor and major roles, respectively, in regional expression of the prosaposin locus in the brain, whereas expression in the spinal cord is independent of RORalpha.",
              "citation": {
                "type": "PubMed",
                "name": "DNA Cell Biol 2001 Dec 20(12) 781-9",
                "id": "11879571"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e3"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "# GeneRif: the orphan nuclear receptor RORalpha regulates bidirectionally Bmal1 (positively) and Per1 (negatively) transcriptions simultaneously # Pubmed:gene: Bidirectional role of orphan nuclear receptor RORalpha in clock gene transcriptions demonstrated by a novel reporter assay system.",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 May 7 565(1-3) 122-6",
                "id": "15135064"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea7d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "Moreover, ROR alpha activation resulted in a decreased expression of alpha v beta 3 integrin and an increased level of expression of beta 4 integrin subunit",
              "citation": {
                "type": "PubMed",
                "name": "Oncol Rep 9(5) 1139-43",
                "id": "12168086"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea10"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "RORalpha ectopic expression activated the cAspAT gene transcription in absence of rosiglitazone, and its protein amount in nuclear extracts is 1.8-fold increased by rosiglitazone treatment of adipocytes. ",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2007 Aug 10 282(32) 23591-602",
                "id": "17545671"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ff"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "Adipocytes",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "Our studies revealed that ROR alpha1 and RVR specifically bind to the human and mouse N-myc ROREs and transactivate and transrepress, respectively, reporter constructs containing the ROREs. Moreover, Northern blot analysis demonstrated a direct modulation of an exogenously introduced N-myc gene by ROR alpha1 and RVR in COS-1 cells",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Apr 17(4) 1860-7",
                "id": "9121434"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "An electrophoretic mobility shift assay showed that melatonin stimulates the DNA-binding activity of activator protein-1 (AP-1) as well as retinoid Z receptor/retinoid receptor-related orphan receptor alpha (RZR/RORalpha). ",
              "citation": {
                "type": "PubMed",
                "name": "Free Radic Biol Med 1999 Oct 27(7-8) 838-47",
                "id": "10515588"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9c1"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Endothelium, Vascular"
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "The co-transfection assay suggested that the MZF-1 might regulate the expression of the LIMK2 isoforms in a different manner. The RORalpha1 might also be involved in the transcriptional regulation of the LIMK2b isoform.",
              "citation": {
                "type": "PubMed",
                "name": "Gene 1999 Aug 20 236(2) 259-71",
                "id": "10452946"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e999"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e968"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "Rev-erbbeta is an orphan nuclear receptor that selectively blocks trans-activation mediated by the retinoic acid-related orphan receptor-alpha (RORalpha)",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2005 Mar 11 280(10) 8651-9",
                "id": "15623503"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e951"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Skeletal"
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "The retinoic acid receptor-related orphan receptor alpha (RORa) and REV-ERBa directly regulate the expression of BMAL1 by binding to a specific ROR/REV-ERB response element in the BMAL1 promoter [6]. RORa stimulates BMAL1 whereas REV-ERBa represses transcription. ",
              "citation": {
                "type": "PubMed",
                "name": "PLoS One 2011 6(3) e17290",
                "id": "21479263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e92e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "# Ariadne: RAR alpha, ROR alpha and AP-1 activated the transcription of the murine laminin B1 gene promoter, which consists of three core elements. [Expression]",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 1996 Mar 18 220(2) 405-10",
                "id": "8645318"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e915"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "Modified assertion",
              "citation": {
                "type": "PubMed",
                "name": "J Mol Endocrinol 1999 Dec 23(3) 337-46",
                "id": "10601979"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "title := \\\"Identification of Reverb(alpha) as a novel ROR(alpha) target gene.\\\"",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2002 Sep 20 277(38) 35013-8",
                "id": "12114512"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e834"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "expression of Rev-erbalpha was upregulated by RORalpha1 but that upregulation was attenuated by Rev-erbalpha itself in A7r5 VSMCs. ",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2004 Mar 12 561(1-3) 69-74",
                "id": "15013753"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e813"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "vascular smooth muscle"
              }
            },
            {
              "bel_statement": "p(HGNC:RORA) actsIn tscript(p(HGNC:RORA))",
              "summary_text": "We demonstrated that ROR alpha is expressed in human primary smooth-muscle cells and that ectopic expression of ROR alpha1 inhibits TNFalpha-induced IL-6, IL-8 and COX-2 expression in these cells.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO Rep 2001 Jan 2(1) 42-8",
                "id": "11252722"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e721"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": "Muscle, Smooth"
              }
            }
          ]
        }
      },
      {
        "source": "kin(p(HGNC:ATM))",
        "relation": "directlyIncreases",
        "target": "kin(p(HGNC:CHEK2))",
        "directed": false,
        "label": "kin(p(HGNC:ATM)) directlyIncreases kin(p(HGNC:CHEK2))",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513f9",
          "evidences": [
            {
              "bel_statement": "kin(p(HGNC:ATM)) directlyIncreases kin(p(HGNC:CHEK2))",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9b0"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "hasComponent",
        "target": "p(HGNC:CLOCK)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051412",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e868"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
              "summary_text": "The critical molecular mechanism is thought to involve CLOCK:BMAL1 heterodimers that drive the rhythmic expression of three Period genes (mPer1–3) and two Cryptochrome genes (mCry1 and mCry2). The resulting proteins form PER:CRY complexes that translocate back into the nucleus to inhibit their own transcription, creating a negative feedback loop. ",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8bb"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
              "summary_text": "5-flanking region of the 1.3 kbp mouse PER1 (period homolog 1) gene consists of three E-boxes and a DBP-binding responsive site. 7.7-fold increase in DBP transcriptional activity was observed on cotransfection of HepG2 cells with CLOCK and BMAL1 heterodimers and only a negligible increase was detected when either CLOCK or BMAL1 was examined alone. Mutation of the upstream E-boxes abolished the transcriptional activation by 1.5-fold, while mutation of the downstream E-box resulted in 4.6-fold reduction, suggesting that CLOCK-BMAL1 act through the E-box elements. The data thus indicate that CLOCK-BMAL1 has the ability to regulate DBP transcription through E-boxes.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2000 Jul 20(13) 4773-81",
                "id": "10848603"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea58"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
              "summary_text": "forced expression of Clock/Bmal1 and Clock/Bmal2 markedly increased Dec2 mRNA levels, and up-regulated the transcription of the Dec2 gene through the CACGTG E-boxes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Aug 15 382(Pt 1) 43-50",
                "id": "15147242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e6"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
              "summary_text": "in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1999 Jan 8 96(1) 57-68",
                "id": "9989497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a4"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
              "summary_text": "the promoter regions of per and cry genes are activated by heterodimers of Clock and Bmal1 proteins",
              "citation": {
                "type": "PubMed",
                "name": "J Cell Mol Med 7(4) 408-16",
                "id": "14754509"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e905"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
              "summary_text": "coexpression of both CLOCK and BMAL1 strongly increased the luciferase signal from both human ER beta and mouse ER beta  promoters 11- or 5-fold, respectively suggesting that the CLOCK-BMAL1 heterodimer is involved in the regulation of ERbeta expression. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2008 Jan 28(2) 784-93",
                "id": "18039858"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8f5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) hasComponent p(HGNC:CLOCK)",
              "summary_text": "CRY1 or CRY2 (or both) showed light-independent interactions with CLOCK and BMAL1, as well as with PER1, PER2, and TIM.",
              "citation": {
                "type": "PubMed",
                "name": "Science 1999 Oct 22 286(5440) 768-71",
                "id": "10531061"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8c5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:BHLHE40)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:BHLHE40)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405140c",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:BHLHE40)",
              "summary_text": "Read the section \"Circadian Molecular Oscillators\"\n\n\"... The positive limb of the\ncircadian loop is under the control of BMAL1, CLOCK\nor NPAS2. BMAL1/CLOCK or BMAL1/NPAS2\nheterodimers bind to E-boxes present in the promoter\nof\nPer, Cry,\nRev-erb\nα\n, ROR\nα\n, Dec1 and Dec2\ngenes,\nand activate their transcription...\".\n\nSee table 2.\nBMAL1 is a alias of ARNTL (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:701)\nDEC1 is a alias of BHLHE40 (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:1046)",
              "citation": {
                "type": "Other",
                "name": "Borgs, L., P. Beukelaers, R. Vandenbosch, S. Belachew, L. Nguyen, and B. Malgrange. 2009. \"Cell \"circadian\" cycle: new role for mammalian core clock genes.\" Cell Cycle no. 8 (6):832-7.",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "pirxtrurl",
                "id": "551d2a0c89e36208c81f6328"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:BHLHE40)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa5"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:BHLHE40)",
        "relation": "decreases",
        "target": "p(HGNC:BHLHE41)",
        "directed": false,
        "label": "p(HGNC:BHLHE40) decreases p(HGNC:BHLHE41)",
        "metadata": {
          "casual": false,
          "createdBy": "pirxtrurl",
          "edgeId": "551d317889e36208c82d68d2",
          "evidences": [
            {
              "bel_statement": "p(HGNC:BHLHE40) decreases p(HGNC:BHLHE41)",
              "summary_text": "In Results, read the section \"Effect of Dec1 overexpression on circadian rhythms of clock gene expression\".\n\nSee Figure 2 and Table 1.\n\nDEC1 is a alias of BHLHE40 (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:1046)\nDEC2 is a alias of BHLHE41 (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:16617)",
              "citation": {
                "type": "Other",
                "name": "Nakashima, A., T. Kawamoto, K. K. Honda, T. Ueshima, M. Noshiro, T. Iwata, K. Fujimoto, H. Kubo, S. Honma, N. Yorioka, N. Kohno, and Y. Kato. 2008. \"DEC1 modulates the circadian phase of clock gene expression.\" Mol Cell Biol no. 28 (12):4080-92. doi: 10.1128/mcb.02168-07.",
                "id": "18411297"
              },
              "metadata": {
                "created_by": "pirxtrurl",
                "id": "551d317889e36208c82d67ce"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "Human fibroblast-like cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "tscript(p(HGNC:BHLHE40))",
        "relation": "decreases",
        "target": "p(HGNC:BHLHE40)",
        "directed": false,
        "label": "tscript(p(HGNC:BHLHE40)) decreases p(HGNC:BHLHE40)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513bb",
          "evidences": [
            {
              "bel_statement": "tscript(p(HGNC:BHLHE40)) decreases p(HGNC:BHLHE40)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea00"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "tscript(p(HGNC:BHLHE40)) decreases p(HGNC:BHLHE40)",
              "summary_text": "In Results, read the section \"Effect of Dec1 overexpression on circadian rhythms of clock gene expression\".\n\nSee Figure 2 and Table 1.\n\nDEC1 is a alias of BHLHE40 (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:1046)",
              "citation": {
                "type": "Other",
                "name": "Nakashima, A., T. Kawamoto, K. K. Honda, T. Ueshima, M. Noshiro, T. Iwata, K. Fujimoto, H. Kubo, S. Honma, N. Yorioka, N. Kohno, and Y. Kato. 2008. \"DEC1 modulates the circadian phase of clock gene expression.\" Mol Cell Biol no. 28 (12):4080-92. doi: 10.1128/mcb.02168-07",
                "id": "18411297"
              },
              "metadata": {
                "created_by": "pirxtrurl",
                "id": "551d318889e36208c82d912f"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "human fibroblast-like cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "relation": "increases",
        "target": "p(HGNC:BHLHE41)",
        "directed": false,
        "label": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:BHLHE41)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051414",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:BHLHE41)",
              "summary_text": "This Network edge has no supporting evidence.  Please add real evidence to this edge prior to deleting.",
              "citation": {
                "type": "PubMed",
                "name": "",
                "id": "0"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaa3"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:BHLHE41)",
              "summary_text": "In results, read the section \"Induction of mDec2 mRNA by Clock/Bmal\".\nSee figure 1.",
              "citation": {
                "type": "Other",
                "name": "Hamaguchi, H., K. Fujimoto, T. Kawamoto, M. Noshiro, K. Maemura, N. Takeda, R. Nagai, M. Furukawa, S. Honma, K. Honma, H. Kurihara, and Y. Kato. 2004. \"Expression of the gene for Dec2, a basic helix-loop-helix transcription factor, is regulated by a molecular clock system.\" Biochem J no. 382 (Pt 1):43-50. doi: 10.1042/bj20031760.",
                "id": "15147242"
              },
              "metadata": {
                "created_by": "pirxtrurl",
                "id": "551d35d589e36208c8367ad2"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "endothelial cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL)) increases p(HGNC:BHLHE41)",
              "summary_text": "Read the section \"Circadian Molecular Oscillators\"\n\n\"... The positive limb of the\ncircadian loop is under the control of BMAL1, CLOCK\nor NPAS2. BMAL1/CLOCK or BMAL1/NPAS2\nheterodimers bind to E-boxes present in the promoter\nof\nPer, Cry,\nRev-erb\nα\n, ROR\nα\n, Dec1 and Dec2\ngenes,\nand activate their transcription...\".\n\nSee table 2.\n\nBMAL1 is a alias of ARNTL (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:701)\nDEC2 is a alias of BHLHE41 (http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=HGNC:16617)",
              "citation": {
                "type": "Other",
                "name": "Borgs, L., P. Beukelaers, R. Vandenbosch, S. Belachew, L. Nguyen, and B. Malgrange. 2009. \"Cell \"circadian\" cycle: new role for mammalian core clock genes.\" Cell Cycle no. 8 (6):832-7.",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "pirxtrurl",
                "id": "551d2a8f89e36208c81f67a6"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:SIRT1),p(HGNC:CLOCK))",
        "relation": "hasComponent",
        "target": "p(HGNC:SIRT1)",
        "directed": false,
        "label": "complex(p(HGNC:SIRT1),p(HGNC:CLOCK)) hasComponent p(HGNC:SIRT1)",
        "metadata": {
          "casual": false,
          "createdBy": "edwardsanders",
          "edgeId": "52cd29b5bf21ca0644152530",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:SIRT1),p(HGNC:CLOCK)) hasComponent p(HGNC:SIRT1)",
              "summary_text": "Circadian rhythms govern a large array of metabolic and physiological functions. The central clock protein CLOCK has HAT properties. It directs acetylation of histone H3 and of its dimerization partner BMAL1 at Lys537, an event essential for circadian function. We show that the HDAC activity of the NAD(+)-dependent SIRT1 enzyme is regulated in a circadian manner, correlating with rhythmic acetylation of BMAL1 and H3 Lys9/Lys14 at circadian promoters. SIRT1 associates with CLOCK and is recruited to the CLOCK:BMAL1 chromatin complex at circadian promoters. Genetic ablation of the Sirt1 gene or pharmacological inhibition of SIRT1 activity lead to disturbances in the circadian cycle and in the acetylation of H3 and BMAL1. Finally, using liver-specific SIRT1 mutant mice we show that SIRT1 contributes to circadian control in vivo. We propose that SIRT1 functions as an enzymatic rheostat of circadian function, transducing signals originated by cellular metabolites to the circadian clock.",
              "citation": {
                "type": "Other",
                "name": "nakahata y, kaluzova m, grimaldi b, et al., \"the nad+-dependent deacetylase sirt1 modulates clock-mediated chromatin remodeling and circadian control,\" cell, 2008, 134:329-40.",
                "id": "18662547"
              },
              "metadata": {
                "created_by": "davidgaralf",
                "id": "54e1332289e362035c31a44a"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "jeg-3 human placental choriocarcinoma cells",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:SIRT1),p(HGNC:CLOCK)) hasComponent p(HGNC:SIRT1)",
              "summary_text": "\"CLOCK and SIRT1 appear to be associated at all times of the circadian cycle (Figure 5) suggesting that they would not only coordinately contribute to the dynamic oscillation of histone acetylation but also regulate a number of nonhistonic targets.\" (p. 337)",
              "citation": {
                "type": "Other",
                "name": "Nakahata Y, Kaluzova M, Grimaldi B, et al., \"The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control,\" Cell, 2008, 134:329-40.",
                "id": "18662547"
              },
              "metadata": {
                "created_by": "edwardsanders",
                "id": "52cd29b5bf21ca0644152442"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "JEG-3 human placental choriocarcinoma cells",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\")",
        "relation": "decreases",
        "target": "p(HGNC:ARNTL)",
        "directed": false,
        "label": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases p(HGNC:ARNTL)",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "552d7d4589e36208d4d90e0f",
          "evidences": [
            {
              "bel_statement": "path(MESHD:\"Pulmonary Disease, Chronic Obstructive\") decreases p(HGNC:ARNTL)",
              "summary_text": "The BMAL1 [HGNC:ARNTL] levels were modestly reduced in the smokers and significantly reduced in lungs of the patients with COPD, compared with levels in lungs of the nonsmokers (Fig. 8A, B).",
              "citation": {
                "type": "Other",
                "name": "FASEB J. 2014 Jan;28(1):176-94. doi: 10.1096/fj.13-232629. Epub 2013 Sep 11.\nCircadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway.\nHwang JW1, Sundar IK, Yao H, Sellix MT, Rahman I.",
                "id": "24025728"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "552d7d4589e36208d4d90cf0"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "COPD",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "bp(GOBP:\"circadian behavior\")",
        "relation": "association",
        "target": "p(HGNC:SIRT1)",
        "directed": false,
        "label": "bp(GOBP:\"circadian behavior\") association p(HGNC:SIRT1)",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "552d81c089e36208d4d9397c",
          "evidences": [
            {
              "bel_statement": "bp(GOBP:\"circadian behavior\") association p(HGNC:SIRT1)",
              "summary_text": "To our knowledge, this is the first study showing that SIRT1 is expressed with a circadian rhythm under clock control in lung tissue. Further, we report for the first time that BMAL1 acetylation in the lung in vivo is due to a CS-dependent reduction in SIRT1 levels. There is emerging evidence that circadian rhythms govern proinflammatory cytokine gene expression (41, 44, 50).",
              "citation": {
                "type": "Other",
                "name": "FASEB J. 2014 Jan;28(1):176-94. doi: 10.1096/fj.13-232629. Epub 2013 Sep 11.\nCircadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway.",
                "id": "24025728"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "552d81c089e36208d4d9385c"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "COPD",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:ARNTL)",
        "relation": "association",
        "target": "bp(GOBP:\"circadian behavior\")",
        "directed": false,
        "label": "p(HGNC:ARNTL) association bp(GOBP:\"circadian behavior\")",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "552d779f89e36208d4d873ad",
          "evidences": [
            {
              "bel_statement": "p(HGNC:ARNTL) association bp(GOBP:\"circadian behavior\")",
              "summary_text": "Most of the core clock genes (bmal1 [HGNC:ARNTL], clock, per1, per2, cry1, cry2, rev-erbα, and rev-erbβ) were rhythmically expressed in lung tissue from mice exposed to air or CS, either acutely (10 d; Fig. 1A, B) or chronically (6 mo; Supplemental Fig. S1A, B).",
              "citation": {
                "type": "Other",
                "name": "FASEB J. 2014 Jan;28(1):176-94. doi: 10.1096/fj.13-232629. Epub 2013 Sep 11.\nCircadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway.\nHwang JW1, Sundar IK, Yao H, Sellix MT, Rahman I.",
                "id": "24025728"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "552d779f89e36208d4d87293"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "relation": "decreases",
        "target": "p(HGNC:PER1)",
        "directed": false,
        "label": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:PER1)",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "552d796389e36208d4d88421",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:PER1)",
              "summary_text": "Most of the core clock genes (bmal1, clock, per1, per2, cry1, cry2, rev-erbα, and rev-erbβ) were rhythmically expressed in lung tissue from mice exposed to air or CS, either acutely (10 d; Fig. 1A, B) or chronically (6 mo; Supplemental Fig. S1A, B)....Chronic CS exposure caused a modest reduction in the amplitude of bmal1 and rev-erbα expression and substantially reduced the amplitude of per1 expression in the lungs (Supplemental Fig. S1A, B). Further, CircWave analyses indicated that chronic CS exposure altered the phase of per1 and per2 expression in the lungs (Supplemental Fig. S1B).",
              "citation": {
                "type": "Other",
                "name": "FASEB J. 2014 Jan;28(1):176-94. doi: 10.1096/fj.13-232629. Epub 2013 Sep 11.\nCircadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway.\nHwang JW1, Sundar IK, Yao H, Sellix MT, Rahman I.",
                "id": "24025728"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "552d796389e36208d4d88305"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "relation": "decreases",
        "target": "p(HGNC:PER2)",
        "directed": false,
        "label": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:PER2)",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "552d7a2f89e36208d4d8ac35",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:PER2)",
              "summary_text": "Chronic CS exposure caused a modest reduction in the amplitude of bmal1 and rev-erbα expression and substantially reduced the amplitude of per1 expression in the lungs (Supplemental Fig. S1A, B). Further, CircWave analyses indicated that chronic CS exposure altered the phase of per1 and per2 expression in the lungs (Supplemental Fig. S1B).",
              "citation": {
                "type": "Other",
                "name": "FASEB J. 2014 Jan;28(1):176-94. doi: 10.1096/fj.13-232629. Epub 2013 Sep 11. Circadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway. Hwang JW1, Sundar IK, Yao H, Sellix MT, Rahman I.",
                "id": "24025728"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "552d7a2f89e36208d4d8ab18"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:SIRT1)",
        "relation": "increases",
        "target": "p(HGNC:ARNTL)",
        "directed": false,
        "label": "p(HGNC:SIRT1) increases p(HGNC:ARNTL)",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "552d86d589e36208d4d9d4fb",
          "evidences": [
            {
              "bel_statement": "p(HGNC:SIRT1) increases p(HGNC:ARNTL)",
              "summary_text": "BMAL1 was acetylated and degraded in the lungs of mice exposed to CS and in patients with chronic obstructive pulmonary disease (COPD), compared with lungs of the nonsmoking controls, linking it mechanistically to CS-induced reduction of SIRT1..........CS significantly reduced SIRT1 protein abundance, concomitant with a reduction in BMAL1 levels, and increased acetylation on lysine residue K537 of the remaining BMAL1 protein.",
              "citation": {
                "type": "Other",
                "name": "FASEB J. 2014 Jan;28(1):176-94. doi: 10.1096/fj.13-232629. Epub 2013 Sep 11.\nCircadian clock function is disrupted by environmental tobacco/cigarette smoke, leading to lung inflammation and injury via a SIRT1-BMAL1 pathway.\nHwang JW1, Sundar IK, Yao H, Sellix MT, Rahman I.",
                "id": "24025728"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "552d86d589e36208d4d9d3d9"
              },
              "experiment_context": {
                "species_common_name": "mouse",
                "disease": "cigarette smoke",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "a(SCHEM:\"Smoke, cigarette\")",
        "relation": "decreases",
        "target": "p(HGNC:SIRT1)",
        "directed": false,
        "label": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:SIRT1)",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "552d842389e36208d4d94945",
          "evidences": [
            {
              "bel_statement": "a(SCHEM:\"Smoke, cigarette\") decreases p(HGNC:SIRT1)",
              "summary_text": "Peripheral lungs of smokers and patients with COPD showed decreased levels of nuclear SIRT1, as compared with nonsmokers, associated with its post-translational modifications (formation of nitrotyrosine and aldehyde carbonyl adducts).",
              "citation": {
                "type": "Other",
                "name": "Am J Respir Crit Care Med. 2008 Apr 15;177(8):861-70. doi: 10.1164/rccm.200708-1269OC. Epub 2008 Jan 3.\nSIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease.\nRajendrasozhan S1, Yang SR, Kinnula VL, Rahman I.",
                "id": "18174544"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "552d842389e36208d4d94824"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "COPD",
                "cell": "",
                "tissue": "lung"
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2))",
        "relation": "hasComponent",
        "target": "p(HGNC:ARNTL)",
        "directed": false,
        "label": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:ARNTL)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051401",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "Here we report that the transcription factor NPAS2 (MOP4) is able to functionally substitute for CLOCK in the master brain clock in mice to regulate circadian rhythmicity.",
              "citation": {
                "type": "PubMed",
                "name": "Nat Neurosci 2007 May 10(5) 543-5",
                "id": "17417633"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e892"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e866"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "in vitro; in vivo; Two-hybrid",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1998 May 12 95(10) 5474-9",
                "id": "9576906"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e71c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:ARNTL),p(HGNC:NPAS2)) hasComponent p(HGNC:ARNTL)",
              "summary_text": "from full text - NPAS2/BMAL1 circadian transcription complex repressed c-Myc promoter expression",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Causes Control 2006 May 17(4) 525-30",
                "id": "16596306"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e93b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "deg(p(HGNC:PER2))",
        "relation": "directlyDecreases",
        "target": "p(HGNC:PER2)",
        "directed": false,
        "label": "deg(p(HGNC:PER2)) directlyDecreases p(HGNC:PER2)",
        "metadata": {
          "casual": true,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c34051420",
          "evidences": [
            {
              "bel_statement": "deg(p(HGNC:PER2)) directlyDecreases p(HGNC:PER2)",
              "summary_text": "This b-catenin enhanced PER2 degradation is reversed when b-TrCP is down regulated by siRNA (Fig. 2C).",
              "citation": {
                "type": "PubMed",
                "name": "J Biochem 2009 Mar 145(3) 289-97",
                "id": "19106159"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e955"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "deg(p(HGNC:PER2)) directlyDecreases p(HGNC:PER2)",
              "summary_text": "both hCKIdelta and hCKIepsilon phosphorylated and caused protein instability of human period 2 protein (hPER2)",
              "citation": {
                "type": "PubMed",
                "name": "FEBS Lett 2001 Feb 2 489(2-3) 159-65",
                "id": "11165242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea21"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:CLOCK)",
        "relation": "actsIn",
        "target": "tscript(p(HGNC:CLOCK))",
        "directed": false,
        "label": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c340513d0",
          "evidences": [
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "Forced expression of Clock/Bmal increased endogenous Dec1 mRNA level, and overexpression of Dec1 resulted in suppression of Dec2, Per2, and Dbp expression",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2004 Jan 2 313(1) 117-24",
                "id": "14672706"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6e2"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "At least dbp has been identified as a direct target gene of BMAL1::CLOCK (BMAL1=ARNTL) in a mouse liver model (Oishi et al., 2003Go). ",
              "citation": {
                "type": "PubMed",
                "name": "Toxicol Sci 2006 Oct 93(2) 422-31",
                "id": "16870687"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9ac"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "forced expression of Clock/Bmal1 and Clock/Bmal2 markedly increased Dec2 mRNA levels, and up-regulated the transcription of the Dec2 gene through the CACGTG E-boxes.",
              "citation": {
                "type": "PubMed",
                "name": "Biochem J 2004 Aug 15 382(Pt 1) 43-50",
                "id": "15147242"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e876"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "Overexpression of Clock and CLIF Induce PAI-1 mRNA Expression. CLOCK and CLIF transactivate the PAI-1 promoter through two E-box  sites. (Figure 3D shows that CLOCK by itself, but not CLIF, also induces PAI-1 mRNA expression).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2000 Nov 24 275(47) 36847-51",
                "id": "11018023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea28"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "108 known genes (Fig. 1) and 27 unknown genes (Fig. 2) showed reduced expression levels in Clock mutant mice",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Oct 17 278(42) 41519-27",
                "id": "12865428"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea62"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "Knockdown of Clock expression markedly reduced the expression of Tip60 in two human cancer PC3 and KB cell lines (Fig. 3A).",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2008 Jun 27 283(26) 18218-26",
                "id": "18458078"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7df"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "CLOCK/BMAL1 and CLOCK/BMAL2 enhance DEC2 transcription via CACGTG E-boxes",
              "citation": {
                "type": "PubMed",
                "name": "Int J Mol Med 2006 Jun 17(6) 1053-6",
                "id": "16685415"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9a0"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "Transcription of mBmal1 was activated by CRY1, CRY2, and PER2, and was repressed by BMAL1-CLOCK dimers",
              "citation": {
                "type": "PubMed",
                "name": "Biochem Biophys Res Commun 2002 Jan 25 290(3) 933-41",
                "id": "11798163"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e940"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "Obesity also did not induce PAI-1 mRNA expression in the lungs, but the Clock mutation significantly reduced the mRNA levels in ob/ob mice (Fig. 3B).",
              "citation": {
                "type": "PubMed",
                "name": "J Thromb Haemost 2006 Aug 4(8) 1774-80",
                "id": "16879220"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8bf"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "Using clock reporter genes TNF-alpha is found here to inhibit CLOCK-BMAL1-induced activation of E-box regulatory elements-dependent clock gene promoters.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2007 Jul 31 104(31) 12843-8",
                "id": "17646651"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8a4"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "These data point to up-regulation of Dec1 and Dec2 by Clock in vivo",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Rhythms 2004 Apr 19(2) 126-34",
                "id": "15038852"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e78a"
              },
              "experiment_context": {
                "species_common_name": "Rat",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "Table 2. Genes regulated in the VTA of Clock mutant mice Genes up-regulated in the VTA of Clock mutant mice vs littermate controls",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 2005 Jun 28 102(26) 9377-81",
                "id": "15967985"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e776"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "p(HGNC:CLOCK) actsIn tscript(p(HGNC:CLOCK))",
              "summary_text": "from full text - However, in Clock mutant (Clock/Clock) mice (26), which carry dominantnegative Clock mutations (27), wee1 expression was low at both ZTs",
              "citation": {
                "type": "PubMed",
                "name": "Science 2003 Oct 10 302(5643) 255-9",
                "id": "12934012"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e76e"
              },
              "experiment_context": {
                "species_common_name": "Mouse",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "complex(p(HGNC:CDK1),p(HGNC:CCNB1))",
        "relation": "hasComponent",
        "target": "p(HGNC:CCNB1)",
        "directed": false,
        "label": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
        "metadata": {
          "casual": false,
          "createdBy": "selventa",
          "edgeId": "524b3517d3fbfd4c3405139a",
          "evidences": [
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "Sil downregulation by plasmid-mediated RNA interference limited the ability of cells to activate the spindle checkpoint and correlated with a reduction of Cdc2/cyclin B1 activity and phosphorylation on T161 on the Cdc2 subunit.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 2005 Aug 25(15) 6660-72",
                "id": "16024801"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6bf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "These results were further strengthened by in vitro kinase assays, in which recombinant Cdk1-Cyclin B, but not Cdk2-CyclinA, efficiently phosphorylated 53BP1 (Figure 3B).",
              "citation": {
                "type": "PubMed",
                "name": "PLoS Biol 2010 8(1) e1000287",
                "id": "20126263"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e70c"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "These data support the hypothesis that b-elemene modulated the expression of cyclin A, cyclin B, Chk2, Cdc25C and p27kip1, and the phosphorylation of Cdc2 (Thr-161 or Tyr-15) and CDK2 (Thr-160), and reduced the activities of cyclin B1-Cdc2, cyclin A-Cdc2 and cyclin A-CDK2 complexes which lead to a cell cycle G2-M block in H460 cells.",
              "citation": {
                "type": "PubMed",
                "name": "Cell Mol Life Sci 2005 Apr 62(7-8) 881-93",
                "id": "15868411"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea84"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "In the absence of doxycycline, cyclin B1 was found only in complex with cdk1, and with cdk1 levels replete, there was a 2.3-fold reduction in cyclin B1-dependent kinase activity in cisplatin-treated cells. In contrast, in cdk1-depleted cells, cyclin B1 was found to coimmunoprecipitate with cdk2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2009 Aug 14 35(3) 327-39",
                "id": "19683496"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea61"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "Lung Neoplasms",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "Coimmunoprecipitated cyclin B1/CDK1 and cyclin D1/CDK4 protein complexes decreased after castration and increased after TP treatment of castrated mice.",
              "citation": {
                "type": "PubMed",
                "name": "J Androl 22(4) 537-48",
                "id": "11451350"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e731"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "CCNB1 (CYCB) interacts with CDC2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1993 Apr 15 268(11) 8298-308",
                "id": "8463339"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e6ad"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "TOPK-Thr-9, a cdk1/cyclin B target residue, was specifically phosphorylated during mitotic and meiotic phases, while TOPK-Thr-198, a key amino acid for the ATP pocket, was constantly phosphorylated irrespective of the cell cycle. These data indicate that spermatogenic germ cells with vital proliferation activity express TOPK. As TOPK-Thr-9 was phosphorylated during both mitosis and meiosis, TOPK was indicted to play a role in cytokinesis and/or chromosomal segregation but not in DNA replication.",
              "citation": {
                "type": "PubMed",
                "name": "Dev Growth Differ 2005 Dec 47(9) 637-44",
                "id": "16316408"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eaab"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "The Myt1 protein kinase functions to negatively regulate Cdc2-cyclin B complexes by phosphorylating Cdc2 on threonine 14 and tyrosine 15. Throughout interphase, human Myt1 localizes to the endoplasmic reticulum and Golgi complex, whereas Cdc2-cyclin B1 complexes shuttle between the nucleus and the cytoplasm. Here we report that overproduction of either kinase-active or kinase-inactive forms of Myt1 blocked the nuclear-cytoplasmic shuttling of cyclin B1 and caused cells to delay in the G2 phase of the cell cycle. The COOH-terminal 63 amino acids of Myt1 were identified as a Cdc2-cyclin B1 interaction domain. Myt1 mutants lacking this domain no longer bound cyclin B1 and did not efficiently phosphorylate Cdc2-cyclin B1 complexes in vitro. In addition, cells overproducing mutant forms of Myt1 lacking the interaction domain exhibited normal trafficking of cyclin B1 and unperturbed cell cycle progression. These results suggest that the docking of Cdc2-cyclin B1 complexes to the COOH terminus of Myt1 facilitates the phosphorylation of Cdc2 by Myt1 and that overproduction of Myt1 perturbs cell cycle progression by sequestering Cdc2-cyclin B1 complexes in the cytoplasm.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1999 Jul 19(7) 5113-23",
                "id": "10373560"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea69"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "Fig. (1). Regulation of CDK1 by phosphorylation in the S phase. Cyclin B dimerizes with CDK1, and this complex is phosphorylated by CDK activity (CAK on Threonine161). wee1 and mik1 phosphorylate tyrosine15 and threonine14, which inactivates the complex. The G2/M transition cdc25 phosphatase dephosphorylates tyrosine15 and threonine14, but phosphorylation of threonine161 is retained, resulting in an active CDK1. Upon the completion of M phase, cyclin B is ubiquitinated and targeted for degradation. (reproduced with permission [64])",
              "citation": {
                "type": "PubMed",
                "name": "Curr Cancer Drug Targets 2004 Aug 4(5) 403-24",
                "id": "15320717"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e906"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "A form of rabdomyosarcoma is caused by a translocation between chromosome 2 or chromosome 1 and chromosome 13, which leads to fusion of the PAX7 or PAX3 gene with the forkhead FOXO1 (5, 6). The fusion product turned out to be a stronger activator compared with PAX3 or PAX7, which function as inhibitors of myogenic differentiation of migrating limb myoblasts (7). Blockage of this terminal differentiation pathway by the PAX-FOXO1 fusion product is the direct cause of this disorder. FOXO3a has been demonstrated to play an important part in cell cycle progression of fibroblast cells by regulating expression of the mitotic genes cyclin B and polo-like-kinase.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 2003 Sep 19 278(38) 35959-67",
                "id": "12857750"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8bd"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "CDC2 (CDK1) interacts with CCNB1 (cyclin B1). This interaction was modeled on a demonstrated interaction between monkey CDC2 and human CCNB1.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 1994 Aug 15 13(16) 3772-81",
                "id": "8070405"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405eabf"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "Both kinases CDK1 (complexed with cyclin B1) and PLK1 were able to phosphorylate APC5.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 Dec 15 22(24) 6598-609",
                "id": "14657031"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea9a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "CDC2 interacts with CCNB1 (cyclin B1) to form a complex.",
              "citation": {
                "type": "PubMed",
                "name": "Proc Natl Acad Sci U S A 1993 Apr 15 90(8) 3521-4",
                "id": "8475101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea7b"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "CCNB1 (cyclin B1) interacts with CDC2.",
              "citation": {
                "type": "PubMed",
                "name": "J Biol Chem 1996 May 31 271(22) 13283-91",
                "id": "8662825"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea4d"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "in vitro; in vivo",
              "citation": {
                "type": "PubMed",
                "name": "Cell 1989 Sep 8 58(5) 833-46",
                "id": "2570636"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405ea15"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "CDC2  activation by cyclin B1 was studied in detail and was found to be accompanied by phosphorylation of CDC2 on Threonine 161. ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1992 May 3(5) 571-82",
                "id": "1535244"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e9e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "The phosphorylation of Cdc2 on either Thr 14 or Tyr 15 reduced the histone H1 kinase activity of Cdc2-cyclin B1 complexes approximately 10-fold.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell Biol 1997 Feb 17(2) 571-83",
                "id": "9001210"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e99f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "A single phosphorylated serine corresponding to amino acid 376 was observed only when GRASP65 was treated with Cdk1–cyclin B1 (SII) (Figure 2C).",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2005 Feb 23 24(4) 753-65",
                "id": "15678101"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8e2"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "from full text - Table 2",
              "citation": {
                "type": "PubMed",
                "name": "Cell Cycle 2009 Mar 15 8(6) 832-7",
                "id": "19221497"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e8de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "The cyclin-dependent kinase CDC2 interacts with cyclin B1.",
              "citation": {
                "type": "PubMed",
                "name": "Cancer Res 1998 Mar 15 58(6) 1095-8",
                "id": "9515786"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e861"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "forced expression of FOXO1 causes a delay in the transition from G2 to M phase. This effect is blocked completely by overexpression of CDK1 and cyclin B1.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 2008 Apr 14",
                "id": "18408765"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e836"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "We identify Ser427 and Thr463 as M phase-specific phosphorylation sites and Cdc2-cyclin B as a Thr463 kinase.",
              "citation": {
                "type": "PubMed",
                "name": "EMBO J 2003 May 1 22(9) 2091-103",
                "id": "12727876"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e80a"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "Progression through mitosis occurs because cyclin B/Cdc2 activation induces the anaphase promoting complex (APC) to cause cyclin B destruction and mitotic exit",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2003 Jun 4(6) 813-26",
                "id": "12791267"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e805"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "Cyclin B1 interacts with Cdk1.",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2005 Jul 1 19(1) 135-41",
                "id": "15989971"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e802"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "The mitotic kinases Aurora A/B and Cdk1/Cyclin B phosphorylate GEF-H1, thereby inhibiting GEF-H1 catalytic activity. ",
              "citation": {
                "type": "PubMed",
                "name": "Dev Cell 2007 May 12(5) 699-712",
                "id": "17488622"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7fe"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "<p9> P53 is phosphorylated at Ser315 by CycA:Cdk2 and by CycB:Cdc2",
              "citation": {
                "type": "PubMed",
                "name": "Mol Biol Cell 1999 Aug 10(8) 2703-34",
                "id": "10436023"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e7de"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "This site is phosphorylated by CDK1/cyclin B1 during mitosis ",
              "citation": {
                "type": "PubMed",
                "name": "Mol Cell 2007 Apr 27 26(2) 301-10",
                "id": "17466630"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e72f"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            },
            {
              "bel_statement": "complex(p(HGNC:CDK1),p(HGNC:CCNB1)) hasComponent p(HGNC:CCNB1)",
              "summary_text": "Gadd45 was also able to physically interact with Cdc2, but not Cyclin B1. Addition of Gadd45 to immunoprecipitated Cdc2/Cyclin B1 in vitro led to a dissociation of this complex, and thus may represent a new checkpoint mechanism whereby Cdc2/Cyclin B1 can be inhibited.",
              "citation": {
                "type": "PubMed",
                "name": "Oncogene 1999 May 6 18(18) 2892-900",
                "id": "10362260"
              },
              "metadata": {
                "created_by": "selventa",
                "id": "524b351fd3fbfd4c3405e70e"
              },
              "experiment_context": {
                "species_common_name": "Human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      },
      {
        "source": "p(HGNC:DEC1)",
        "relation": "decreases",
        "target": "complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "directed": false,
        "label": "p(HGNC:DEC1) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
        "metadata": {
          "casual": false,
          "createdBy": "susana.martinez.arbas",
          "edgeId": "553eb7b689e3620a8020839a",
          "evidences": [
            {
              "bel_statement": "p(HGNC:DEC1) decreases complex(p(HGNC:CLOCK),p(HGNC:ARNTL))",
              "summary_text": "We found that the expression of mDec1 mRNA is circadian in the liver (Fig. 3) as well as in the SCN (18)....DEC1 has shown to repress CLOCK/BMAL1-induced transactivation by direct protein-protein interaction and/or competition for E box elements.",
              "citation": {
                "type": "Other",
                "name": "J Biol Chem. 2003 Oct 17;278(42):41519-27. Epub 2003 Jul 15.\nGenome-wide expression analysis of mouse liver reveals CLOCK-regulated circadian output genes.\nOishi K1, Miyazaki K, Kadota K, Kikuno R, Nagase T, Atsumi G, Ohkura N, Azama T, Mesaki M, Yukimasa S, Kobayashi H, Iitaka C, Umehara T, Horikoshi M, Kudo T, Shimizu Y, Yano M, Monden M, Machida K, Matsuda J, Horie S, Todo T, Ishida N.",
                "id": "12865428"
              },
              "metadata": {
                "created_by": "susana.martinez.arbas",
                "id": "553eb7b689e3620a80208276"
              },
              "experiment_context": {
                "species_common_name": "human",
                "disease": "",
                "cell": "",
                "tissue": ""
              }
            }
          ]
        }
      }
    ]
  }
}
